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INTRODUCTION
This paper explores the nature of legal controversies
generated by technological change, using as an example in vitro
fertilization (IVF), first successfully used to produce the birth of
Louise Brown, the world’s first “test tube baby,”1 in 1978. It
* Associate in Law, Columbia Law School 2002-2004. B.Sc. (Hons.),
LL.B., University of New South Wales, LL.M., J.S.D. Candidate, Columbia
Law School. The author would like to thank Professors Harold Edgar, Peter
Strauss, and William Sage of Columbia Law School and Amelia Simpson of the
Australian National University for their useful insights and helpful comments
as well as faculty editors Susan Wolf and Jim Chen for their corrections and
excellent suggestions. Of course, the author bears sole responsibility for any
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grows out of an earlier essay, which classified the ways in
which legal and political institutions are called on to adapt to
technological change, and briefly compared the ability of courts
and legislatures to do so.2 By exploring different legal and
political responses to IVF and related technologies in the
United States, United Kingdom, and Australia and their
consequences, this article aims to evaluate the advantages and
disadvantages of different means of adapting to technological
change.
Parts I and II of this article explore the nature of
technological change and the challenges it poses for law.
General criticisms of the law’s failure to keep up with
technological change arise from four classes of problems: (1)
there may be a perceived need for new laws to ban a technology
or to limit the way in which it is practiced; (2) technological
change may reveal latent ambiguities in the law, creating new
uncertainties; (3) existing rules may be based on explicit or
implicit assumptions about technological feasibility that are no
longer reasonable; and (4) existing rules may be over-inclusive
or under-inclusive with respect to the new technology and
related conduct. This four-way classification facilitates an
understanding of the nature and desirability of legal and
political responses to technological change.
Part III sets out the legal responses to IVF in three
common law countries: the United Kingdom and parts of
Australia and the United States. All three countries have
become leaders in IVF. However, the birth of Louise Brown,
which took place in England after United States government
reluctance to fund IVF research, sparked significant
controversy in each of these jurisdictions. Initially, there were
debates in the media as well as in academia and politics as to
whether IVF was a “good thing” or ought to be banned. In all
three countries, arguments in favor of a ban failed, but residual
concerns remained. Most of those concerns were of the first two
types: first, the possible need for new regulatory laws and
remaining errors.
1. Historically, the term “test tube baby” has sometimes been used to
refer to children conceived with the assistance of artificial insemination and
other non-IVF techniques. This article uses the term in its narrower sense, to
refer to children born following an ex utero fertilization procedure, that is,
fertilization not in vivo (in the body) but in vitro (outside the body, literally “in
glass”).
2. Lyria Bennett Moses, Adapting the Law to Technological Change: A
Comparison of Common Law and Legislation, 26 U.N.S.W.L.J. 394 (2003).
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second, the prevalence of uncertainty in the application of
existing laws. The jurisdictions considered exemplify different
responses to these problems.
Parts V and VI consider and compare these different
responses to arguments for increased regulation and increased
certainty. The strengths and weaknesses of each approach are
analyzed, from the point of view of both the capacity of that
approach to resolve the problem identified and its ability to
withstand ongoing technological change. My conclusion is that
to a large extent, the desirability of using a particular
mechanism not only depends on the circumstances but is also
contestable. However, it is possible to devise a general
framework for considering the desirability of particular
approaches in specific contexts. I apply the general framework
to evaluate the advantages and disadvantages of different
responses to two specific issues—the problem of multifetal
pregnancies resulting from in vitro fertilization and related
techniques, and uncertainty as to the person entitled to
exercise control over frozen embryos.
Our intuition that the law faces problems following the
introduction of a new technology is correct, and is reflected in
metaphors of law struggling to keep up. However, the reflexive
response that legislation is required to facilitate the law’s
adaptation to technological change may be wrong; legislation is
inferior to the alternatives in some circumstances. In some
cases, there may be benefits in adopting a “wait and see”
approach, observing the performance of other mechanisms
prior to implementing a statutory or administrative regime.
Awareness of the benefits of these alternatives is important in
weighing proposals for reform.
I. THE ARRIVAL OF A NEW TECHNOLOGY
A. IN VITRO FERTILIZATION AND OTHER REPRODUCTIVE
TECHNOLOGIES
Few technologies arrive unannounced and few remain
unchanged over time. Technologies are not unaffected by the
shift from new invention to widely used phenomenon. The
development of techniques to facilitate the fertilization of
human eggs or ova is no exception.3 There is thus no single
3. See generally JENNIFER GUNNING & VERONICA ENGLISH, HUMAN IN
VITRO FERTILIZATION: A CASE STUDY IN THE REGULATION OF MEDICAL
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date on which all legal issues associated with IVF blossomed,
but there are some significant points along the way, including
birth of the first IVF baby in 1978, as well as the use of
cryopreserved, or frozen, embryos and donated ova in 1983.4 As
the number of people affected by each of these developments
grew and general awareness of them increased over time,
political, legal, and professional institutions were urged to
respond.
The notion of “test-tube babies” was anticipated in Aldous
Huxley’s Brave New World,5 first published in 1932. At around
the same time, there were reports of successful fertilization of
mammalian eggs in vitro.6 By 1969, the same feat had been
accomplished with human eggs.7 These and similar events
raised questions about the moral and legal status of a human
embryo outside its mother’s body. In fact, one early case in the
United States, Del Zio v. Presbyterian Hospital,8 which
commenced before any human child conceived in vitro had been
born, raised the issue of tort liability for destruction of a human
embryo in vitro.
Despite these early developments and musings, there was
relatively little public awareness of IVF technology or
widespread concern about its implications until Louise Brown,
the world’s first IVF baby, was born in the United Kingdom on
July 25, 1978.9 Her birth was followed by similar achievements
in other countries: Candice Reid was born in Victoria, Australia
INNOVATION 1-12 (1993).
4. See generally Alan Trounson & Linda Mohr, Human Pregnancy
Following Cryopreservation, Thawing and Transfer of an Eight-Cell Embryo,
305 NATURE 707 (1983); Peter Lutjen et al., The Establishment and
Maintenance of Pregnancy Using In Vitro Fertilization and Embryo Donation
in a Patient with Primary Ovarian Failure, 307 NATURE 174 (1984); Alan
Trounson et al., Pregnancy Established in an Infertile Patient After Transfer of
a Donated Embryo Fertilised In Vitro, 286 BR. MED. J. 835 (1983).
5. ALDOUS HUXLEY, BRAVE NEW WORLD (Harper & Row 1969) (1932).
6. Gregory Pincus & E. V. Enzmann, The Comparative Behavior of
Mammalian Eggs In Vivo and In Vitro, 62 J. EXP. MED. 665 (1935); Miriam F.
Menkin & John Rock, In Vitro Fertilization and Cleavage of Human Ovarian
Eggs, 55 AM. J. OBSTETRICS & GYNECOLOGY 440 (1948).
7. R.G. Edwards et al., Early Stages of Fertilization In Vitro of Human
Oocytes Matured In Vitro, 221 NATURE 632 (1969).
8. Del Zio v. Presbyterian Hosp., No. 74 Civ. 3588, 1978 U.S. Dist.
LEXIS 18443 (S.D.N.Y. Apr. 13, 1978) (motion to dismiss denied); Del Zio v.
Presbyterian Hosp., No. 74 Civ. 3588 (CES), 1978 U.S. Dist. LEXIS 14450
(S.D.N.Y. Nov. 14, 1978) (motion to set aside verdict denied).
9. See generally P.C. Steptoe & R.G. Edwards, Birth After the
Reimplantation of a Human Embryo, 2 LANCET 366 (1978).
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in July 1980,10 and Elizabeth Carr was born in Virginia in the
United States in December 1981.11
The IVF technique, in its simplest form, involves hormonal
monitoring and stimulation of the woman producing ova,
harvesting the ova, mixing them with sperm in a petri dish
containing a culture medium, waiting for approximately three
days for embryo development, and then transferring one or
more embryos,12 back to the woman. The precise technique has
varied over time, as IVF practitioners have learned more about
the process of fertilization and have improved their ability to
predict which embryos are most likely to lead to a successful
pregnancy. One variation, for example, is “blastocyst transfer,”
whereby embryos are allowed to develop for a longer period of
time (approximately five days) prior to transfer in an effort to
increase the chances of successful implantation.13
Two other important developments were cryopreservation
of embryos and the use of donated ova.
Embryo
cryopreservation was developed in Australia (with the first live
birth in 1985) and quickly moved to the United States.14
Although the use of donated ova was foreseeable from the first
days of IVF, the first reported case did not come until 1983.15 A
more recent variation of ova donation, cytoplasm transfer, has
In that
been successfully performed in New Jersey.16
10. New South Wales Law Reform Commission, Artificial Conception: In
Vitro Fertilization, Discussion Paper 15 para. 1.14 (1987), available at
http://www.lawlink.nsw.gov.au/lrc.nsf/pages/dp15chp1 (last visited Apr. 6,
2005).
11. Walter Sullivan, Test Tube Baby Born in US, Joining Successes
Around the World, N.Y. TIMES, Dec. 29, 1981, at C1.
12. The term “pre-embryos” has been used to distinguish embryos in the
first 14 days of development. For convenience, the term “embryo” shall be
used throughout to refer to the product of fertilization.
13. See, e.g., Del Marek et al., Introduction of Blastocyst Culture and
Transfer for all Patients in an In Vitro Fertilization Program, 72 FERTILITY &
STERILITY 1035, 1035 (1999).
14. See generally Trounson & Mohr, supra note 4; Alan Trounson,
Preservation of Human Eggs and Embryos, 46 FERTILITY & STERILITY 1
(1986); see also Edward F. Fugger, Clinical Status of Human Embryo
Cryopreservation in the United States of America, 52 FERTILITY & STERILITY
986 (1989); Richard P. Marrs et al., Successful Pregnancies from Cryopreserved
Human Embryos Produced by In Vitro Fertilization, 156 AM. J. OBSTETRICS &
GYNECOLOGY 1503, 1503 (1987); X.J. Wang et al., The Contribution of Embryo
Cryopreservation to In-Vitro Fertilization/Gamete Intra-Fallopian Transfer: 8
Years Experience, 9 HUM. REPROD. 103 (1994).
15. See P. Lutjen et al., supra note 4, at 174, 175.
16. Jacques Cohen et al., Birth of Infant After Transfer of Anucleate Donor
Cytoplasm into Recipient Eggs, 350 LANCET 186, 186-87 (1997).
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technique, the cytoplasm from a donor’s ovum is injected into
the ovum of an infertile woman together with the father’s
sperm.17 It allows an older woman or a woman whose
mitochondria are defective to be the near-genetic mother of her
child, the genetic material in the mitochondria being the
exception. The technique has raised some ethical concerns, and
the Food and Drug Administration has determined that further
use of the technique would require an Investigative New Drug
(IND) application.18
There are also procedures that at some time have served as
alternatives to standard IVF. An embryo can be washed out of
a woman’s uterus before it implants and then transferred to
another woman’s uterus with “embryo flushing.” In Gamete
Intra-Fallopian Transfer (GIFT), ova and sperm are injected
into a woman’s fallopian tube so that fertilization occurs in the
usual place.19 With Zygote Intra-Fallopian Transfer (ZIFT), the
ova and sperm might still meet in vitro but be transferred into
the fallopian tube shortly thereafter.20 The ova’s protective
layer might be perforated to enhance prospects of fertilization
with “Zona Drilling” or “Partial Zona Dissection.”21 Finally,
rather than mixing sperm and ova in vitro, one might inject a
single sperm into an ovum with “Intra-Cytoplasmic Sperm
Injection” (ISCI) or inject a small number of sperm into an
ovum with “Sub-Zonal Insemination” (SUZI).22 Standard IVF
and ISCI are the most commonly used techniques in the United
States.23
17. Jason A. Barritt et al., Cytoplasmic Transfer in Assisted Reproduction,
7 HUM. REPROD. UPDATE 428, 429 (2001).
18. See Denise Grady, Doctors Using Hybrid Egg to Tackle Infertility in
Older Women, N.Y. TIMES, Oct. 10, 1998, at A16; John A. Robertson, Oocyte
Cytoplasm Transfers and the Ethics of Germ-Line Intervention, 26 J.L. MED. &
ETHICS 211, 213 (1998).
19. See Ricardo H. Asch et al., Preliminary Experiences with Gamete
Intrafallopian Transfer (GIFT), 45 FERTILITY & STERILITY 366, 366 (1986).
20. Paul Devroey et al., Zygote Intrafallopian Transfer as a Successful
Treatment for Unexplained Infertility, 52 FERTILITY & STERILITY 246, 246-47
(1989).
21. Jacques Cohen et al., Implantation Enhancement by Selective Assisted
Hatching Using Zona Drilling of Human Embryos with Poor Prognosis, 7
HUM. REPROD. 685, 685 (1992).
22. Gianpiero Palermo et al., Pregnancies After Intracytoplasmic Injection
of Single Spermatozoon into an Oocyte, 340 LANCET 17, 17-18 (1992); see also
Christopher J. De Jonge & Jessica Pierce, Intracytoplasmic Sperm Injection-What Kind of Reproduction Is Being Assisted?, 10 HUM. REPROD. 2518, 2518
(1995) (discussing risks and ethical concerns).
23. See CENTERS FOR DISEASE CONTROL AND PREVENTION, 2002 ASSISTED
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All these techniques aim to facilitate of fertilization of
human gametes in order to enable pregnancy. Such techniques
will be referred to generally here as “reproductive
technologies,” “assisted reproductive technologies,” or “ARTs.”
There are other, more controversial, techniques that are often
associated with these technologies. For example, embryos may
be destroyed in order to create embryonic stem cells, and
animals can be cloned, bypassing the need for fertilization of
gametes. The current debate revolves largely around the ethics
of proceeding to create embryonic stem cells or cloned embryos
at all, or with public funding. Although technological change is
continuous rather than discrete, so that any line drawn is
necessarily arbitrary, this paper focuses on reproductive
techniques that are or have been generally practiced in the
United States, United Kingdom, and Australia.
B. THE NATURE OF TECHNOLOGICAL CHANGE
The introduction of IVF and the development of related
techniques are examples of technological change. There is no
single accepted definition of technology, and much depends on
context. A focus on the consequences of technology might lead
one to adopt a definition such as: “Technology consists of those
material objects, techniques and knowledge that allow human
beings to transform and control the inanimate world.”24 A
broader definition would include control of the animate world,
such as: “man’s use of devices or systematic patterns of thought
and activity to control physical phenomena in order to serve his
desires with a minimum of effort and a maximum of
efficiency.”25 Both definitions stress the power of technology to
effect human control. On the other hand, an account of the
historical development of technology might describe
technological change as a process of knowledge change,
increasing the ability or potential of a people or society to solve
problems.26
While these and similar definitions are useful in the
contexts in which they are employed, they do not explain why
REPRODUCTIVE TECHNOLOGY SUCCESS RATES: NATIONAL SUMMARY AND
FERTILITY CLINIC REPORTS 1-2 (2004).
24. RON WESTRUM, TECHNOLOGIES AND SOCIETY: THE SHAPING OF
PEOPLE AND THINGS 7 (1991).
25. RALPH PARKMAN, THE CYBERNETIC SOCIETY 3 (1972).
26. See GOVINDAN PARAYIL, CONCEPTUALIZING TECHNOLOGICAL CHANGE:
THEORETICAL AND EMPIRICAL EXPLORATIONS 9, 146 (1999).

BENNETT_MOSES_4-24-05

2005]

7/11/2006 6:41:19 PM

RESPONSES TO TECHNOLOGICAL CHANGE

513

technological change has captivated and troubled legal
scholars. When legal scholars discuss legal issues arising out of
a new technology, they are rarely concerned with regulation of
knowledge or problem-solving per se, and only sometimes
concerned with technology’s effects on the natural world.
Rather, they generally wish to describe what legal
consequences do and ought to flow from certain conduct, in this
case, conduct related to the new technology.
The focus on conduct is not surprising given the models
commonly employed for understanding the nature of law. Hans
Kelsen described a legal order as a system of norms, where a
norm is the meaning of an act by which a certain behavior is
commanded, permitted or authorized.27 For H.L.A. Hart,
primary rules require people to do or abstain from doing certain
actions.28 Within these models, technological change increases
the range of actions that can practically be carried out by
people living at a particular time. In vitro fertilization leading
to the birth of a child has been theoretically possible since the
dawn of man. But it was not proved to be a practical possibility
until 1978, and was probably not even contemplated as a
possibility before the twentieth century. In other words, before
1978 (or perhaps slightly earlier), laws regulating the practice
of IVF would have made as little sense as traffic rules for
passenger cars that can move vertically would today. If IVF
had remained a single isolated event, as some had initially
thought it would,29 legal reform would have been similarly
perceived as unnecessary.30 However, after the technology
became more widely employed, the perceived need for a legal
response increased. Thus, for current purposes at least, one
can think of technological change as the invention, adoption,
and diffusion of a new product or process that makes
practicable new forms of conduct.31
27. HANS KELSEN, PURE THEORY OF LAW 4-5 (Max Knight ed., 1967).
28. H.L.A. HART, THE CONCEPT OF LAW 81 (1961).
29. Seth Mydans, N.Y. TIMES ABSTRACTS, Aug. 11, 1978, at 76 (quoting
Soviet physician, Dr. Leonid Persianinov).
30. It has often been observed that, unless taken up, invention has little
social impact. See, e.g., Knut H. Sørensen, Social Shaping on the Move? On
the Policy Relevance of the Social Shaping of Technology Perspective, in
SHAPING TECHNOLOGY, GUIDING POLICY 19, 23 (Knut H. Sørensen & Robin
Williams eds., 2002).
31. There are no clear boundaries between technological and other types
of change. For example, the discovery that conduct is safer or more pleasant
than previously thought increases the probability that people will engage in
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C. IN VITRO FERTILIZATION AS AN EXAMPLE OF TECHNOLOGICAL
CHANGE
In order to understand how a technology makes possible
many new forms of conduct, consider the example of IVF. By
making possible the fertilization of a human ovum outside the
body of the mother, IVF technology led to several new
activities:
(i) It allowed some otherwise infertile couples to bear and
raise a genetically related child.
(ii) It created a new field of activity, providing IVF
services, that could potentially be carried out by people with
different ranges of knowledge, skill and experience, exercising
different degrees of care.
(iii) By moving an existing entity (the embryo) to a new
location, it created the possibility of new tests and
manipulations. It also increased the ease with which an
embryo may be destroyed. It can also, of course, be transferred
to the uterus of a woman.
Taking into account techniques associated with IVF:
(iv) Fertile people may now use IVF, for example to avoid
birth of a child affected by a genetic anomaly of concern.
(v) Embryos may be cryopreserved and stored for an
arbitrary period of time. A cryopreserved embryo can be tested,
manipulated, or destroyed. It can also be thawed and either
transferred to the uterus of a woman, allowed to perish, or used
in research.
(vi) The woman gestating a child need not be its genetic
mother. A woman may undergo ovarian stimulation and have
her ova removed so that another woman may become pregnant.
Contracts related to this transaction may be entered into
(characterizing it as ova donation or surrogacy). Such contracts
have the potential to lead to increased commercialization of
reproduction.
(vii) Children genetically the product of one generation
may be born into a different generation.
(viii) Because a woman’s uterus remains receptive to a
pregnancy after menopause, post-menopausal women can
become gestational mothers using ova provided by a younger
woman.
that conduct. At the extreme, it might be said that the conduct was not really
practicable before the discovery (perhaps because people thought it would kill
them).
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(ix) More than one embryo can be transferred into the
uterus of a woman at the same time.
Each of these new activities can be commanded, prohibited,
restricted, or authorized by law. They can also be encouraged
or discouraged through education, government funding,
taxation and the potential for civil suits. As each of these new
forms of conduct became possible, and came to the attention of
scholars and decision-makers, it made sense to talk about
deducing or altering their legal consequences. In addition,
because ART services can be advertised as well as covered or
denied coverage under health insurance contracts, questions
specific to ART might arise in other areas of law as well.32
II. NEW TECHNOLOGIES AND CRITICISM OF LAW
A. THE NATURE OF CRITICISM
Scholars examining legal issues posed by technological
change such as IVF are often critical of the law. The law is
frequently accused of containing gaps,33 of being slow or
outpaced34 and thus lagging behind technology,35 and of
32. See, e.g., Kinzie v. Physician’s Liab. Ins. Co., 750 P.2d 1140, 1142-43 (Okla.
1987) (insurance); Egert v. Conn. Gen. Life Ins. Co., 900 F.2d 1032, 1036-38 (7th Cir.
1990) (insurance); Karlin v. IVF Am., Inc., 93 N.Y.2d 282, 293 (N.Y. 1999) (advertising).
33. E.g., Laura A. Brill, When Will the Law Catch Up with Technology?
Jaycee B. v. Superior Court of Orange County: An Urgent Cry for Legislation
on Gestational Surrogacy, 39 CATHOLIC L. 241, 268 (1999) (“Paradoxically,
absent fully encompassing legislation, and with a body of case law that leaves
gaps with respect to key issues, the very methods that can create a family can
also destroy it.”); Richard F. Storrow, Parenthood by Pure Intention: Assisted
Reproduction and the Functional Approach to Parenthood, 53 HASTINGS L.J.
597, 601 (2002) (“Moreover, very few contests between genetic, gestational and
intending mothers have been resolved in the courts, leaving gaps in the law
that render unclear the outcome of potential future disputes.”).
34. James E. Bailey, An Analytical Framework for Resolving the Issues
Raised by the Interaction Between Reproductive Technology and the Law of
Inheritance, 47 DEPAUL L. REV. 743, 814 (1998) (“the source of the legal
conundrums discussed here is the inherent inability of law to maintain pace
with technologically-driven social change.”); Kathryn Venturatos Lorio,
Alternative Means of Reproduction: Virgin Territory for Legislation, 44 LA. L.
REV. 1641, 1641 (1984) (“[M]edical advances have outpaced the ability of
society to accommodate those advances.”); Lynne M. Thomas, Comment,
Abandoned Frozen Embryos and Texas Law of Abandoned Personal Property:
Should There Be a Connection, 29 ST. MARY'S L.J. 255, 259 (1997) (“The law,
however, generally develops at a much slower pace than technology.”); David
M. Vukadinovich, Assisted Reproductive Technology Law: Obtaining Informed
Consent for the Commercial Cryopreservation of Embryos, 21 J. LEGAL MED.
67, 67 (2000) (“Unlike the leaps that technology has taken, the law and public
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needing to respond to new technologies36 and address new
Even when the law is not directly criticized,
issues.37
technology is seen as challenging law.38 When law is praised, it
is for responding speedily.39 These metaphors conjure images
of technology racing ahead of, and perhaps overwhelming, a
policy have been slower to advance.”).
35. Mount Isa Mines Ltd. v. Pusey (1970) 125 C.L.R. 383, 395 (per
Windeyer, J.) (“Law, marching with medicine but in the rear and limping a
little”); Michael Kirby, Medical Technology and New Frontiers of Family Law,
1 AUST. J. FAM. L. 196, 212 (1987) (“The hare of science and technology lurches
ahead. The tortoise of the law ambles slowly behind.”); Joseph J. Saltarelli,
Note, Genesis Retold: Legal Issues Raised by the Cryopreservation of
Preimplantation Human Embryos, 36 SYRACUSE L. REV. 1021, 1021 (1985)
(“In recent years, dramatic advances have been made in the technology of
artificial human reproduction, giving rise to a variety of moral, ethical, and
legal issues. The law has, however, constantly lagged far behind science in the
formulation of workable responses to such breakthroughs.”). Note also the
title of Weldon E. Havins & James J. Dalessio, The Ever-Widening Gap
Between the Science of Artificial Reproductive Technology and the Laws Which
Govern That Technology, 48 DEPAUL L. REV. 825 (1999).
36. Patricia A. Martin & Martin L. Lagod, The Human Preembryo, the
Progenitors, and the State: Toward a Dynamic Theory of Status, Rights and
Research Policy, 5 HIGH TECH. L.J. 257, 261 (1990) (“our legal institutions
must respond to the challenge of IVF technology”); see also Sheila A. M.
McLean, Some Legal Aspects of Modern Reproductive Technology, in TOUGH
CHOICES: IN VITRO FERTILIZATION AND THE REPRODUCTIVE TECHNOLOGIES
147, 147 (Patricia Stephenson & Marsden G. Wagner eds., 1993).
37. Sharon M. Steeves, Comment, Artificial Human Reproduction: Legal
Problems Presented by the Test Tube Baby, 28 EMORY L.J. 1045, 1046-47
(1979) (“Neither common law principles nor statutory enactments in the
majority of states address the legal issues presented by artificial reproductive
technology.”).
38. Robert S. Summers, Law, Technology and Values, in LAW, LIFE AND
THE IMAGES OF MAN: MODES OF THOUGHT IN MODERN LEGAL THEORY 65, 66
(Frank Fleerackers et al. eds., 1996) (“Nearly all technological developments
pose challenges for law and government.”); Colleen M. Browne & Brian J.
Hynes, Note, The Legal Status of Frozen Embryos: Analysis and Proposed
Guidelines for a Uniform Law, 17 J. LEGIS. 97, 97 (1990) (“These dynamic
medical advancements [IVF and cryopreservation] have challenged the legal
community to keep reins on practices affecting embryos.”); M. Karen
McCartan, A Survey of the Legal, Ethical, and Public Policy Considerations of
In Vitro Fertilization, 2 NOTRE DAME J.L. ETHICS & PUB. POL’Y 695, 695
(1986) (“A rapidly advancing technological civilization challenges a legal
system which historically has responded to existing problems and seldom has
anticipated them.”).
39. Michael D.A. Freeman, Responding to the Reproductive Revolution:
Law Reform – Dilemmas and Difficulties, in LAW REFORM AND HUMAN
REPRODUCTION 3, 3 (Sheila A.M. McLean ed., 1992) (“The law, both in its
legislative and judicial forms, has, in most relevant countries, responded with
some rapidity and vigour to the new territory explored by the exponents of
assisted conception.”).

BENNETT_MOSES_4-24-05

2005]

7/11/2006 6:41:19 PM

RESPONSES TO TECHNOLOGICAL CHANGE

517

legal system trapped in the past. As technologies move more
rapidly from invention to widespread application,40 so too does
the speed with which the law must move.
It is easy to understand the frustration with the law felt by
these authors. On occasion, it can seem as if some laws were
designed for an older world and now outmoded technology.41
Several types of criticisms of the law can be found in the
literature on IVF, namely, that law is uncertain, normatively
undesirable, or nonexistent. Critics argue, at least in certain
cases, that technological change creates reasons to change the
law. Then authors take the failure to make the sorts of
changes suggested by them promptly as a sign that the law is
outpaced by or has failed to respond to technological change.
The proposals for change can be grouped into the following
categories (although a single author may propose more than
one):
(i) New rules. We need to regulate certain new forms of
conduct and new, specially tailored, laws are required to do
this. In some cases, it may even be appropriate to ban a
particular technology or particular applications of that
technology.
(ii) Uncertainty. The law is uncertain as it applies to new
forms of conduct. In other words, it is not clear whether such
conduct is commanded, prohibited, or authorized. Existing
rules need to be clarified.
(iii) Scope of rules. Existing rules were not formulated
with new technologies in mind. Thus, some rules in their
current form inappropriately include or exclude new forms of
conduct.
(iv) Justification for rules. Some existing rules are
explicitly or implicitly based on a premise that no longer exists,
and are thus no longer justified.
The list does not include criticisms that are not related to
technological change. It is possible (and common) to criticize
legislatures for enacting a faulty law, a judge for
misinterpreting the law or for lacking expertise,42 or to blame
existing rules for contributing to social problems.
Such
40. RICHARD C. DORF, TECHNOLOGY, SOCIETY AND MAN 14 (1974).
41. See Monroe E. Price, The Newness of New Technology, 22 CARDOZO L.
REV. 1885, 1888 (2001).
42. On the latter, see generally Mark Mansour et al., Regulating
Biotechnology: Science, Ethics, Law and Governance Meet Head On in the Age
of Informed Ignorance, 21 TEMP. ENVTL. L. & TECH. J. 93, 94 (2003).
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criticisms are, however, ongoing and are not affected by the
introduction or diffusion of a new technology. Technological
change is neither a sufficient nor necessary condition for the
existence of uncertain, ineffective, and bad laws; yet it is often
the occasion for them. In these cases, one might sensibly use
concepts such as “catching up,” “responding,” and “adapting” to
describe the process by which problems arising as a result of
technological change are resolved.
B. LIMITING LEGAL RESPONSES
Sometimes there will be limits on the nature of legal
changes that might otherwise take place in response to
technological change. For example, a law that might otherwise
be thought beneficial could be unconstitutional.
Even
unenforceable higher norms, such as those found in
international law, can play an important role in political
argument and legal discourse. In the context of reproductive
technologies, both actual and hypothetical laws have been
challenged on the grounds that they restrict procreative liberty,
an alleged constitutional or international law right.
1. International Law
There is no enforceable principle of international law that
would prevent a state from prohibiting or restricting the
practice of IVF or related technologies. However, reproductive
rights have been recognized internationally since the 1948
In
Universal Declaration of Human Rights (UDHR).43
particular, Article 16 provides for the right to marry and found
a family “without any limitation due to race, nationality or
religion” and states that the family is the natural and
fundamental group unit of society and is entitled to protection
by society and the state.44 These rights and recognitions are
repeated in Article 23 of the International Covenant on Civil
and Political Rights.45 It is unclear whether these provisions,
even if enforceable, would do more than prevent a state from
interfering with a person’s natural coital capacity to
43. Universal Declaration of Human Rights, G.A. Res. 217A, U.N. GAOR,
3d Sess., Supp. No. 3, U.N. Doc. A/810 (1948).
44. Id.
45. International Covenant on Civil and Political Rights, G.A. Res. 2200A
(XXI), 21 U.N. GAOR Supp. (No. 16) at 52, U.N. Doc. A/6316 (1966) (The
United States, the United Kingdom, and Australia are all parties to this
Covenant).
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reproduce.46 Certainly, they do not require the government to
assist the infertile with ART.47 Even if these provisions apply
to the infertile, they may only apply to infertile people who are
married.48
2. European Law
The European Convention for the Protection of Human
Rights and Fundamental Freedoms49 is, through the Human
Rights Act 1998 (U.K.), part of the law of the United Kingdom.
Article 12 of the Convention is similar to Article 16 of the
UDHR, providing a right to marry and found a family; as such,
its scope is subject to similar comments.50
Article 8 of the Convention may also be relevant to those
advocating for reproductive rights. It provides that “[e]veryone
has the right to respect for his private and family life, his home
and his correspondence” and that no public authority can
interfere with this right except:
such as is in accordance with the law and is necessary in a democratic
society in the interests of national security, public safety or the
economic well-being of the country, for the prevention of disorder or
crime, for the protection of health or morals, or for the protection of
the rights and freedoms of others.51

The broad nature of the exception, in particular the reference to
protection of morals, may limit the usefulness of this Article for
those seeking to promote reproductive liberty.
3. United States Constitution
The Due Process Clause of the Fourteenth Amendment of
the United States Constitution52 has been held to protect
certain fundamental rights, including rights related to freedom
of choice in matters relating to marriage and family life.53
46. See McLean, supra note 36, at 147, 151.
47. Bernard M. Dickens, Reproduction Law and Medical Consent, 35 U.
TORONTO L.J. 255, 256 (1985).
48. See John Murphy, Public Representation and the Legal Regulation of
Assisted Conception in Britain, in NATURE RISK AND RESPONSIBILITY 117, 119
(Patrick O’Mahoney ed., 1999).
49. European Convention for the Protection of Human Rights and
Fundamental Freedoms, Nov. 4, 1950, ETS No. 155, 213 U.N.T.S. 221.
50. Id. art. 12.
51. Id. art. 8.
52. U.S. CONST. amend. XIV, § 1.
53. Griswold v. Connecticut, 381 U.S. 479, 485-86 (1965) (freedom to use
of contraception within marital relationship); Eisenstadt v. Baird, 405 U.S.
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Laws that prohibit or otherwise restrict IVF might be
unconstitutional if a right to non-coital reproduction were held
to be fundamental.54 No Supreme Court case deals directly
with this question, but there are some indications that such a
right could be found to exist.
The main case cited to support a right to reproduce, as
opposed to a right to avoid reproduction, is Skinner v.
In that case, a state statute provided for
Oklahoma.55
mandatory sterilization of criminals who had been convicted
three or more times for particular crimes.56 The statute was
struck down, but on equal protection grounds.57 However,
advocates of reproductive rights might point to the language of
Justice Douglas’s opinion, which described the right to marry
and procreate as “fundamental to the very existence and
survival of the race.”58 Similar statements include the Court’s
comment in Meyer v. Nebraska,59 that the liberty guaranteed by
the Fourteenth Amendment included “the right of an individual
. . . to marry, establish a home and bring up children,”60 and its
observation in Stanley v. Illinois61 that “[t]he rights to conceive
438, 453 (1972) (freedom to use of contraception by unmarried couples); Carey
v. Population Servs. Int’l, 431 U.S. 678, 685 (1977) (freedom to use
contraception); Roe v. Wade, 410 U.S. 113, 153 (1973) (woman’s freedom to
choose to terminate a pregnancy); Planned Parenthood v. Casey, 505 U.S. 833,
846 (1992) (woman’s freedom to choose to terminate a pregnancy prior to
viability); Loving v. Virginia, 388 U.S. 1, 12 (1967) (freedom to marry a person
of another race); Pierce v. Soc’y of Sisters, 268 U.S. 510, 534-35 (freedom to
direct the upbringing and education of children); Lawrence v. Texas, 539 U.S.
558, 578 (2003) (freedom to engage in consensual adult sodomy); see also
Prince v. Massachusetts, 321 U.S. 158 (1944); Skinner v. Oklahoma, 316 U.S.
535 (1942).
54. Professor John Robertson is a leading proponent of this view. See, e.g.,
JOHN A. ROBERTSON, CHILDREN OF CHOICE (1994); John A. Robertson,
Procreative Liberty and the Control of Conception, Pregnancy and Childbirth,
69 VA. L. REV. 405 (1983) [hereinafter Robertson, Procreative Liberty]; John A.
Robertson, Decisional Authority over Embryos and Control of IVF Technology,
28 JURIMETRICS J. 285 (1988) [hereinafter Robertson, Decisional Authority];
John A. Robertson, Procreative Liberty and Harm to Offspring in Assisted
Reproduction, 30 AM. J. L. & MED. 7, 20 (2004).
55. 316 U.S. 535 (1942).
56. Id. at 536-37.
57. Id. at 538. Chief Justice Stone concurred in the result, but did not
agree that the equal protection clause was the appropriate rationale. Id. at
543-44.
58. Id. at 541.
59. 262 U.S. 390 (1923) (case concerned right of parents to control the
education of their children).
60. Id. at 399.
61. 405 U.S. 645 (1972).
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and raise one’s children have been deemed ‘essential,’ ‘basic
civil rights of man,’ and ‘rights far more precious . . . than
property rights.’”62 One can also point to comments in some of
the Court’s cases involving the right not to reproduce.63
Some lower courts have dealt with the issue of a right to
use ARTs more directly.
Federal district courts have
recognized the right to submit to medical procedures that may
bring about pregnancy, such as artificial insemination64 and
embryo transfer.65
Although there is no Supreme Court precedent precisely on
point, it seems likely that the Court would classify the right to
use IVF as fundamental. If this is correct, then laws that
prohibit or severely restrict the use of IVF would be
unconstitutional.
Even if the Constitution protects the right of couples to use
technologies such as IVF to have children, that right would not
be absolute. It could be overridden by a compelling government
interest.66 The Court has recognized a government interest in
preservation of a fetus’ potential life and protection of maternal
health.67 In the context of abortion, the Supreme Court has
stated that regulation that does not pose an undue burden on
the protected right is permitted.68 Thus a state could probably
mandate distribution of literature regarding the risks of IVF
62. Id. at 651 (internal citations omitted) (case concerned right to raise
children).
63. See Eisenstadt v. Baird, 405 U.S. 438, 453 (1972) (referring to “the
right of the individual, married or single, to be free from unwarranted
governmental intrusion into matters so fundamentally affecting a person as
the decision whether to bear or beget a child.”); Planned Parenthood v. Casey,
505 U.S. 833, 851 (1992) (“These matters [including the decision whether to
bear or beget a child], involving the most intimate and personal choices a
person may make in a lifetime, choices central to personal dignity and
autonomy, are central to the liberty protected by the Fourteenth
Amendment.”); Carey v. Population Servs. Int’l, 431 U.S. 678, 685 (1977)
(referring to the right of an individual “without unjustified government
interference” to make “personal decisions relating to marriage . . . procreation .
. . contraception . . . family relationships . . . and child rearing and education”
and declared that “the decision whether or not to beget or bear a child is at the
very heart of this cluster of constitutionally protected choices.”).
64. Cameron v. Bd. of Educ., 795 F. Supp. 228, 237 (S.D. Ohio 1991).
65. Lifchez v. Hartigan, 735 F. Supp. 1361, 1376-77 (N.D. Ill. 1990).
66. See, e.g., Shapiro v. Thompson, 394 U.S. 618, 634 (1969); Roe v. Wade,
410 U.S. 113, 155-56 (1973).
67. Roe v. Wade, 410 U.S. 113, 162-63 (1973); Planned Parenthood v.
Casey, 505 U.S. at 871, 878.
68. See, e.g., Planned Parenthood v. Casey, 505 U.S. at 874-79.
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generally or particular practices such as the transfer of high
numbers of embryos, discussed infra in Part V.C. Further,
while the government might be compelled to allow ARTs, it
would not be required to provide funding for such artificial
reproductive technologies.69
C. REASONS TO BAN IVF OR RELATED TECHNOLOGIES
One reason why the law might be accused of falling behind
technology is that bans are either not being imposed, or are not
being imposed quickly enough. For example, one author, in the
course of criticizing state governments for failing to restrict
certain ART practices, writes, “[W]ith the ever-changing and
quick development of new technology, the states, unlike our
foreign counterparts, are outpaced by science and medicine.”70
Although few continue to argue that IVF ought to be banned,
some did argue for a ban when IVF was first introduced.
By containing new intrinsic possibilities, even in its most
basic form, IVF also advances certain values. As artificial
insemination enabled procreation without resort to sexual
intercourse, IVF moved the act of fertilization as well as human
embryos from women’s bodies to the laboratory. Especially in
the 1970s and 1980s, this conflicted with many prevailing
conceptions of the sanctity of human life and the role of women
in procreation. The conflict between the values embedded in
the technology and prevailing or sectoral social values affected
the willingness of some to accept the technology, and led to
calls for a ban from various quarters.71 Although many of these
arguments are now only of historic interest, one can see how
they gave rise to possible reasons for banning or restricting the
use of IVF.
One strand of arguments against IVF comes from
organized religions. Although many religions find particular
aspects of the technology problematic (such as donated gametes
or surrogacy), Catholic doctrine condemns the entire
69. See id.; see also Maher v. Roe, 432 U.S. 464, 480 (1977); Harris v.
McRae, 448 U.S. 297, 311 (1980); Webster v. Reprod. Health Services, 492 U.S.
490, 507-11 (1989); Rust v. Sullivan, 500 U.S. 173, 193 (1991).
70. Sherri A. Jayson, Comment, “Loving Infertile Couple Seeks Woman
Age 18-31 to Help Have Baby. $6,500 plus Expenses and a Gift”: Should We
Regulate the Use of Assisted Reproductive Technologies by Older Women?, 11
ALB. L.J. SCI. & TECH. 287, 299-300 (2001) (emphasis added).
71. A similar observation was made with respect to artificial insemination
in Gaia Bernstein, The Socio-Legal Acceptance of New Technologies: A Close
Look at Artificial Insemination, 77 WASH. L. REV. 1035, 1041-42 (2002).
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enterprise.72 As well as disapproving of the destruction of
embryos, the Church opposes the separation of procreation
from the act of conjugal union, and finds it contrary to notions
of dignity and equality that the technology places human life
within the power of technologists.73
A broader religious complaint, made more commonly
against techniques such as genetic manipulation than against
IVF, is that they constitute an illicit attempt to “play God.” A
secular version of the same criticism might point to the fact
that biotechnology gives us power to alter nature without
endowing us with a sufficient (God-like) understanding of the
possible consequences.74 In a similar vein, many commentators
sought to condemn technological interference with reproduction
on the ground of its unnaturalness.75 For example, Reverend
William B. Smith, spokesperson for the Archdiocese of New
York, likened IVF to “switching the marital bed into a
chemistry set.”76
There are also concerns about the health of children
conceived through IVF. In the early days of IVF, some
commentators considered it unethical experimentation because
insufficient data existed about the possible negative effects on
the resulting child.77 There is now more data available on the
nature of risks to IVF children. Studies now show only minor
deviations in birth weight and age, at least where multiple
births are ignored; furthermore, such deviations may also be
explained by other factors such as maternal age and

72. Congregation for the Doctrine of the Faith, Instruction on Respect for
Human Life in Its Origin and on the Dignity of Procreation – Replies to
Certain Questions of the Day (February 22, 1987), available at
http://www.vatican.va/roman_curia/congregations/cfaith/documents/rc_con_cfa
ith_doc_19870222_respect-for-human-life_en.html (last visited Apr. 6, 2005).
73. Id.
COUNCIL
ON
BIOETHICS,
BEYOND
THERAPY:
74. PRESIDENT’S
BIOTECHNOLOGY AND THE PURSUIT OF HAPPINESS 287 (2003), available at
http://www.bioethics.gov/reports/beyondtherapy/ (last visited Apr. 6, 2005).
75. See, e.g., Leon Kass, Making Babies – The New Biology and the ‘Old’
Morality, 26 PUB. INT. 18, 48-50 (1972) (“the laboratory production of human
beings is no longer human procreation”).
76. The First Test Tube Baby, TIME, July 31, 1978, at 58, 69.
77. See, e.g., Hans O. Tiefel, Human In Vitro Fertilization: A Conservative
View, 247 JAMA 3235, 3237-38 (1982); Paul Ramsey, Shall We “Reproduce?” I.
The Medical Ethics of In Vitro Fertilization, 220 JAMA 1346, 1347 (1972); Leon
R. Kass, Babies By Means of In Vitro Fertilization: Unethical Experiments On
the Unborn?, 285 NEW ENG. J. MED. 1174, 1175-76 (1971).
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primogeniture.78 While some studies have also suggested that
IVF children are more likely to suffer from birth defects,79 the
defects are more likely related to maternal characteristics80 and
the prevalence of multiple births than to IVF itself.81 While
possible links between IVF and specific conditions have been
identified, additional investigation is required before informed
conclusions can be drawn.82
In the 1980s, some feminists and feminist groups such as
the Feminist International Network of Resistance to
Reproductive and Genetic Engineering (FINRRAGE) advocated
a different set of objections to IVF.83 They raised a variety of
concerns, including that IVF transfers power away from
women84 and distracts from efforts to prevent infertility or deal
with more important health issues.85 Other concerns raised
78. ALASTAIR G. SUTCLIFFE, IVF CHILDREN: THE FIRST GENERATION 30
(2002); Med. Research Council Working Party on Children Conceived by In
Vitro Ferilisation, Births in Great Britain Resulting from Assisted Conception,
1978-87, 300 BRIT. MED. J. 1229, 1232 (1990).
79. See, e.g., Michèle Hanson et al., The Risk of Major Birth Defects After
Intracytoplasmic Sperm Injection and In Vitro Fertilization, 346 NEW ENG. J.
MED. 725, 729-30 (2002).
80. SUTCLIFFE, supra note 78, at 30-31; T. Bergh et al., Deliveries and
Children Born After In-Vitro Fertilization in Sweden 1982-95: A Retrospective
Cohort Study, 354 LANCET 1579, 1583-84 (1999).
81. Bergh, supra note 80, at 1583-84; see also Press Release, ASRM Media
Advisory, ASRM Comments on Release of Report on Outcomes Study of ART
Children
(Oct.
19,
2004),
available
at
http://www.asrm.org/Media/Press/ART_child_study.html (last visited Apr. 6,
2005).
82. See, e.g., A.C. Moll et al., Incidence of Retinoblastoma in Children
Born After In-Vitro Fertilisation, 361 LANCET 309, 309-10 (2003); Rosie.
Mestel, Some Studies See Ills for In Vitro Children: Evidence of Increases in
Eye Cancer and Mental Retardation Needs to be Verified, L.A. TIMES, Jan. 24,
2003, at A1; see also SUTCLIFFE, supra note 78, at 36 (discussing a study that
showed a possible link between IVF and increased cancer rates). See generally
MED. RESEARCH COUNCIL, ASSISTED REPRODUCTION: A SAFE, SOUND FUTURE
(2004) (discussing need for and design of future research), available at
http://www.mrc.ac.uk/index/publications/publications-research_reviews/publicassisted_reproduction_report.htm (last visted Mar. 29, 2005).
83. See generally Resolution from the FINRRAGE Conference, July 3-8,
1985, Vällinge, Sweden, in MADE TO ORDER: THE MYTH OF REPRODUCTIVE
AND GENETIC PROGRESS 211-12 (Patricia Spallone & Deborah Lynn Steinberg
eds., 1987).
84. See, e.g., Robyn Rowland, Of Women Born, But for How Long? The
Relationship of Women to the New Reproductive Technologies and the Issue of
Choice, in MADE TO ORDER: THE MYTH OF REPRODUCTIVE AND GENETIC
PROGRESS 67, 77, 80 (Patricia Spallone & Deborah Lynn Steinberg eds., 1987).
85. See, e.g., Lori B. Andrews, Alternative Modes of Reproduction, in
REPRODUCTIVE LAWS FOR THE 1990S 361, 262-63 (Sherill Cohen & Nadine
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were that IVF was experimental, onerous, usually unsuccessful
and possibly dangerous, and that women were coerced or
misled into bearing the risks and the costs.86
Some objections to the practice of IVF might, with
hindsight, be characterized as Luddite objections to the new.
Overly simplistic analogies fall in this category.87 For example,
Leo Abse, a British MP, stated that “[t]he issue is how far we
play God, how far we are going to treat mankind as we would
animal husbandry.”88 One can always compare a technology
such as human IVF to its past associations, but the argument
is meaningless unless the similarities and differences between
human and non-human reproductive technologies are explored.
Some objections to a new technology are based on “fear,
ignorance, prejudice, or raw emotion”89 or are an example of a
pessimistic attitude towards new things.90
Both negative reflex reactions and more sophisticated
objections to new technology generally soften over time.91 For
example, between 1978 and 1994, acceptance of IVF in the
United States increased from 60% to 75%,92 and between 1981
Taub eds., 1989); Gena Corea et al., Prologue, in MADE TO ORDER: THE MYTH
OF REPRODUCTIVE AND GENETIC PROGRESS 8 (Patricia Spallone & Deborah
Lynn Steinberg eds., 1987).
86. GENA COREA, THE MOTHER MACHINE: REPRODUCTIVE TECHNOLOGIES
FROM ARTIFICIAL INSEMINATION TO ARTIFICIAL WOMBS 166-85 (1985); see also
Gena Corea & Susan Ince, Report of a Survey of IVF Clinics in the United
States, in MADE TO ORDER: THE MYTH OF REPRODUCTIVE AND GENETIC
PROGRESS 133-39 (Patricia Spallone & Deborah Lynn Steinberg eds., 1987).
87. See generally Michael H. Shapiro, Illicit Reasons and Means for
Reproduction: On Excessive Choice and Categorical and Technological
Imperatives, 47 HASTINGS L.J. 1081 (1996) (discussing the misuse of analogy
in the context of the debate on reproductive technologies).
88. The First Test Tube Baby, TIME, July 31, 1978, at 58, 69.
89. Arthur Caplan, Introduction, in BEYOND BABY M: ETHICAL ISSUES IN
NEW REPRODUCTIVE TECHNIQUES 5-6 (Dianne M. Bartels et al. eds, 1990).
90. See E. Donald Elliott, Against Ludditism: An Essay On the Perils of
the (Mis)Use of Historical Analogies in Technology Assessment, 65 S. Cal. L.
Rev. 279, 281-82 (1991).
91. See Tabitha Rowledge, Reproductive Technologies and the Bottom
Line, in EMBRYOS, ETHICS AND WOMEN’S RIGHTS: EXPLORING THE NEW
REPRODUCTIVE TECHNOLOGIES 203, 203 (Elaine Hoffman Baruch et al. eds.,
1988); ALLAN MAZUR, THE DYNAMICS OF TECHNICAL CONTROVERSY 97-98
(1981); see also ANDREA L. BONNICKSEN, IN VITRO FERTILIZATION: BUILDING
POLICY FROM LABORATORIES TO LEGISLATURES 45 (1989). See generally
Bernstein, supra note 71, at 1060-71 (analyzing how artificial insemination
gained social and legal acceptance).
92. Keith Alan Byers, Infertility and In Vitro Fertilization: A Growing
Need for Consumer-Oriented Regulation of the In Vitro Fertilization Industry,
18 J. LEGAL MED. 265, 283-84 (1997) (reporting the results of an attitudinal
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and 2000, the proportion of Australians who approved of IVF
for married couples rose from 77% to 85%.93 Eventually, public
attention turns from thoughts of whether a new technology
ought to be used to how it ought to be used and what
consequences ought to flow from its use.
Of course, a
disastrous event may turn the public’s mind back to the initial
question. Even where negative reactions merely delay, rather
than prevent the introduction of a new technology, the
controversy itself can prove to be beneficial because it may lead
to greater public awareness and, in some cases, increased
regulation or oversight. 94
D. REASONS TO REGULATE IVF AND RELATED TECHNOLOGIES
If no decision is made to ban a new technology, a more
modest desire might be to control its use.95 Failure of political
institutions to impose such limits may be described as a “legal
vacuum.”96
There are various reasons why it might be thought
desirable to subject a new technology to regulation.
Sometimes, the mere exercise of centralized control can allay
public fears as to the direction the technology might otherwise
take.97 For example, the Warnock Report,98 commissioned in
the United Kingdom to examine the implications of
developments in ART, frequently referred to the need to allay

survey by Princeton Survey Research Associates).
93. The Roy Morgan Research Centre Finding No. 3359, Vast Majority of
Australian’s Support Medicare-Funded IVF, But Most Oppose Sperm Bank Use
By Single Women or Lesbian Couples, THE BULLETIN, Jan. 9, 2001, available
at http://www. roymorgan.com/news/polls/2001/3359/ (last visited Apr. 6,
2005).
94. See generally ALLAN MAZUR, supra note 91, at 126-27.
95. See, e.g., Alexander Morgan Capron, The New Reproductive
Possibilities: Seeking a Moral Basis for Concerted Action in a Pluralistic
Society, 12 L. MED. & HEALTH CARE 192, 192-93 (1984).
96. See, e.g., Nicholas P. Terry, "Alas! Poor Yorick," I Knew Him Ex Utero:
The Regulation of Embryo and Fetal Experimentation and Disposal in
England and the United States, 39 VAND. L. REV. 419, 456 (1986)
(emphasizing the “legal vacuum” that has allowed embryo research to take
place outside a regulatory regime).
97. See Margaret Brazier, Regulating the Reproduction Business?, 7 MED.
L. REV. 166, 168 (1999) (referring to the common plea that “something must be
done” about the reproduction business and that “something” usually takes the
form of external regulation).
98. REPORT OF THE COMMITTEE OF INQUIRY INTO HUMAN FERTILISATION
AND EMBRYOLOGY, July 1984, Cmnd. 9314 [hereinafter Warnock Report].
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public fears.99 The Foreword to the Warnock Report refers to
the fact that people want “some principles or other” to govern
the development and use of the new techniques,”100, including
“some barriers”101 and “some limits.”102 The Conclusion makes
a similar point, indicating a desire to protect society “from its
real and very proper fear of a rudderless voyage into unknown
and threatening seas.”103 Regulation can thus serve a symbolic
function; the mere existence of limits reassures people that the
technology is under control.104
The usual purpose of regulation, however, is to protect
those affected by the use of a technology.
“Technology
assessment” refers to the process used to determine the
effectiveness, safety, and appropriate use of a new
technology.105 Technology assessment is primarily concerned
with predicting the future consequences (economic, social, or
environmental) of technological development.106 Typically,
harmful consequences are avoided by prescribing the manner
in which a technology is designed or employed or by
discouraging its use.107 Such regulation can increase efficacy,
as well as protect the health and safety of technologists, those
seeking to benefit from the technology, others in society, and
even the environment. Of course, not all technologies will pose

99. Janet Gallagher, Embryos, Eggs and Fetuses: Anxiety and the Law, in
REPRODUCTIVE TECHNOLOGIES: GENDER, MOTHERHOOD AND MEDICINE 139,
147 (Michelle Stanworth ed., 1987).
100. MARY WARNOCK, A QUESTION OF LIFE: THE WARNOCK REPORT ON
HUMAN FERTILIZATION AND EMBRYOLOGY, WITH TWO NEW CHAPTERS BY MARY
WARNOCK 2 (1985) (emphasis in original).
101. Id. (emphasis in original).
102. Id. (emphasis in original).
103. Id. at 100.
104. See McCartan, supra note 38, at 713 (“The goals of policy in the IVF
arena should emphasize control and containment of present applications and
procedures.”).
105. See, e.g., H. David Banta, Technology Assessment and Infertility Care,
in TOUGH CHOICES: IN VITRO FERTILIZATION AND THE REPRODUCTIVE
TECHNOLOGIES 53, 60 (Patricia Stephenson & Marsden G. Wagner eds., 1993).
See generally DORF, supra note 40, at 289; NAT’L ACAD. OF SCIENCES PANEL
ON TECH. ASSESSMENT, TECHNOLOGY: PROCESSES OF ASSESSMENT AND
CHOICE 1-19 (1969).
106. See NAT’L ACAD. OF SCIENCES PANEL ON TECH. ASSESSMENT, supra
note 105, at 1-19.
107. See Richard B. Stewart, Regulation, Innovation, and Administrative
Law: A Conceptual Framework 69 Cal. L. Rev. 1256, 1263-73 (1981). See
generally Laurence H. Tribe, Legal Frameworks for the Assessment and
Control of Technology, 9 MINERVA 243 (1971).
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the same threats; in the case of IVF, the focus of regulation
tends to be on the effectiveness of the procedure, the health of
the woman seeking access to IVF, the proper treatment of the
embryo, and the health of the child born as a result of the
procedure.
Not all regulation need be aimed at ensuring health and
safety; it may be economic in character or may relate to the
preservation of other interests and values that are less easily
subjected to utilitarian calculation.108 There is often vigorous
social disagreement on what values are implicated by
biotechnologies and their relative importance. In the case of
IVF, one frequently hears reference to values such as family,
community, privacy, and human dignity. In Louisiana, for
example, restrictive legislation regulating IVF serves the
symbolic function of classifying an embryo as the moral
equivalent of a person.109 The perceived need to preserve social
values or place limits on a technology, as well as the desire to
maximize its benefits and minimize its harms, are all reasons
why regulation might be seen as a necessary response to
technological change.
E. REASONS TO ENHANCE CERTAINTY
The problem of uncertainty in law is pervasive; it will
never be possible to determine the precise meaning of all legal
rules so as to be able to answer all legal questions
unequivocally. H.L.A. Hart described legal rules as having a
penumbra of uncertainty, created in part by the open texture of
language.110 Technological change thus enters onto a stage
occupied by an already uncertain law. While it does not create
the problem of uncertainty, it may exacerbate it by revealing
latent ambiguities in the law and raising new legal questions
for which there are no clear answers. References to technology
outpacing law can portray the slow pace at which such new
108. See Derek Morgan & Robert Lee, Assisted Conception in Common Law
Jurisdictions, in BIOMEDICINE, THE FAMILY AND HUMAN RIGHTS 479, 484-92
(Marie-Thérèse Meulders-Klein et al. eds., 2002) (exploring society’s interest
in the ethical concerns surrounding assisted conception); Cynthia B. Cohen,
Unmanaged Care: The Need to Regulate New Reproductive Technologies in the
United States, 11 BIOETHICS 348, 350 (1997) (arguing the validity of social and
moral concerns associated with the nature of family and value of children).
109. LA. REV. STAT. ANN. § 9:123 (West 2003). See generally id. §§ 9.121133.
110. See HART, supra note 28, ch. 7; H.L.A. Hart, Positivism and the
Separation of Law and Morals, 71 HARV. L. REV. 593, 607-08 (1958).
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questions are answered.111 In describing the gap between
technology and the law caused by uncertainty, the terms “legal
vacuum” and “legal void” are sometimes used.112
Generally speaking, uncertainties arise when new entities,
relationships, or activities do not fit easily into existing
conceptual and legal categories.
Our rules assume the
existence of “property” (which can be traded or transmitted via
will) and “persons” (who can own and inherit), and it can be
difficult to classify new entities such as cryopreserved embryos
for the purposes of these rules. Although notions of property
and persons are inherently contestable, even previously clear
concepts can acquire more than one meaning. Prior to the use
of reproductive technologies, the woman who gave birth to a
child, necessarily a genetic parent, was its mother (subject to
rules on adoption). Yet the notion of motherhood harbored
latent ambiguity, which was revealed once it became possible to
separate genetic from gestational motherhood.113
Consider the Tennnessee custody dispute addressed in
Davis v. Davis.114 Following a divorce, Mary Sue Davis wanted
to attempt pregnancy with cryopreserved embryos created with
her eggs and her husband’s sperm; the husband, Junior Davis,

111. See, e.g., Vukadinovich, supra note 34, at 67; Wendy Dullea Bowie,
Comment, Multiplication and Division – New Math for the Courts: New
Reproductive Technologies Create Potential Legal Time Bombs, 95 DICK. L.
REV. 155, 156, 163 (1990); Michael Booth, Fate of Frozen Embryos Brings NJ
Again to Bioethics Fore, N.J.L.J., Mar. 9, 1998, at 1; NEW SOUTH WALES
HEALTH DEPARTMENT, REVIEW OF THE HUMAN TISSUE ACT 1983 (1997)
(discussion
paper),
available
at
http://www.health.nsw.gov.au/csd/llsb/legislation/humantiss.html (last visited
Apr. 6, 2005).
112. See, e.g., Lee M. Silver & Susan Remis Silver, Confused Heritage and
the Absurdity of Genetic Ownership, 11 HARV. J.L. & TECH. 593, 610 (1998);
Laura D. Heard, Comment, A Time to be Born, a Time to Die: Alternative
Reproduction and Texas Probate Law, 17 ST. MARY'S L.J. 927, 928 (1986);
Kelly L. Frey, Comment, New Reproductive Technologies: The Legal Problem
and a Solution, 49 TENN. L. REV. 303, 318-19 (1982).
113. See, e.g., In re Marriage of Buzzanca, 72 Cal. Rptr. 2d 280 (Cal. Ct.
App. 1998) (involving parentage of child born because a couple agreed to have
an embryo genetically unrelated to either of them transferred to a surrogate);
Parm Belluck & Adam Liptak, Split Gay Couples Face Custody Hurdles:
Judges Lack Road Maps for Laws Unintended for Same-Sex Unions, N.Y.
TIMES, Mar. 24, 2004, at A18 (concerning a dispute following the breakup of a
lesbian relationship in which one partner had served as the gestational
mother and the other as the genetic mother).
114. Davis v. Davis, No. E-14496, 1989 WL 140495 (Tenn. Cir. Ct. Sept. 21,
1989).
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wanted to avoid involuntary parenthood.115 The trial court
could have potentially treated the cryopreserved embryos as
“children,” whose custody would be determined in the best
interests of the child or as “property,” in which case they would
be jointly owned by the parties.116 Trial court Judge W. Dale
Young found that “human life begins at the moment of
conception” and that the best interests of the child would be
served by granting custody of the embryos to Mary Sue.117
The Davis case was appealed to the Court of Appeals of
Tennessee, by which time Mary Sue wanted to donate the
embryos to another couple.118 The appellate court held that the
trial court’s decision violated Junior’s reproductive rights, and
ordered that the parties be given joint control over the
embryos.119 On appeal from that decision, the Tennessee
Supreme Court struck a middle ground between the two
positions.120 Embryos were neither persons nor property, but
were entitled to special respect because of their potential for
human life.121 Ultimately, therefore, neither analogy was
considered appropriate, the court instead resolving the dispute
by balancing the parties’ interests.122 Prior to Davis v. Davis,
there was real uncertainty as to how disputes over
cryopreserved embryos would be viewed.
Another potential source of uncertainty, peculiar to the
common law, arises out of the reliance on stare decisis in
determining the content of common law rules. Where
technological change makes possible new forms of conduct,
there will automatically be a difference between the first case
involving that conduct and all previous cases. Determining
whether the new conduct in question is “like” existing forms of
conduct may be difficult. Seeking to rely on a precedent will
often prove futile—a particular judge’s conception of the
appropriate legal rule is unlikely to clarify the status of conduct
that was not possible, and possibly not even foreseen, at the
time.
115. Id. at *18-20.
116. Id. at *9.
117. Id. at *9, *11.
118. Davis v. Davis, No. 180, 1990 WL 130807, at *2, *3 n.1 (Tenn. Ct.
App. Sept. 13, 1990).
119. Id. at *2-3.
120. Davis v. Davis, 842 S.W.2d 588 (Tenn. 1992).
121. Id. at 597.
122. Id. at 603-04.
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This does not mean that the outcome in every case
involving the application of a common law rule to new conduct
will be uncertain. At one extreme, the immateriality of some
facts is obvious. At the opposite extreme, there might be a
perception (whether later proved true or false) that no existing
rules apply to new forms of conduct merely because they are
new. This tendency was evident in some of the earlier
literature on law and the Internet.123 More common is the view
that the applicability of at least some old rules to new forms of
conduct is uncertain.
F. REASONS TO REJECT EXISTING RULES
Law reform may be urged where new technologies alter the
facts that had justified existing common law and statutory
rules.124 An example of reform can be found in early cases
addressing the question of whether artificial insemination of a
woman with sperm originating from a man other than her
husband constituted adultery. The first hurdle the law needed
to address was uncertainty: it was unclear whether artificial
insemination constituted adultery, that is, whether adultery
was sexual intercourse outside of marriage or sharing
reproductive capacity outside marriage.125 A Canadian court
initially held that adultery was sharing reproductive capacity
outside of marriage,126 but subsequent cases decided that it was
Once that
sexual intercourse outside of marriage.127
uncertainty was resolved, the rationale for the evidentiary rule
relating conception of another man’s child to adultery was
undermined. The rule was therefore abandoned.128
Because rules may become obsolete, unenforceable, or too
expensive, the law may be criticized for dealing with new
technologies “in terms of existing statutes or cases which were
written at a time when these new modes of reproduction were

123. See, e.g., David R. Johnson & David Post, Law and Borders -- The Rise
of Law in Cyberspace, 48 STAN. L.R. 1367, 1367, 1400-02 (1996).
124. See generally David Friedman, Does Technology Require New Law?, 25
HARV. J.L. & PUB. POL’Y 71 (2001–02) (arguing technological change can alter
facts used to justify existing law, and in such situations the legal system may
alter existing law).
125. Orford v. Orford, 58 D.L.R. 251, 258 (Ont. 1921).
126. Id.
127. See Bernstein, supra note 71, at 1067; see also MacLennan v.
MacLennan 1958 Sess. Cas. 105, 113-15 (Scot.).
128. See Bernstein, supra note 71, at 1067.
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not envisioned.”129 As Justice Felix Frankfurter stated, when
factual assumptions on which a law is premised change, “law
cannot be static . . . for facts are stubborn and will not yield.”130
If laws that have lost their reason for being continue in force,
the law might well be accused of responding too slowly in a
changing world.
G. REASONS TO EXPAND OR CONTRACT EXISTING RULES
Where a rule is created prior to some technological change,
it will rarely be drafted with that change in mind. Such a rule
may either include within its scope conduct that its creators
would have (had they thought of it) excluded or exclude conduct
that would have been included. Most rules are over-inclusive
and under-inclusive, even in the absence of technological
change. A person drafting a rule will need to balance the
problems of over-inclusiveness and under-inclusiveness against
other considerations, such as whether the rule as drafted is
clear and easy to apply.131 We might assume that a competent
drafter would reach an acceptable (if controversial) balance.
But the rule may also apply (or fail to apply) to conduct that
could not have been foreseen at the time of its creation. A
better balance might be reached by deliberately excluding (or
including) that new conduct. In these cases, technological
change might argue in favor of amending the rule.
In the IVF context, consider the following Virginia law,
enacted in 1984:
With the exception of hair, blood and other self-replicating body
fluids, it shall be unlawful for any person to sell, to offer to sell, to
buy, to offer to buy, or to procure through purchase any natural body
part for any reason including, but not limited to, medical and
scientific uses such as transplantation, implantation, infusion or
injection. 132

At the time that law was enacted, ovum donation was a
very new technique. Ova are not self-replicating, and their sale
therefore fell within the prohibition. Yet selling ova is not
necessarily equivalent to selling a kidney because a donor has
129. Lorio, supra note 34, at 1642.
130. Felix Frankfurter, The Zeitgeist and the Judiciary, in LAW AND
POLITICS: OCCASIONAL PAPERS OF FELIX FRANKFURTER, 1913-1938, at 6
(1939).
131. See Colin S. Diver, The Optimal Precision of Administrative Rules, 93
YALE L.J. 65, 67 (1983) (discussing the importance of balancing a rule’s
transparency, accessibility, and congruency).
132. VA. CODE ANN. §§ 32.1-289.1 (Michie 1991).
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many more spare ova than kidneys. In fact, the Virginia law
was amended in 1991 to exclude transactions in ova.133
Conversely, rules may fail to include conduct that falls
within the rule’s rationale. Many states have laws regulating
sperm donation and artificial insemination. For example, in
2001, forty-two states had laws regulating sperm donation.134
These often include safety regulations requiring testing for
communicable or genetic diseases, mandatory record keeping to
avoid sperm switching and create a genetic data resource for
future children, and special consent requirements.135 Such
laws should be equally applicable to the practice of ovum
donation. Yet, without further amendment, the legislation only
covers the use of male gametes.
There are other examples of rules that were criticized for
being over-inclusive or under-inclusive in light of the use of
IVF. Some have argued that stealing embryos ought to
constitute “theft” despite the limitation in some laws that theft
only applies to property.136 Many states require insurers to
cover or offer coverage for particular medical services; and
many amended their statutes to include IVF.137
The problem of over-inclusiveness and under-inclusiveness
is greater with statutes than with common law rules. This is
because common law rules are read with greater reference to
their underlying justifications.138 Consider, by way of example,
an imaginary rule providing: “Any person driving a carriage led
by one or more horses who collides with a pedestrian shall be
liable for the damages so caused irrespective of negligence.” If
the source of this rule were a statute, the rule would create a
133. 1991 Va. Acts ch. 600.
134. NAT’L CONF. OF STATE LEGISLATURES, GENETICS POLICY REPORT:
REPRODUCTIVE TECHNOLOGIES 9-10 (Alissa Johnson & Cheye Calvo eds.,
2001).
135. Id.
136. See generally infra Part V.B.2.a.iii.
137. See, e.g., ARK. CODE ANN. §§ 23-85-137, 23-86-118 (Michie 2005);
CONN. GEN. STAT. § 38a-536 (2003); HAW. REV. STAT. ANN. §§ 431:10A-116.5,
432:1-604 (Michie 2003); 215 ILL. COMP. STAT. 5/356m (2003); MD. CODE ANN.,
INS. § 15-810 (2002); MASS. GEN. LAWS ANN. § 47H, ch. 176A, § 8K, ch. 176B, §
4J (West 2003); MONT. CODE ANN. § 33-31-102 (2003); N.J. STAT. ANN. §§
17:48-6x, 17B:27-46.1x, 26:2J-4.23 (West 2001 & Supp. 2003); OHIO REV. CODE
ANN. § 1751.01 (Anderson 2003); R.I. GEN. LAWS §§ 27-18-30, 27-19-23, 27-2020, 27-41-33 (2003); TEX. INS. CODE ANN. §§ 1366.001-007 (Vernon 2004).
138. See FREDERICK SCHAUER, PLAYING BY THE RULES: A PHILOSOPHICAL
EXAMINATION OF RULE-BASED DECISION-MAKING IN LAW AND IN LIFE 174-81
(1991).
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regime of strict liability in the circumstances contemplated.
Even if the purpose of the rule were a concern for pedestrian
welfare in light of the faster and heavier horse-drawn
carriages, it would not extend to injury caused by an
Although the purpose of the statute is
automobile.139
important in deducing meaning, it cannot extend the meaning
beyond the limits that words will bear.
Common law rules are not bound to their words in the
same way. There is no single authoritative text for common
law rules. Even when a rule is stated in canonical form, the
rule will not necessarily bind courts according to its terms. It is
always open to a later court to create a new exception to the
rule or extend it by analogy. If the horse-drawn carriage rule
were found in the common law, it would likely be extended by
analogy to new situations when justified by the rule’s
underlying rationale. The fact that common law rules can be
extended or retracted in light of their underlying justifications
is a crucial advantage when making laws intended to apply in
the context of rapidly changing technologies. This is discussed
further in Parts V.B.4 and VI.A.
H. DIFFERING DILEMMAS
Following technological change, law may confront the
range of challenges described here. However, the particular
challenges that arise will vary by technological change and
jurisdiction. In fact, many new technologies pose no challenges
for law—one does not find lawmakers struggling with the
implications of the electric can-opener, for example.
Consider the separation of genetic and gestational
motherhood introduced by the use of IVF with surrogate
gestation in two hypothetical jurisdictions. The first has laws
expressly stating that the woman who gives birth to a child is
to be registered as its mother. In the second, the law contains
no such explicit statement, presumably because it seemed
obvious. The difference was almost an accident since the
practice in all jurisdictions prior to the use of IVF is identical;
the woman giving birth to a child is registered as its mother
(mater est quam gestatio demonstrat).140
139. There has been some commentary on the question of whether statutes
might be extended to situations not contemplated at the time of their
enactment by use of analogy. See, e.g., Roscoe Pound, Common Law and
Legislation, 21 HARV. L. REV. 383, 385 (1908).
140. J.K. MASON & R.A. MCCALL SMITH, LAW AND MEDICAL ETHICS 57 (2d
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Yet, once genetic and gestational motherhood are
separated, each jurisdiction is in a different dilemma. In the
first jurisdiction, the laws treating the birth mother as mother
were accidental and were not the result of any balancing of
interests of a gestational mother and a separate genetic
mother.
After IVF becomes possible using gestational
surrogacy, controversy results. Some may believe that the
original rule is right and that the gestational mother should be
registered as the child’s parent, despite the absence of a genetic
link. Others may argue that the legal position ought to be
changed as a result of new technology and that, until the law is
changed, it is stuck in the past. Whatever position is taken, all
groups would agree that the original rule was formulated in the
context of factual assumptions that are no longer correct. The
question of whether a genetic or gestational mother has a right
to be recognized as the child’s legal parent ought to be resolved
on its own merits. In the second jurisdiction, the question is
one of pure uncertainty, rather than one of existing rules being
arguably out of date.
Not only may different dilemmas exist in different
jurisdictions, but different dilemmas may be perceived in the
same jurisdiction. While people may agree that the factual
assumptions on which a law was formulated have changed or
that existing rules were drafted without contemplation of new
technologies, they may disagree as to whether the law should
be changed. Those arguing for the law to remain static may
feel that existing rules are nevertheless justified or that the
application of an existing rule to new conduct is desirable, even
if fortuitous. Others, perhaps rhetorically pointing to the law’s
inability to keep up with technology, may argue for legal
change. Thus, pressure for law reform might be felt more
strongly in some jurisdictions than in others. Nevertheless, it
is difficult to deny that technological change has generated a
reason to change or clarify the law; what is really in dispute is
the extent to which this reason is sufficient.
Where technology does provide a reason to change or
clarify the law, that reason may fit in more than one of the
categories set out above. For example, uncertainty in relation
to family relationships may itself be a reason to ban or restrict
the use of certain ARTs. Alternatively, the fact that an existing
rule is over-inclusive with respect to new forms of conduct
ed. 1987).
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might lead some to conclude that it ought to be repealed
entirely.
III. DIFFERENT PATHS – RESPONSES TO IVF
Although it would be surprising if all common law
countries subjected IVF to the same laws, it is interesting that
different jurisdictions have taken widely divergent routes. The
three countries discussed here―the United States, the United
Kingdom, and Australia―are subject to different constitutional
and regional norms, and differ in their political and legal
cultures.141 Because of these differences, approaches taken in
one jurisdiction may be impossible or ineffective in another.142
But it would be going too far to assume that comparisons
between these jurisdictions are meaningless. As will be evident
from Parts V and VI, these countries also share common
problems and common goals. They all have a common law
system, and state control is exercised in legislative and
administrative fora. Despite cultural and political differences,
each country can still learn from the experience of others—the
outcomes of differing choices. The result of the comparison
may be to question assumptions about the optimum legal and
political response to technological change.
This Part briefly describes the legal responses to IVF in
most of the United States, the United Kingdom, and two states
in Australia. Because the discussions in Parts V and VI below
focus on particular aspects of each regime, only an outline is
included here.
A. UNITED STATES
American law on IVF is complicated by the fact that it is
largely state-based. For example, Louisiana places tight reins
on the practice of IVF, based on the principle that an in vitro

141. See Kathryn Venturatos Lorio, The Process of Regulating Assisted
Reproductive Technologies: What We Can Learn from Our Neighbors – What
Translates and What Does Not, 45 LOY. L. REV. 247, 249 (1999). See generally
P.S. ATIYAH & ROBERT S. SUMMERS, FORM AND SUBSTANCE IN ANGLOAMERICAN LAW (1987).
142. See, e.g., PRESIDENT’S COUNCIL ON BIOETHICS, REPRODUCTION &
RESPONSIBILITY: THE REGULATION OF NEW BIOTECHNOLOGIES 12 (2004)
[hereinafter
REPRODUCTION
&
RESPONSIBILITY],
available
at
http://www.bioethics.gov/reports/reproductionandresponsibility/index.html
(last visited Apr. 6, 2005).
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embryo has the same legal status as a person.143 New
Hampshire also has detailed laws regarding liability, the
length of time that embryos can be stored in vitro, and patient
selection.144 Florida prohibits the sale of embryos, mandates
agreements to provide for disposition of embryos and gametes
in the event of death or divorce, and states that a child
conceived after the death of a parent does not inherit.145
Virginia requires HIV testing for gamete donors, requires
physicians to provide certain disclosures to patients, and states
that an ART child born after a decedent’s death may inherit.146
In addition, many states have laws determining parentage of
ART children.147
States have also tended to deal with particular issues
surrounding ART and IVF. For example, California requires
consent for embryo and gamete donation;148 Kansas permits
destruction of embryos;149 Kentucky prohibits the use of public
facilities for research purposes if embryonic destruction may
result;150 New Mexico requires that embryos be transferred to a
woman to avoid clinical experimentation restrictions;151 New
Jersey deals with questions of inheritance, requiring that an
heir be in gestation at the time of the decedent’s death;152
Oklahoma prescribes conditions for egg and embryo
143. LA. REV. STAT. ANN. §§ 9:121-133 (West 2000).
144. N.H. REV. STAT. ANN. §§ 168-B:12-B:15, B:29-B:31 (2001).
145. FLA. STAT. ANN. ch. 742.17 (West 1997); FLA. STAT. ANN. ch. 873.05
(2000).
146. VA. CODE ANN. §§ 32.1-45.3, 64.1-68.1 (Michie 2004); VA. CODE ANN. §
54.1-2971.1 (Michie 2002).
147. North Dakota and Virginia have laws based on the UNIFORM STATUS
OF CHILDREN ASSISTED CONCEPTION ACT, 9B U.L.A. 191 (West Supp. 1999).
N.D. CENT. CODE § 14-18-01 to 07 (2003); VA. CODE ANN. § 20-158 (Michie
2004). Colorado, Delaware, Texas, Washington, and Wyoming have laws
based on the UNIFORM PARENTAGE ACT (2000). COLO. REV. STAT. §§ 19-4-101,
-106 (2003); DEL. CODE ANN. tit. 13, §§ 8-101 to -102, 8-701 to -707 (Supp.
2004); TEX. FAM. CODE ANN. §§ 160.101-102, 160.701-763 (Vernon 2002 &
Supp. 2004); WASH. REV. CODE ANN. §§ 26.26.010-011, 26.26.700-740 (Supp.
2004); WYO. STAT. ANN §§ 14-2-401 to -402, 14-2-901 to -907 (Michie 2003).
Florida and Illinois make provision for gestational surrogacy agreements. FLA.
STAT. ANN. ch. 742.11-17 (West 1997 & Supp. 2004); 750 ILL. COMP. STAT. §§
47/1-47/75 (West 2004). Many more states have laws dealing with pre-IVF
issues such as sperm donation. See infra note 559.
148. CAL. PENAL CODE § 367g (West 1999); CAL. BUS. & PROF. CODE § 2260
(West 2003 & Supp. 2005).
149. KAN. STAT. ANN. § 65-6702 (2002).
150. KY. REV. STAT. ANN. § 311.715 (Michie 2002).
151. N.M. STAT. ANN. §§ 24-9A-1 to -7 (Michie 2003).
152. N.J. STAT. ANN. § 3B:5-8 (West 2004).
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donation;153 and Pennsylvania requires that certain IVF
statistics be reported.154 Many states have laws, often tied in
with laws regulating abortion, that restrict what can be done
with in vitro embryos.155 Further, some states have laws
requiring certain insurers to provide or offer coverage for
IVF.156
There are various theories that attempt to explain the lack
of federal legislation on IVF, including constitutional
restrictions on government action, deference to medical
practitioners, anti-regulation and free market ideology, and
entanglement with the contentious abortion debate.157 Yet,
despite knowledge of these factors, many had predicted that
legislation would be passed,158 and there has been some public
demand for regulation.159
153. OKLA. STAT. ANN. tit. 10, § 554-556 (West Supp. 2004).
154. 18 PA. CONS. STAT. ANN. § 3213(e) (West 2000).
155. See 720 ILL COMP. STAT. 5/9-1.2 (West 2002) (prohibiting killing any
unborn child, defined as an “individual of the human species from fertilization
until birth”); ME. REV. STAT. ANN. tit. 22, § 1593 (West 2004) (prohibiting the
use, transfer, or distribution of in utero and ex utero fetuses for
experimentation); MASS ANN. LAWS ch. 112, § 12J (Law. Co-op. 2004)
(prohibiting research on a fetus, defined to include embryos); MICH. COMP.
LAWS ANN. § 333.2685 (West 2004) (prohibiting non-therapeutic research on
embryos); MINN. STAT. ANN. §§ 609.266–.2691 (West 2003) (providing for
various offenses against unborn children, defined to be “the unborn offspring
of a human conceived, but not yet born”), MINN. STAT. ANN. §§ 145.421, 422
(West 1998 & Supp. 2004) (prohibiting research on a living human conceptus,
defined to include human organism from fertilization through the first 265
days thereafter); N.M. STAT. ANN. §§ 24-9A-1, -3, -5 (Michie 2003) (prohibiting
research on a fetus, defined as the product of conception); N.D. CENT CODE 1402.2-01 (2004) (prohibiting research on a fetus “before or after expulsion from
its mother’s womb”); 18 PA. CONS. STAT. ANN. §§ 3203, 3216 (West 2000)
(prohibiting non-therapeutic research on an unborn child, defined as a human
from fertilization until live birth); R.I. GEN. LAWS § 11-54-1 (2002) (prohibiting
research on a live fetus, defined to include an embryo); S.D. CODIFIED LAWS §§
34-14-16 to -20 (Michie 2004) (prohibiting research on an embryo, defined to
include in vitro embryos from the single-celled stage); UTAH CODE ANN. § 76-7310 (2003) (prohibiting research on live unborn children; held
unconstitutionally vague in Jane L. v. Bangerter, 61 F.3d 1493, 1502 (10th
Cir. 1995)); WIS. STAT. ANN. § 940.04 (West 1996 & Supp. 2004) (prohibiting
destruction of an unborn child, defined as a human being from conception
until live birth).
156. See supra note 137.
157. See George J. Annas, The Shadowlands: The Regulation of Human
Reproduction in the United States, in CROSS CURRENTS: FAMILY LAW AND
POLICY IN THE UNITED STATES AND ENGLAND 143, 143 (Sanford N. Katz et al.
eds., 2000); REPRODUCTION & RESPONSIBILITY, supra note 142, at 8-12.
158. See, e.g., Robertson, Procreative Liberty, supra note 54, at 427.
159. See, e.g., Guidelines Sought on Fertilization, N.Y. TIMES, Aug. 9, 1984,
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The history of IVF provides another explanation for the
lack of federal government involvement. In the late 1970s, the
Carter administration appointed an Ethics Advisory Board to
consider issues of research involving human IVF. Federally
funded embryo research had to be reviewed by the Board before
it could proceed.160 The Board issued a report on May 4, 1979,
concluding that it was acceptable from an ethical standpoint to
undertake and fund research involving human IVF and embryo
transfer subject to various qualifications.161 On the moral
status of the embryo, the Board concluded that “the human
embryo is entitled to profound respect; but this respect does not
necessarily encompass the full legal and moral rights
attributed to persons.”162 The Board recommended that a
model or uniform law be drafted dealing with the legal status of
children born as a result of IVF.163
However, the Board’s funding was denied under the
Carter, Reagan, and first Bush administrations. Because
federally funded research in this area had to be approved by
the Board, the lack of Board funding created a de facto ban on
such research. This Board approval requirement was removed
in 1993.164
In 1994, the Human Embryo Research Panel, an advisory
panel within the National Institutes for Health, endorsed
funding for embryo research as well as embryonic stem cell
research.165 While President Clinton approved the Panel’s
overall recommendation on human embryo research, he
prohibited the use of federal funding for the creation of
embryos to be used in research.166 However, in 1995 and
subsequent years, Congress has attached a rider to its
appropriations bill, effectively precluding all funding for
at D23; Pressure to Regulate In Vitro Fertilization Grows as Demand Rises,
N.Y. TIMES, July 28, 1988, at B7.
160. 45 C.F.R. § 46.204(d) (1993).
161. Report and Conclusions: HEW Support of Research Involving Human
In Vitro Fertilization and Embryo Transfer, 44 Fed. Reg. 35,033, 35,056 (June
18, 1979).
162. Id.
163. Id. at 35,058.
164. National Institutes of Health Revitalization Act of 1993, Pub. L. No.
103-43, § 121, 107 Stat. 122, 133 (1993).
165. 1 NAT’L INSTITUTES OF HEALTH, REPORT OF THE HUMAN EMBRYO
RESEARCH PANEL xvi – xviii (1994).
166. See John Schwartz & Ann Devroy, Clinton to Ban U.S. Funds For
Some Embryo Studies, WASH. POST, Dec. 3, 1994, at A1.
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embryo research by the NIH.167 The debate has since moved on
to questions involving embryonic stem cell research.168
It is both the lack of legislative intervention and private
nature of IVF practice and research that gives the area a “Wild
West” image.169 The National Conference of State Legislatures,
for example, complains, “[A] substantial portion of research and
innovative therapy in reproductive medicine need not be
subject to peer review, may not conform to current standards
for informed consent, and may be offering services that have
never been fully evaluated for safety and efficiency.”170
Jonathan Von Blerkom, co-director of the Reproductive
Genetics In Vitro, a Denver clinic, similarly commented that
“[t]hings are done in this field that would never, ever be done in
any other field of medicine without review or without big
studies that look at efficacy or safety.”171
The only direct federal regulation of IVF is found in the
Fertility Clinic Success Rate and Certification Act of 1992,172
which effectively came into operation in 1996, when the
Department of Health and Human Services began to fund its
implementation.173 There are two parts to this Act―reporting
and certification. The reporting requirement, which is now in
operation, institutes a system of centralized annual reporting
on pregnancy success rates.174 The success rates are published
along with a list of clinics that fail to disclose their pregnancy
success rates in accordance with the regulations.175 Not all

167. See, e.g., Consolidated Appropriations Act, 2004, Pub. L. No. 108-199,
§ 510 (2004).
168. See Dep’t of Health and Hum. Services, Fact Sheet (July 14, 2004), at
http://www.hhs.gov/news/press/2004pres/20040714b.html (last visited Feb. 16,
2005).
169. See Alexander N. Hecht, The Wild Wild West: Inadequate Regulation
of Assisted Reproductive Technology, 1 HOUS. J. HEALTH L. & POL'Y 227, 228
(2001).
170. NAT’L CONF. OF STATE LEGISLATURES, supra note 134, at 28.
171. Tracy Weber & Julie Marquis, In Quest for Miracles, Did Fertility
Clinic Go Too Far?, L.A. TIMES, June 4, 1995, at A1.
172. 42 U.S.C. §§ 263a-1 to -7 (2000).
173. Weldon E. Havins & James J. Dalessio, The Ever-Widening Gap
Between the Science of Artificial Reproductive Technology and the Laws Which
Govern that Technology, 48 DEPAUL L. REV. 825, 844 (1999).
174. 42 U.S.C. § 263a-1; see also Reporting of Pregnancy Success Rates
from Assisted Reproductive Technology Programs, 65 Fed. Reg. 53,310 (Sept.
1, 2000).
175. Id. § 263a-5.
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clinics comply with the reporting requirement,176 and the
President’s Council on Bioethics177 has suggested stronger
penalties for noncompliance.178 The Act also directs the
Secretary of Health and Human Services to develop a model
program for the certification of embryo laboratories to be
carried out by the states,179 which was done in 1999.180 To
date, the model program has not been adopted in any state.181
IVF clinics are also affected by more general regulations.
For example, the Clinical Laboratory Improvement
Amendments of 1988 amended the Public Heath Service Act182
to require the certification of “laboratories,” which includes
facilities that examine “materials derived from the human body
for the purpose of providing information for the diagnosis,
prevention, or treatment of any disease or impairment of, or
assessment of the health of, human beings.”183 ART facilities
are not covered by this definition, but the Act does apply to
andrology and endocrinology tests performed at these
facilities.184 Requirements under the Act are confined to issues
of quality control, and states may obtain an exemption from the
Act if they adopt more stringent laboratory certification
requirements.185 The Food and Drug Administration also
exercises jurisdiction over facilities donating, processing, or
storing of sperm, ova, and embryos through its power to
176. In the report for 2002, 391 clinics reported data in compliance with
the Act, and 37 clinics were listed as non-reporting (meaning that their data
were not reported or that verification was not provided by the clinic medical
director). See CENTERS FOR DISEASE CONTROL AND PREVENTION, supra note
23, at 5-6, 509-10.
177. The President’s Council on Bioethics is a Presidential advisory
committee established by Pres. George W. Bush under the Federal Advisory
Committee Act “to advise the President on bioethical issues that may emerge
as a consequence of advances in biomedical science and technology.” Exec.
Order No. 13,237, 66 Fed. Reg. 59,851 (Nov. 28, 2001).
178. REPRODUCTION & RESPONSIBILITY, supra note 142, at 210-14.
179. 42 U.S.C. § 263a-2.
180. Implementation of the Fertility Clinic Success Rate and Certification
Act of 1992 – A Model Program for the Certification of Embryo Laboratories,
64 Fed. Reg. 39,374, 39,382 (July 21, 1999).
181. REPRODUCTION & RESPONSIBILITY, supra note 142, at 50.
182. Pub L. No. 100-578, 102 Stat. 2903 (codified as amended at 42 U.S.C.
§ 263a (2000)).
183. 42 U.S.C. § 263a(a).
184. REPRODUCTION & RESPONSIBILITY, supra note 142, at 63. However,
these tests are not covered by the Act when undertaken as an adjunct to the
performance of ART services. Id.
185. 42 U.S.C. § 263a(p)(2).
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prevent the spread of communicable disease and its power to
regulate drugs, devices and biological products.186 In addition,
the manufacture of certain devices related to the practice of
IVF is regulated.187
Various bodies have considered legislative responses to
issues raised by IVF and other reproductive technologies. The
now defunct Office of Technology Assessment published
Infertility: Medical and Social Choices in 1988, setting out
issues raised by the technology.188 More recent official analyses
of the issues related to reproductive technologies can be found
in the work of the President’s Council on Bioethics. Although
all of the reports issued by the President’s Council touch on
issues related to the practice of IVF,189 the most relevant is the
recent report entitled Reproduction & Responsibility: The
Regulation of New Biotechnologies.190 The New York State
Task Force on Life and the Law has also issued an influential
report.191
The absence of formal government regulation does not
mean that IVF is necessarily the Wild West of medicine.
Various professional groups have imposed extra-legal
standards relating to professional qualifications and the
manner in which procedures ought to be carried out, as well as
opinions on what is and is not acceptable. The bodies that
currently articulate standards for the practice of IVF in the
United States are:
-American Medical Association (AMA). The AMA’s
House of Delegates maintains a code of conduct consisting in
part of nine Principles of medical ethics.192 In addition, the
186. See Human Cells, Tissues, and Cellular and Tissue-Based Products;
Establishment Registration and Listing, 66 Fed. Reg. 5447, 5452-53 (Jan. 19,
2001).
187. 21 C.F.R. §§ 884.6100-.6190 (2004).
188. See Princeton Office of Technology Assessment Website, at
http://www.wws.princeton.edu/~ota/
(last
visited
Mar.
21,
2005),
http://www.wws.princeton.edu/~ota/ns20/alpha_f.html (last visited Mar. 21,
2005) (describing the legacy of the OTA and providing the text of the report).
189. See, e.g., PRESIDENT’S COUNCIL ON BIOETHICS, HUMAN CLONING AND
HUMAN DIGNITY (2002); PRESIDENT’S COUNCIL ON BIOETHICS, MONITORING
STEM CELL RESEARCH (2004); PRESIDENT’S COUNCIL ON BIOETHICS, supra note
74.
190. REPRODUCTION & RESPONSIBILITY, supra note 142.
191 N.Y. STATE TASK FORCE ON LIFE AND THE LAW, ASSISTED
REPRODUCTIVE TECHNOLOGIES: ANALYSIS AND RECOMMENDATIONS FOR
PUBLIC POLICY 170 (1998).
192. AM. MED. ASSOC., PRINCIPLES OF MEDICAL ETHICS, available at
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AMA’s Council on Ethical and Judicial Affairs publishes its
current opinions on how the code applies to specific issues in
medicine.193 These include opinions relevant to the field of
reproductive medicine.194
-American Society for Reproductive Medicine
(ASRM), formerly the American Fertility Society. ASRM
describes itself as a voluntary, non-profit organization
established “for the advancement of the art, science, and
practice of reproductive medicine.”195 The Practice Committee
and Ethics Committee of the ASRM issue guidelines on
particular topics.196 None of these are mandatory, although
they are very influential. The ASRM has also adopted a
Reproductive Laboratory Accreditation Program in conjunction
with the College of American Pathologists.197
-Society for Assisted Reproductive Technology
(SART). SART describes itself as “the premiere organization
of professionals dedicated to the practice of ARTs in the United
States.”198 SART has 370 members, representing over 95% of
clinics practicing ART.199 SART members must report their
success rates annually in accordance with federal law (in fact,
they have been required to report their success rates since
1987),200 allow inspections, and run or use accredited
http://www.ama-assn.org/ama/pub/category/2512.html (last visited Mar. 20,
2005).
193. See Council on Ethical and Judicial Affairs, Code of Medical Ethics:
Current Opinions, at http://www.ama-assn.org/ama/pub/category/4325.html
(last visited Feb. 4, 2005).
194. See E-2.055: Ethical Conduct in Assisted Reproductive Technology, at
http://www.ama-assn.org/ama/pub/category/4325.html (last visited Jan. 20,
2005).
195. ASRM Website, at http://www.asrm.org/mission.html (last visited Feb.
3, 2005).
196. See id., at http://www.asrm.org/Media/Practice/practice.html (last
visited Feb. 4, 2005), http://www.asrm.org/Media/Ethics/ethicsmain.html (last
visited Feb. 4, 2005).
197. See
College
of
American
Pathologists
Website,
at
http://www.cap.org/apps/docs/laboratory_accreditation/lap_info/specialty.html
(last visited Mar. 29, 2005).
198. SART Website, at http://www.sart.org/whatis.html (last visited Jan.
20, 2005).
199. Id.
200. See Med. Research Int’l et al., In Vitro Fertilization / Embryo Transfer
in the United States: 1987 Results from the National IVF-ET Registry, 51
FERTILITY & STERILITY 13 (1989). There are also retrospective reports for 1985
and 1986. Med. Research Int’l & Am. Fertility Soc’y Special Interest Group, In
Vitro Fertilization / Embryo Transfer in the United States: 1985 and 1986
Results from the National IVF/ET Registry, 49 FERTILITY & STERILITY 212
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embryology laboratories. Members of SART are also obliged to
comply with ASRM and SART guidelines, with loss of
membership as the penalty for non-compliance. As of 2001, this
penalty had never been imposed.201 SART also organizes the
National Coalition for Oversight of Assisted Reproductive
Technology, which brings together representatives from various
government agencies and professional, legal, and consumer
groups to discuss mutual issues.202
-American
College
of
Obstetricians
and
Gynecologists (ACOG). Although IVF practitioners need not
join ACOG, many choose to join both ACOG and the Society for
Reproductive Endocrinology and Infertility, an organization
comprised of practitioners certified by the American Board of
Gynecologists in Obstetrics and Gynecology and the
subspecialty of Reproductive Endocrinology.203 Membership in
these organizations is limited to those satisfying certain
professional requirements.204 Those who do join ACOG may be
expelled for failure to comply with ACOG’s rules and ethical
guidelines.205
Although compliance with ASRM, SART, and ACOG
standards is not generally compulsory, it may be required in
particular circumstances. Some health insurance contracts
that cover the cost of IVF for patients, for example, limit
coverage to IVF performed by members of organizations such
as SART or to procedures complying with guidelines issued by
ACOG or ASRM. The reason for this limitation can often be
found in state insurance requirements.206 However, a person
with resources and the willingness to travel can obtain
treatment deemed unethical by the relevant professional
societies. Also, many of the guidelines are themselves worded
(1988).
201. Howard W. Jones, Jr. & Jean Cohen, IFFS Surveillance 01, 76
FERTILITY & STERILITY S5, S10 (2001).
202. SART Website, at http://www.sart.org/whatis.html (last visited Jan.
20, 2005).
203. See SREI Website, at http://www.socrei.org/ (last visited Feb. 17,
2005).
204. See
id.;
ACOG
Website
,
at
http://www.acog.org/departments/dept_notice.cfm?recno=22&bulletin=2635
(last visited Feb. 17, 2005).
205. See ACOG Website, at http://www.acog.org/from_home/acogcode.pdf
(last visited Feb. 17, 2005).
206. Hawaii, Illinois, Maryland, New Jersey, and Texas all limit their
insurance requirements to services provided at clinics complying with
professional codes of practice. See supra note 137.
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The
as advice rather than mandatory requirements.207
President’s Council on Bioethics has recommended
strengthening the enforcement of such professional
requirements.208
B. UNITED KINGDOM
The United Kingdom was where the first IVF child was
born, and it was among the first countries to consider the
ethical and legal implications of IVF. Policies were devised by
the Medical Research Council as early as March 1979.209 In
July of 1982, the Committee of Inquiry into Human
Fertilisation and Embryology was commissioned.210 Its charge
was to consider recent and potential developments in medicine
and science related to human fertilization and embryology; to
consider what policies and safeguards should be applied,
including consideration of the social, ethical, and legal
implications of these developments; and to make
recommendations.211 Dame Mary Warnock was appointed
chair of the Committee and its final report, published in July
1984, became known as the Warnock Report.212 While the
Report was being prepared, other organizations offered
guidelines.213 The Warnock Report concluded that IVF was an
acceptable technique that had passed the research stage and
become an “established form of treatment for infertility.”214 It
recommended the establishment of a statutory licensing
scheme for IVF practitioners, to be administered by a statutory
authority.215 As an interim measure, in 1985 the Medical
Research Council and the Royal College of Obstetricians and
Gynecologists formed a Voluntary Licensing Authority (from
207. REPRODUCTION & RESPONSIBILITY, supra note 142, at 186.
208. Id. at 192.
209. See GUNNING & ENGLISH, supra note 3, at 15.
210. Warnock Report, supra note 98, at 1.2.
211. Id.
212. See id.
213. See Med. Research Council (UK), Research Related to Human
Fertilisation and Embryology, 285 BRIT. MED. J. 1480 (1982); British Med.
Ass’n, Working Group on In Vitro Fertilization and Embryo Replacement and
Transfer, Interim Report on Human In Vitro Fertilisation and Embryo
Replacement and Transfer, 286 BRIT. MED. J. 1594 (1983); Royal Coll. of
Obstetricians and Gynaecologists, Report of the RCOG Ethics Committee on In
Vitro Fertilization and Embryo Replacement or Transfer (1983), discussed in
GUNNING & ENGLISH, supra note 3, at 27-31.
214. Warnock Report, supra note 98, at 5.15.
215. Id. at 13.3.
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1989, renamed the Interim Licensing Authority) to regulate the
The
practice of IVF, including licensing IVF centers.216
Warnock Report was debated in the House of Commons and
House of Lords soon after its release,217 but it was not until
December 1986 that the government published a Consultative
Paper,218 followed by a White Paper in November 1987.219
The Human Fertilisation and Embryology Act 1990 (“UK
Act”),220 which largely implemented the recommendations in
the Warnock Report, was introduced in 1989, passed by a free
vote, and received Royal Assent a year later. The UK Act
creates three levels of control over IVF and other reproductive
technologies.221 The first level, the Act itself, directly prohibits
certain procedures, namely keeping or using an embryo after
the appearance of the primitive streak,222 placing a human
embryo in an animal, and replacing the nucleus of the cell of an
embryo.223 It also instructs practitioners to take account of the
interests of the child to be born, including its need for a father,
The second level consists of
and to offer counseling.224
regulations promulgated by the Secretary of State for Health
which, depending on the subject area, either must be placed
before Parliament and subjected to the possibility of
annulment, or else must receive positive parliamentary
approval.225 The third level covers the responsibilities of the
216. Frances Price, Establishing Guidelines: Regulation and the Clinical
Management of Infertility, in BIRTHRIGHTS: LAW AND ETHICS AT THE
BEGINNING OF LIFE 37, 38-39 (Robert Lee & Derek Morgan eds., 1989).
217. See Douglas Cusine, NEW REPRODUCTIVE TECHNOLOGIES: A LEGAL
PERSPECTIVE 193-96 (1988).
218. See LEGISLATION ON HUMAN INFERTILITY SERVICES AND EMBRYO
RESEARCH: A CONSULTATION PAPER, 1986, Cm. 46. This paper suggested
three alternatives for the control of IVF and related research: (1) a statutory
authority as recommended in the Warnock Report; (2) licenses issued by the
Secretary of State for Health, as suggested by some pro-life groups; and (3)
self-regulation, along the lines of the Voluntary Licensing Authority. See id.
at 9-13.
219. See DEP’T OF HEALTH AND SOC. SEC., HUMAN FERTILISATION AND
EMBRYOLOGY: A FRAMEWORK FOR LEGISLATION, 1987, Cm. 259.
220. Human Fertilisation & Embryology Act (UK Act), 1990 (U.K.).
221. See R (Quintavalle) v. Secretary of State for Health, [2003] 2 W.L.R.
692 at [4].
222. Deemed to have occurred before the “end of the period of 14 days
beginning with the day the gametes are mixed, not counting any time during
which the embryo is stored.” UK Act § 3(4).
223. See id. §§ 3(3)(b), (d).
224. See id. §§ 13(5), (6).
225. See id. § 45.
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Human Fertilisation and Embryology Authority (HFEA), a nondepartmental public body226 reporting to the Secretary of State
for Health. The members of HFEA are appointed in accordance
with the requirements set out in Schedule One of the UK
Act.227 These provisions are designed to ensure that HFEA
includes, but is not controlled by, medical practitioners and
those involved in the infertility industry.228 HFEA’s role is to
license clinics and research centers, including imposing license
conditions, to advise the Secretary of State if called upon, to
issue directions on certain matters, and to prepare and update
a Code of Practice.229 The Secretary of State and Parliament
have some opportunity to monitor HFEA’s activities: the
Secretary and Parliament are presented with an annual
report230 as well as an auditor’s report,231 and the Code of
Practice must be approved by the Secretary of State and laid
before Parliament.232
The UK Act regulates IVF by limiting what activities may
be licensed and controlling the behavior of licensees. It
provides for three categories of licenses―treatment, research,
and storage.233 An application for a license is handled by a
licensing committee, which is a subcommittee of HFEA.234 An
application for a license is followed by an inspection of the
Interim inspections continue to take place
premises.235
annually with additional spot checks, and the license must be
renewed every three years.236 It is possible to appeal to HFEA
from the decision of a licensing committee on the merits,237 and
there is also the possibility of judicial review to correct an error
of law.238
226. HFEA is nominally independent of the public service but relies upon
government funding.
227. See id. § 5; see also id. sch. 1, para. 4.
228. See id. sch. 1, para. 4.
229. See UK Act, §§ 8, 9, 11, 23, 25.
230. See id. § 7(1).
231. See id. § 6(3).
232. See id. § 26(4).
233. See id. § 11.
234. See id. § 9.
235. See UK Act § 9(7).
236. See HUMAN FERTILISATION AND EMBRYOLOGY AUTH., THIRTEENTH
ANNUAL REPORT AND ACCOUNTS 2003/04, at 7 (2004), available at
http://www.hfea.gov.uk/HFEAPublications/AnnualReport/ (last visited Mar.
28, 2005).
237. See UK Act § 20.
238. See id. § 21.
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The first Code of Practice was published in 1991, with
subsequent editions in 1993, 1995, 1998, 2001, and 2003 (the
sixth edition came into effect in March 2004). These revisions
were necessary to address practical problems, new procedures,
new information, and changing legal requirements.239 Section
25(6) of the UK Act provides that, although a failure to observe
a provision of the Code of Practice does not create liability, it
may be taken into account by a licensing committee considering
whether there has been a failure to comply with the conditions
of a license or whether a license ought to be varied or revoked.
The current edition of the Code includes both requirements
and statements of proper conduct.240 Breaches of the Code
must be promptly reported to HFEA.241 The Code of Practice is
significantly more detailed than the Voluntary Licensing
Authority guidelines it replaced.242 According to a survey
published in 1994, clinics are generally satisfied with the
system of licensing and the Code of Practice.243
The Public Health Minister announced in January 2004
that the Department of Health will begin to review the UK Act,
followed by full public consultation in 2005.244 The reasons
given for the review included the need to ensure that “the Act
remains effective in the 21st century,” and was said to be in
response to, inter alia, new procedures and technologies as well
as changing public perceptions of assisted reproduction.245 It is
likely that HFEA will eventually be merged with the Human
Tissue Authority, as established under the Human Tissue Act

239. Lynn Hagger, The Role of the Human Fertilisation and Embryology
Authority, 3 MED. L. INT’L 1, 5-6 (1997).
240. See HUMAN FERTILISATION AND EMBRYOLOGY AUTH., CODE OF
PRACTICE 12 (6th ed. 2003).
241. See id. para. 2.25.
242. The first Code of Practice was forty pages, compared with four pages
of guidelines. See GUNNING & ENGLISH, supra note 3, at 116.
243. See B.A. Lieberman et al., The UK Human Fertilisation and
Embryology Act 1990 – How Well is it Functioning?, 9 HUM. REPROD. 1779,
1779 (1994) (73% of clinics reported that they were satisfied with the system of
licensing and 78% felt that the Code of Practice was working well).
244. DEP’T OF HEALTH, REVIEW OF THE HUMAN FERTILISATION AND
EMBRYOLOGY
ACT
1990
(2004),
available
at
http://www.dh.gov.uk/PolicyAndGuidance/HealthAndSocialCareTopics/Assiste
dConception/AssistedConceptionGeneralInformation/AssistedConceptionGene
ralArticle/fs/en?CONTENT_ID=4069149&chk=MSMizC (last visited Jan. 31,
2005).
245. Id.
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2004.246
Professional organizations in the United Kingdom also
have a role in monitoring the practice of IVF and related
technologies.
For example, the Association of Clinical
Embryologists, representing over 90% of embryologists in the
UK,247 maintains a Code of Conduct, and members are required
to sign a form stating their willingness to comply.248 The Code
contains laudable, but general, goals such as safeguarding
patient interests and exercising due care.249 Non-compliance
with the code may constitute professional misconduct and
entail loss of registration as a clinical embryologist. The Royal
College of Obstetricians and Gynaecologists also publishes
clinical guidelines on the assessment and treatment of
infertility problems.250 This offers advice on what are best
practices, but does not constitute a mandatory code.251
Presumably because of extensive government regulation,
professional bodies have been less involved in the oversight of
IVF in the United Kingdom than in the United States and
Australia.252
C. NEW SOUTH WALES, AUSTRALIA
Like the United States, Australia has a federal system in
which the regulation of medical practice is generally left to the
states. Jurisdiction over the determination of parental rights is
split, with the federal government having power to determine
such rights only in the context of divorce or matrimonial
causes.253 Determination of parental rights for all purposes
246. Human Tissue Act, 2004 (U.K.); HUMAN FERTILISATION AND
EMBRYOLOGY AUTHORITY, supra note 236, at 12.
247. Press Release, Association of Clinical Embryologists, available at
http://ace.ivf.net/ace/press.php (last visited Jan. 31, 2005).
248. ASS’N OF CLINICAL EMBRYOLOGISTS, CODE OF PROFESSIONAL
CONDUCT FOR CLINICAL EMBRYOLOGISTS (2d ed. 2003), available at
http://www.ace.ivf.net/ace/coc2004.doc. (last visited Jan. 31, 2005).
249. See id.
250. NAT’L COLLABORATING CTR. FOR WOMEN’S AND CHILDREN’S HEALTH,
CLINICAL GUIDELINE, FERTILITY – ASSESSMENT AND TREATMENT FOR PEOPLE
FERTILITY
PROBLEMS
(Feb.
2004),
available
at
WITH
http://www.rcog.org.uk/resources/Public/Fertility_full.pdf (last visited Jan. 31,
2005).
251. See id. at 1.
252. See Martin H. Johnson, Should the Use of Assisted Reproduction
Techniques be Deregulated?: The UK Experience: Options for Change, 13 HUM.
REPROD. 1769, 1774-75 (1998).
253. See AUSTL. CONST. ch. 1, pt. V, § 51(xxii).
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therefore requires both state and federal legislation. The
federal Family Law Act includes a section regarding parentage
of children born as a result of artificial conception
procedures.254 The provisions of that section only apply if in
accord with state law. In New South Wales, the Status of
Children Act 1996 is the relevant law.255 Reading the two acts
together, a child born to a married woman as a result of
fertilization procedures such as IVF carried out with the
consent256 of both spouses is presumed to be a child of the
woman and her husband.257 The same applies for co-habiting
unmarried heterosexual couples.258
There is no comprehensive state regulation of IVF in New
South Wales. This is not for lack of consideration. In October
1983, the Attorney General of New South Wales asked the New
South Wales Law Reform Commission to inquire into and
report on the need to make laws with respect to ART.259 The
Commission issued a Discussion Paper in 1987 and its final
report in 1988.260 Compared to the Warnock Committee in the
United Kingdom, the Commission expressed greater confidence
in the possibility of professional self-regulation and greater
doubt about the benefits of legislative schemes, in part because
of their tendency to become “almost immediately obsolete.”261
The recommended approach was to deal with matters of
“fundamental importance” in legislation and to establish an

254. See Family Law Act, 1975, § 60H (Austl.) (as amended by the Family
Law (Amendment) Act, 1987, § 24 (Austl.) inserting § 60H, titled “Children
Born as a Result of Artificial Conception Procedures,” into the Family Law
Act).
255. See Status of Children Act, 1996 (N.S.W.).
256. Consent is presumed. See id. § 14(5); Family Law Act, 1975, § 60H
(Austl.).
257. See Status of Children Act, 1996, § 14(1) (N.S.W.); Family Law Act,
1975, § 60H (Austl.).
258. See Status of Children Act, 1996, § 14(6) (N.S.W.); Family Law Act,
1975, § 60H(4) (Austl.).
259. See NEW SOUTH WALES LAW REFORM COMM’N, REP. NO. 58,
ARTIFICIAL CONCEPTION: IN VITRO FERTILIZATION xv-xvi (1988), available at
http://www.lawlink.nsw.gov.au/lrc.nsf/pages/R58toc (last visited Feb. 21,
2005).
260. See id.
261. Id. at 2.17, 4.1. Similar sentiments were expressed by the then-Law
Reform Commissioner. Russell Scott, Experimenting and the New Biology: A
Consummation Devoutly to be Wished, in 1ST INTERNATIONAL CONFERENCE ON
HEALTH LAW AND ETHICS (Sydney 1986), cited in Helen Szoke, The Nanny
State or Responsible Government?, 9 J.L. & MED. 470, 476 (2002).
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independent body that would operate similarly to HFEA.262
However, no legislation along the lines recommended by the
Commission was enacted.
A national approach to regulation was suggested by the
Family Law Council of Australia in 1985.263 The Council
suggested establishing a national body to advise federal and
state governments as well as the community on the
implications of reproductive technologies and develop ethical
and practice guidelines.264 No such body was established,
although a National Bioethics Consultative Committee was set
up and it produced a number of reports on bioethical issues.265
Eventually, the Australian Health and Welfare Ministers
decided at a joint meeting to transfer responsibility for advising
on bioethical issues to the National Health and Medical
Research Council (NHMRC), a statutory authority266 operating
as the major funding body for medical research in Australia.267
The regulation of IVF is thus left to non-mandatory
guidelines. The Fertility Society of Australia began issuing
standards for the practice of reproductive medicine in 1986,
with the publication of the Code of Practice for Centers using
Assisted Reproductive Technology. In 1987, it established the
Reproductive Technology Accreditation Committee (RTAC),
allocating to it the responsibility for recommending changes in
the Code as required, reviewing applications for accreditation,
monitoring compliance with the Code, encouraging good
practice among clinics, and publishing lists of accredited
clinics.268 Some practices, such as transferring a human
262. See NEW SOUTH WALES LAW REFORM COMM’N, REP. NO. 58, supra
note 259, at 4.2-4.10 (1988).
263. See FAMILY LAW COUNCIL OF AUSTL., CREATING CHILDREN: A
UNIFORM APPROACH TO THE LAW AND PRACTICE OF REPRODUCTIVE
TECHNOLOGY IN AUSTRALIA (1993). The Family Law Council’s role is to advice
the Attorney-General of Australia on matters related to family law. See
Family Law Act, 1975, § 115 (Austl.).
264. See FAMILY LAW COUNCIL OF AUSTL., CREATING CHILDREN: A
UNIFORM APPROACH TO THE LAW AND PRACTICE OF REPRODUCTIVE
TECHNOLOGY IN AUSTRALIA 107 (1993).
265. H.W. Gordon Baker, Problems with the Regulation of Assisted
Reproductive Technology: A Clinician’s Perspective, 9 J.L. & MED. 457, 468
(2002).
266. See National Health and Medical Research Council Act, 1992 (Austl.).
267. Helen Szoke, Regulation of Assisted Reproductive Technology: The
State of Play in Australia, in CONTROVERSIES IN HEALTH LAW 240, 243 (Ian
Freckelton & Kerry Petersen eds., 1999).
268. FERTILITY SOC’Y OF AUSTL., REPRODUCTIVE TECHNOLOGY
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embryo to an animal uterus, are described as “not acceptable”
in the RTAC Guidelines.269 RTAC conducts regular audits to
monitor compliance with the Guidelines and reviews
accreditation periodically (clinics are normally accredited for
three years).270 RTAC also requires that accredited clinics
comply with guidelines issued by the NHMRC.271
The NHMRC guidelines, like the RTAC guidelines, are not
mandatory. The first NHMRC statement on IVF was published
Following public consultation, the NHMRC
in 1982.272
published Ethical Guidelines on Assisted Reproductive
Technology in 1996.273 Although focused primarily on research,
the Guidelines also addressed innovations in clinical practice,
as well as ordinary clinical issues such as consent, counseling,
and record-keeping.274 As in the RTAC guidelines, some
practices were described as “ethically unacceptable” and
“prohibited.”275 The NHMRC required that those offering
reproductive technology services also obtain accreditation from
RTAC and comply with RTAC guidelines. A revised set of
guidelines, with greater emphasis on clinical issues, was
released in 2004.276
In 2002, two federal statutes, the Research Involving
Human Embryos Act, 2002 (Austl.) and the Prohibition of
Human Cloning Act, 2002 (Austl.), were enacted. They have
been either adopted or mirrored in state law. The former Act
regulates the use of “excess ART embryos,”277 and in particular
ACCREDITATION COMMITTEE, CODE OF PRACTICE FOR CENTRES USING
ASSISTED REPRODUCTIVE TECHNOLOGY 4 (2002).
269. See id. at 11.
270. See id. at 12.
271. See id. at 11.
272. NAT’L HEALTH AND MED. COUNCIL, STATEMENT ON HUMAN
EXPERIMENTATION, SUPPLEMENTARY NOTE 4: STATEMENT ON IN VITRO
FERTILIZATION AND EMBRYO TRANSFER (Sept. 3, 1982).
273. NAT’L HEALTH AND MED. RESEARCH COUNCIL, ETHICAL GUIDELINES
ON
ASSISTED REPRODUCTIVE TECHNOLOGY
(1996),
available
at
http://www.nhmrc.gov.au/rescinded/pdf/e28.pdf (last visited Apr. 7, 2005).
274. Id. at iv.
275. Id. at 15.
276. AUSTRALIAN HEALTH ETHICS COMM., NAT’L HEALTH AND MED.
RESEARCH COUNCIL, ETHICAL GUIDELINES ON THE USE OF ASSISTED
REPRODUCTIVE TECHNOLOGY IN CLINICAL PRACTICE AND RESEARCH, DRAFT
FOR
PUBLIC
CONSULTATION
(2004),
available
at
http://www.nhmrc.gov.au/publications/synopses/e56syn.htm (last visited Apr.
7, 2005).
277. Research Involving Human Embryos Act, No. 145, 2002, § 9 (Austl.),
available at http://www.health.gov.au/nhmrc/embryo/pdf/embryact.pdf (last
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research on such embryos.278 Such use must be licensed unless
it is one of a number of specified uses ordinarily carried out in
the course of clinical practice.279 The latter Act prohibits the
creation of a human embryo clone for any purpose as well as
various other activities, some of which had already been
banned.280
The cooperation between state and federal governments on
legislation relating to cloning and research on embryos was the
result of agreement reached by the Council of Australian
Governments.281 This Council also considered the possibility of
a uniform approach to the regulation of ARTs.282 On April 5,
2002, it agreed that national consistency could be achieved
largely through the existing reliance on professional selfregulation through RTAC.283
Although RTAC accreditation and compliance with RTAC
and NHMRC guidelines are not mandatory, there are strong
incentives for compliance. For example, only clinics accredited
by RTAC can access drugs through the government-funded
program284 and only clinics complying with NHMRC guidelines
visited Apr. 7, 2005). This term is defined to refer to those embryos created in
the course of treatment that beyond the reproductive needs of the woman or
couple for whom they were created.
278. Research Involving Human Embryos Act, No. 22, 2003, §§ 3, 5 (Austl.,
N.S.W.), available at http://scaleplus.law.gov.au/html/pastereg/3/1783/top.htm
(last visited Apr. 7, 2005).
279. Research Involving Human Embryos Act, No. 145, 2002, § 10 (Austl.),
available at http:// http://www.nhmrc.gov.au/embryo/pdf/embryact.pdf (last
visited Apr. 7, 2005). As discussed in the text accompanying notes 288 and
289 infra, some of these activities are only exempt if carried out by an
infertility center accredited by RTAC.
280. Id. at §§ 13-23; Research Involving Human Embryos Act, No. 22,
2003,
§§
8-18
(Austl.,
N.S.W.),
available
at
http://scaleplus.law.gov.au/html/pastereg/3/1783/top.htm (last visited Mar. 30,
2005); Gene Technology Act, No. 169, 2000, §§ 192B-D (Austl).
281. The Council of Australian Governments comprises the Prime
Minister, the Premier of each state, the Chief Minister of each territory, and
the President of the Australian Local Government Association.
282. Communique, Council of Australian Governments’ Meeting, June 8,
2001, available at http://www.coag.gov.au/meetings/080601/index.htm#cloning
(last visited Apr. 7, 2005).
283. Communique, Council of Australian Governments’ Meeting, Apr. 5,
2002, Attachment: Arrangements for Nationally-Consistent Bans on Human
Cloning and Other Unacceptable Practices, and Use of Excess Assisted
Reproductive Technology (ART) Embryos,
paras. 11-13, available at
http://www.coag.gov.au/meetings/050402/cloning.htm (last visited Apr. 7,
2005).
284. Szoke, supra note 267, at 244.
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can receive public research funds.285 Further, failure to comply
with guidelines may have consequences in a tort action or an
action for breach of employment contract286, and may create
adverse publicity.287 More recently, the Research Involving
Human Embryos Act, 2002 (Austl.) has created additional
incentives for clinics to obtain RTAC accreditation.
For
example, the use of excess embryos that are not biologically fit
for implantation for diagnostic purposes and the reproductive
use of donor embryos are only exempt from the licensing
requirements in the Act if carried out by an RTAC-accredited
clinic.288 More importantly, it is an offence to intentionally
“use” a human embryo that is not an “excess ART embryo”
outside the body of a woman except for a purpose relating to
the treatment of a woman carried out by an RTAC-accredited
clinic.289 It is unclear what constitutes “use” of an embryo
outside the body of a woman, but if preparing an embryo for
transfer to a woman were to constitute “use,” the new law
would effectively require that all IVF clinics be accredited by
RTAC.290
In 2003, the New South Wales Health Department
released a draft Assisted Reproductive Technology Bill,
The
following public consultation beginning in 1997.291
285. National Health and Medical Research Council Act, No. 255, 1992, §
51(3) (Austl.). This provides that recipients of government funds must comply
with NHMRC guidelines that relate to the ethical conduct of medical research
involving humans. Paragraph 11 of the NHMRC NATIONAL STATEMENT ON
ETHICAL CONDUCT IN RESEARCH INVOLVING HUMANS (1999) specifically refers
to the NHMRC ETHICAL GUIDELINES ON ASSISTED REPRODUCTIVE
TECHNOLOGY (1996).
286. At least where the employment contract requires the employee to
comply with NHMRC and/or RTAC guidelines.
287. Loane Skene, An Overview of Assisted Reproductive Technology
Regulation in Australia and New Zealand, 35 TEX. INT’L L.J. 31, 47-48 (2000).
288. Research Involving Human Embryos Act, No. 145, §§ 10(2)(d), (e)
(2002) (Austl.), available at http://www.nhmrc.gov.au/embryo/pdf/embryact.pdf
(last visited Apr. 7, 2005). These provisions came into force on June 19, 2003.
They came into force under New South Wales law on Oct. 1, 2003. N.S.W.
Government Gazette No. 154, Sept. 26, 2003, at 9522.
289. Research Involving Human Embryos Act, No. 145, 2002, § 11 (Austl.),
available at http://www.nhmrc.gov.au/embryo/pdf/embryact.pdf (last visited
Apr. 7, 2005).
290. Id.
291. NEW SOUTH WALES DEP’T OF HEALTH, DISCUSSION PAPER: REVIEW OF
THE
HUMAN
TISSUE
ACT,
1983
(1997),
available
at
http://www.health.nsw.gov.au/csd/llsb/legislation/artqxd.pdf (last visited Apr.
7, 2005); NEW SOUTH WALES DEP’T OF HEALTH, CONSULTATION DRAFT BILL:
ASSISTED REPRODUCTIVE TECHNOLOGY BILL (Dec. 2003), available at
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Department concluded that:
a combination of health professional and private health facility
regulation with significant self-regulation, has been effective in
respect of many of the clinical aspects of ART. However a range of
issues relating to the social and ethical aspects of ART were identified
as needing to be addressed through specific legislation.292

The draft Bill provides for the registration of practitioners and
allows the Director General of the Department of Health to
prohibit persons from carrying on a business that provides ART
services “if there are reasonable grounds to do so” and, in
particular, if the person has breached relevant legislation.293
There is a separate requirement that treatment be provided by,
or under the supervision of, a medical practitioner.294 Other
parts of the Bill deal with surrogacy, infection control
standards, the requirement that counseling be made available,
the provision of information to patients and gamete donors,
requirements for the consent of gamete providers, and
establishment of a central gamete donor register to allow
gamete donors and their offspring to find out select information
about each other.295
D. VICTORIA, AUSTRALIA
At approximately the same time as the Warnock
Committee was considering issues related to reproductive
technology in the United Kingdom, a similar committee was
considering the same issues in Victoria. Known as the Waller
committee,296 this group worked between May 1982 and August
1984. It issued an interim report in 1982, unanimously
agreeing that IVF for married couples with their own gametes
was ethically acceptable.297 The report seemed to take for
http://www.health.nsw.gov.au/csd/llsb (last visited Apr. 7, 2005).
292. NEW SOUTH WALES DEP’T OF HEALTH, INFORMATION GUIDE,
CONSULTATION DRAFT: ASSISTED REPRODUCTIVE TECHNOLOGY BILL, § 1.1
(2003)
available
at
http://www.health.nsw.gov.au/csd/llsb/legislation/Informationguide.pdf
(last
visited Apr. 7, 2005).
293. CONSULTATION DRAFT BILL, supra note 291, at pt. 2, div. 1, cls. 7, 59.
294. Id. at cl. 11.
295. Id. at pts. 2-5.
296. Its official title was the “Committee to Consider the Social, Ethical
and Legal Issues Arising from In Vitro Fertilization.”
297. VICTORIAN GOV’T COMM. TO CONSIDER THE SOCIAL, ETHICAL AND
LEGAL ISSUES ARISING FROM IN VITRO FERTILISATION: INTERIM REPORT para.
5.5 (Sept. 1982), reprinted in PETER SINGER AND DEANE WELLS, MAKING
BABIES: THE NEW SCIENCE OF CONTRACEPTION 192-93 (1984).
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granted the notion that any restrictions on the practice of IVF
ought to be contained in legislation, as opposed to
A second
administrative or professional requirements.298
report regarding donor gametes was published in 1983.299 The
third and final report was published in 1984, dealing with
further procedures, including cryopreservation of embryos,
embryo experimentation, and surrogate motherhood.300
In 1984, two companion bills were passed by the Victorian
Parliament: the Infertility (Medical Procedures) Act301 and the
Status of Children (Amendment) Act.302 The latter concerns
parentage of children, and corresponds roughly to the
equivalent New South Wales provisions.303 The former, later
amended by the Infertility (Medical Procedures) (Amendment)
Act, 1987, came into force in stages between 1984 and 1988.
This Act was the first legislation regulating IVF and related
It largely followed the
techniques in the world.304
recommendations of the Waller committee. The Act prohibited
cloning and cross-fertilization between human gametes and
animal gametes.305 IVF itself was permitted, but only if carried
out by approved hospitals on married couples306 who were
either infertile or at risk of passing on a genetic disease,
consented to the procedure, and received counseling.307
298. Id. at par. 5.10.2; Louis Waller, Australia: The Law and Infertility –
the Victorian Experience, in LAW REFORM AND HUMAN REPRODUCTION 17, 20
(Sheila A.M. McLean ed., 1992).
299. VICTORIAN GOV’T COMM. TO CONSIDER THE SOCIAL, ETHICAL AND
LEGAL ISSUES ARISING FROM IN VITRO FERTILISATION: REPORT ON DONOR
GAMETES IN IVF (Aug. 1983), reprinted in PETER SINGER AND DEANE WELLS,
MAKING BABIES: THE NEW SCIENCE OF CONTRACEPTION 194-96 (1984).
300. VICTORIAN GOV’T COMM. TO CONSIDER THE SOCIAL, ETHICAL AND
LEGAL ISSUES ARISING FROM IN VITRO FERTILISATION: REPORT ON THE
DISPOSITION OF EMBRYOS PRODUCED BY IN VITRO FERTILIZATION (Aug. 1984)
reprinted in PETER SINGER AND DEANE WELLS, MAKING BABIES: THE NEW
SCIENCE OF CONTRACEPTION 196-97 (1984).
301. Infertility (Medical Procedures) Act, No. 10,163, 1984 (Austl., Vic.).
302. Status of Children Act, No. 8602, 1974 (Austl., Vic.).
303. Current Victorian provisions are in the Status of Children Act, No.
8602, 1974, §§. 10A-10F (Austl., Vic.).
304. Price, supra note 216, at 38.
305. Infertility (Medical Procedures) Act, No. 10,163, 1984, §§ 6(1), 6(2)
(Austl., Vic.).
306. There was an exception for unmarried, cohabitating heterosexual
couples who had already commenced treatment. Id. § 3(2). This type of
limitation has been held to be contrary to federal anti-discrimination law and
therefore invalid. McBain v. State of Victoria (2000) 1009 FCA 116, 123.
307. Infertility (Medical Procedures) Act, No. 10163, 1984, §§ 10-13
(Austl., Vic.).
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In 1995, a replacement Act was passed, the Infertility
Treatment Act.308 The direct prohibitions in that Act are
broader than those in the 1984 Act.309 It also created
mandatory requirements in relation to gamete and embryo
storage, record keeping, and confidentiality.310 As in the earlier
legislation, access to IVF was restricted,311 and consent and
counseling were made mandatory.312 Breach of the Act’s
requirements can lead to criminal penalties.313 In addition, the
1995 Act established a system of approvals of those carrying
out the procedures and licenses of the premises where the
procedures are carried out.314
The 1995 Act also established the Infertility Treatment
Authority (ITA) to administer the licensing and approvals
systems under the Act, including formulating license
conditions.315 One licensing condition imposed by ITA is a
requirement that licensed centers be accredited by RTAC.316
The licensing process is undertaken simultaneously with the
RTAC accreditation process; RTAC addresses technical,
scientific, and clinical matters and the ITA looks at legal
compliance.317
Compared to the regime in the United Kingdom, however,
the Minister of Health and the ITA have relatively little power
to keep the legislation up to date. In Victoria, regulations must
relate to one of a number of topics itemized in the Act.318 The
regulations power in the United Kingdom is broader; for
example, regulations can prohibit or require licenses for
conduct not mentioned in the Act.319
308. Infertility Treatment Act, No. 63, 1995 (Austl., Vic.).
309. Id. at pt. 5, div. 1.
310. Id. at pt. 5, div. 2, and pt. 7.
311. Id. at pt. 8.
312. Id. at pt. 8, div. 2 and pts. 9, 11. Additional consent requirements exist
when donor gametes are used.
313. Id. at pt. 8, div. 5 (establishes that violations result in “480 penalty
units or 4 years imprisonment or both”).
314. Infertility Treatment Act, pt. 8.
315. Id. at pt. 9, div. 1.
316. INFERTILITY TREATMENT AUTH., CONDITIONS FOR LICENCE:
APPLICATIONS FOR LICENCES BY HOSPITALS AND DAY PROCEDURE CENTRES 2.1
(5th ed. 2004), available at http://www.ita.org.au (last visited Apr. 7, 2005)
(referring to provisions of section 93 of the Infertility Act (1995)).
317. INFERTILITY TREATMENT AUTH., ANNUAL REPORT 2004, at 9, available
at http://www.ita.org.au (last visited Apr. 7, 2005).
318. See Infertility Treatment Act, No. 63, 1995, pt. 13, § 165 (Austl., Vic.).
319. Human Fertilisation & Embryology Act (UK Act), 1990, §§ 3(3)(c),
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E. TYPES OF RESPONSES
Each of the jurisdictions discussed here has adopted a
different response to the issues raised by IVF. Throughout
most of the United States, there is little legislation aimed at
controlling the practice of IVF. Federal legislation is primarily
used to correct perceived market flaws, for example by
centralizing the collection of information and comparing the
performance of IVF clinics.320 A few states, such as Louisiana,
New Hampshire, New Mexico, and Virginia have laws
prescribing the manner in which IVF procedures must be
carried out.321 More pervasive than legislation are guidelines
provided by professional associations. New South Wales is
similar, except that there are greater pressures on clinics to
comply with RTAC guidelines.
Two jurisdictions, the United Kingdom and Victoria, have
introduced legislation with the goal of regulating IVF. A
significant difference between the two Acts is the extent to
which the legislature intends its instructions to apply directly
to private parties, rather than through an administrative
body.322 The UK Act contains a broader regulations power and
grants more discretion to HFEA.
The legal uncertainties arising with the introduction of
IVF have also been dealt with differently in each jurisdiction.
In some parts of the United States, for example, there are laws
clarifying who may exercise control over embryos, parentage of
an IVF child, and the circumstances in which an IVF child can
inherit.323 The overall result is patchy, with some jurisdictions
resolving issues legislatively, and most other jurisdictions
relying on the courts to resolve the issues as they arise. In
Australia, issues surrounding parentage of IVF children are
resolved for some, but not all, situations and many new
4(2)-(4), sch. 2, para. 1(g) (U.K.).
320. On the use of compulsory reporting as a form of regulation in the
health care context, see generally William M. Sage, Regulating Through
Information: Disclosure Laws and American Health Care, 99 COLUM. L. REV.
1701 (1999).
321. See supra notes 143, 144, 153 and accompanying text.
322. Edward L. Rubin, Law and Legislation in the Administrative State, 89
COLUM. L. REV. 369, 381 (1989) (Rubin explains that “within the category of
external statutes [statutes addressing the behavior of private parties], there is
an enormous variation in the extent to which the legislation specifies the
effects on private parties that it wants the implementation mechanism to
produce.”).
323. See supra notes 143-155 and accompanying text.
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questions remain unanswered. The United Kingdom has
sought to resolve uncertainties surrounding parentage,
inheritance and control of embryos by legislation.
IV. COMPARATIVE INSTITUTIONAL ANALYSIS
As a result of decisions made at the legislative level, the
regulation of IVF and the resolution of uncertainties arising in
its wake have taken place in different institutions in each of
the jurisdictions described in Part III above. Thus legislatures,
administrative agencies, professional societies, and courts have
had different roles in determining how IVF is practiced and in
answering legal questions posed by IVF-related conduct.
Various schools of thought have emerged on the proper role
of legislators, administrators, and judges in the development of
the law. The “legal process” school attempted to document the
function of each institution in the legal system based on its
area of competence.324 Although this movement has fallen out
of favor following criticism from law and economics and critical
legal studies scholars, the idea of comparing decisional
institutions has not.325
Nevertheless, in the context of urging the law to adapt to
technological change, comparisons between institutions are
usually made fleetingly and are overwhelmed by the
substantive issue. Thus, the discovery and use of a new
product or process is frequently followed by commentary
identifying new ambiguities or criticizing the content or scope
of existing law.326 Rarely is there any detailed discussion of the
means by which the law ought to be changed, and proposals for
reform usually assume that legislation or the establishment of
an administrative body provide the best means of resolving the
problem identified.
At least one commentator has observed that legislative
reform can sometimes cause as much harm as good. In his
book, Limits,327 Roger Dworkin undertook a detailed
324. See generally HENRY M. HART, JR. & ALBERT M. SACKS, THE LEGAL
PROCESS: BASIC PROBLEMS IN THE MAKING AND APPLICATION OF LAW (William
N. Eskridge & Phillip P. Frickey eds., 1994) (tentative edit., 1958).
325. See Edward L. Rubin, Commentary: The New Legal Process, the
Synthesis of Discourse, and the Microanalysis of Institutions, 109 HARV. L.
REV. 1393, 1403-04 (1996). See also Cass R. Sunstein & Adrian Vermeule,
Interpretation and Institutions, 101 MICH. L. REV. 885, 915 (2003).
326. See supra notes 33-39 and accompanying text.
327. ROGER B. DWORKIN, LIMITS: THE ROLE OF THE LAW IN BIOETHICAL
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comparison of legal responses to bioethical questions in the
rapidly advancing fields of biology and medicine.328 Dworkin
explored the dangers of relying on constitutional law or
legislation rather than allowing time for common law evolution
in response to bioethical issues such as those arising out of
sterilization techniques, assisted reproduction, and the
availability of genetic information. He concluded that “[g]iven
our present legal institutions and any that seem likely to
emerge, the soundest response to a social issue posed by
biomedical advance is to begin by assuming that no legal
response is necessary” and that “[i]f a legal response to a
problem is necessary, the common law should be the
The legislature and
presumptive first-line response.”329
government should only intervene where “a real problem exists
that the common law is demonstrably incapable of dealing
with.”330
Dworkin’s
conclusions
are
expressed
broadly,
encompassing all the temptations that a government might
have to intervene. However, it is not that simple. For a start,
legislation, the common law, and the market are “imperfect
alternatives”; each has disadvantages that make it unsuitable
in some situations.331 Further, it is not necessarily the case
that the same institution provides the best solution for each of
the four types of challenge the law faces following technological
change. Nevertheless, there are some general factors to
consider in evaluating the capacity of different institutions to
resolve the sorts of problems brought about by technological
change.
A. PARTICIPATION AND INTEREST GROUP CONFLICT
Any claim that the law needs to change in a particular way
following technological change is contestable. Part II explained
how technological change can generate reasons to implement a
ban, regulate new practices, resolve uncertainty, repeal
existing rules, or alter the scope of existing rules. Whether
these reasons will persuade and override arguments that
change is unnecessary or counterproductive will depend on the
DECISION MAKING (1996).
328. See generally id.
329. Id. at 169-170.
330. Id. at 170.
331. See generally NEIL KOMESAR, IMPERFECT ALTERNATIVES: CHOOSING
INSTITUTIONS IN LAW, ECONOMICS, AND PUBLIC POLICY (1994).
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specifics. Various scholars are likely to take different positions
on whether and how the law ought to adapt. In the real world,
interest groups will inevitably take different positions.
For example, the possibility of IVF raises the question of
whether it ought to be banned, restricted, discouraged, or
encouraged with government funds. At least in the 1970s and
1980s, arguments were made in favor of each of these positions,
and these arguments appealed to different social groups. Some
religious conservatives supporting a ban on IVF expounded
arguments against unnatural reproduction and destruction of
embryos; radical feminists generally came down on the same
side, but for different reasons; libertarians favored noninterference; and other groups, such as the infertile and
infertility specialists had a more personal interest in the
debate.
Where a new technology challenges interests or values,
some or all groups may seek to bring their arguments to the
attention of legislators. Where the issue at stake is within the
power of an administrative agency or a court, individuals and
groups with a personal or philosophical stake may, to the
extent permitted, present their views to that body. It is
therefore impossible to compare institutions without
considering the manner in which they are likely to be
influenced by competing interest groups.
The influence of different interest groups is difficult to
measure precisely. In general, however, the greater the
participation by people with a particular viewpoint in a
decision-making process, the more likely it is that viewpoint
will prevail.332 This is because all decision-making processes
rely, directly or indirectly, on the involvement of outsiders for
their information. The effect of participation on outcomes is
perhaps even stronger when the subject matter is technical; in
such cases, decision-makers rely heavily on the expertise of
others. Scientific and technical explanations can themselves
become powerful vehicles for advocacy, the seeming objectivity
often disguising the biases of the author.333 When those with
expertise have a particular viewpoint, or only one viewpoint is
represented in the technical material submitted to and
332. Id. at 54-56.
333. See, e.g., Dorothy Nelkin, Science, Technology, and Political Conflict:
Analyzing the Issues, in CONTROVERSY: THE POLITICS OF TECHNICAL
DECISIONS 9, 17 (Dorothy Nelkin ed., 2d ed. 1984) (explaining that expert
opinions in an area of controversy are often related to political values).
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considered by the decision-maker, the impact can be
substantial.
People are more likely to participate in politics or court
proceedings if their interest in the outcome is sufficiently high
to make it worth the investment of time. In the case of politics,
perspectives are more likely to be presented and considered if
represented by a group that is sufficiently active and
collectively powerful to attract the interest of politicians. When
the members of a large, diverse group each have only a small
interest in the outcome, generally only the intervention of a
catalytic subgroup will create the momentum needed to
facilitate political influence.334 When a majority becomes
actively interested in an issue, however, its sheer size gives it
Thus interest group
significant political influence.335
participation can lead to minoritarian or majoritarian bias.336
Because courts and legislators rely on different sources for
information and ask different types of questions, they may
reach different conclusions as to what the law ought to be.
Because legislators are less confined in the range of
considerations they may take into account, they can be strongly
influenced by interest group pressures. Political decisions will
be biased towards groups that are organized and politically
powerful.
Courts, on the other hand, will be strongly
influenced by the position of the parties presenting the issue to
the court. Those with an interest in the outcome who are not
parties to the proceedings in which an issue is raised are at a
significant disadvantage in presenting information and
arguments to the court. Thus an embryo’s right to life is more
likely to be taken account of in legislation in those jurisdictions
where this right has political support than in a courtroom.
Louisiana, for example, requires that unwanted embryos be
donated to another couple, even if this is contrary to the wishes
of the gamete providers.337 Some other states prohibit the
destruction of embryos.338 Yet, although the courts in several
334. KOMESAR, supra note 331, at 82-84.
335. Id. at 74.
336. Id. at 97.
337. LA. REV. STAT. ANN. § 9:129-130 (West 2003). The constitutionality of
these provisions have not been tested.
338. See 720 ILL. COMP. STAT. § 5/9-1.2 (West 2002) (prohibiting killing any
unborn child, defined as an “individual of the human species from fertilization
until birth”); MINN. STAT. ANN.. §§ 609.266–.2691 (West 2003) (providing for
various offenses against unborn children, defined to be “the unborn offspring
of a human conceived, but not yet born”); N.M. STAT. ANN. §§ 24-9A-1 to -7
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jurisdictions have considered the fate of frozen embryos, the
rights of the gamete providers (who were parties to the action)
have been controlling, not an embryo’s right to life.339 Thus,
the existence of interest group conflict will have an effect on the
choice of institutional response to technological change and the
consequences of that choice.
B. GOAL-ORIENTED COMPARISON
The existence of interest group conflict makes it essential
that institutional comparisons be made in the context of a
particular goal. Otherwise, disagreement about which
institution ought to deal with a particular issue can mask
disagreement about what the resolution ought to be. Where
there is extensive controversy over ends, arguments about
means play a justifiably minor role. For this reason, it is best
to refrain from comparing potential, different institutional
means for achieving contested objectives.
The comparison of institutions is likely to be more fruitful
when there is relative consensus on the goals to be achieved;
the performance of different institutions can then be measured.
Yet complete agreement on goals is impossible. Controversies
continue over the extent to which patient autonomy should be
sacrificed for the sake of health, safety, and consumer
protection.
V. NEW REGULATORY MEASURES
A. TYPES OF REGULATION
As discussed in Part II.D above, technological change can
create reasons to enact new laws. In the case of IVF, people
may be concerned that the technology involves health and
safety risks to practitioners, patients, or children-to-be, or
undermines social values considered important, such as human
(Michie 2003) (requiring that embryos be transferred to a woman to avoid
clinical experimentation restrictions); WIS. STAT. ANN.. § 940.04 (West 1996 &
Supp. 2004) (prohibiting destruction of an unborn child, defined as a human
being from conception until live birth).
339. See infra Part VI.D. Although the embryo’s right to life was
considered relevant by the trial court in Davis v. Davis, No. E-14496, 1989 WL
140495, at *9, *11 (Tenn. Cir. Ct. Sept. 21, 1989), this approach was rejected
on appeal. Davis v. Davis, No. 180, 1990 WL 130807, at *2, *3 (Tenn. Ct. App.
Sept. 13, 1990); Davis v. Davis, 842 S.W.2d 588, 597, 603-04 (Tenn. 1992).
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dignity, family values, equality, and fairness. While this has
not led to a ban, it has led in some jurisdictions to restrictions.
There are various means (often used in combination) by
which technology might be controlled:
-Approval (technology): requiring that any new product
or process in a particular category obtain advance approval or a
license from a public or private body;
-Approval (people): requiring that manufacturers,
technologists, or users be approved or licensed by a public or
private body;
-Criteria340 (technology): requiring that a new product
meet certain design specifications or a new process only be
performed in a specific way;
-Criteria (people): requiring that manufacturers,
technologists, or users possess certain qualifications or
characteristics; and
-Criteria (performance): requiring that a new product or
process meet certain performance indicators.
Approval regimes can be used to regulate an established
class of products or processes by requiring that new members of
that class be approved by a designated body, usually an
administrative agency. For example, the UK Act requires that
each entity performing a new procedure involving in vitro
fertilization of human gametes or donated gametes for the first
time obtain a license to do so from HFEA.341 However, approval
regimes are only useful in regulating new members of a class of
established technologies; by the time the UK Act was enacted
in 1990, reproductive technologies were an established class.
Where new types of technology enter the stage, there may be no
approvals regime in place. At that point, a decision must be
made whether to ban or regulate the new technology and
whether to impose a regime to govern future similar
technologies. Of course, new technologies might be included
within broadly drafted existing approval regimes. In the United
States, for example, the Food and Drug Administration invoked
its authority over drugs, devices and biologics in order to

340. The word “standards” is often used in place of the word “criteria.” The
latter has been chosen here to avoid confusion with the use of the word
“standard” as the opposite of “rule.”
341. Human Fertilisation & Embryology Act (UK Act), 1990, §§ 16, 17
(U.K.); HUMAN FERTILISATION AND EMBRYOLOGY AUTH., CODE OF PRACTICE
1.5-1.19 (6th ed. 2003).
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effectively ban human cloning.342 In the United Kingdom,
HFEA was able to use its existing powers to consider whether
to license clinics to perform genetic testing and tissue typing of
embryos prior to transfer in order to determine which embryos
would be both free of genetic disease and a suitable tissue
match for a sick sibling.343
Criteria requirements specify characteristics that the
technology or persons associated with it must possess. These
requirements might be either rule-like, in that the content of
the requirement is specified in advance, or standard-like, in
that the content of the requirement remains vague until
applied in a specific case.344 Rule-like restrictions on the
technology itself offer precise guidelines to technologists, and
the deterrence effect is strong. The main drawback is the
possibility that technology will become frozen in its current
state of development, hindering further improvements in
efficacy and safety.345 The extent of this problem will depend on
the nature of the rule adopted; in some cases, benefits of
technological advancement may not become available until the
rules are amended. Because lobbying for changes in the rule
can be expensive, especially if the rule is legislative, the very
existence of rule-like criteria creates a disincentive for those
who otherwise would seek to advance the technology. Rule-like
performance criteria can place fewer constraints on
342. Letter from Stuart L. Nightingale, M.D., Assoc. Comm’r, FDA, to
multiple
recipients
(Oct.
26,
1998),
available
at
http://www.fda.gov/oc/ohrt/irbs/irbletr.html (last visited Apr. 7, 2005); Issues
Raised by Human Cloning Research: Hearing Before the House Subcommittee
on Oversight and Investigations, House Committee on Energy and Commerce,
107th Cong. 79-81 (2001) (statement of Kathryn C. Zoon, Dir., Ctr. for
Biologics
Evaluation
and
Research,
FDA),
available
at
http://energycommerce.house.gov/107/Hearings/03282001hearing141/Zoon205.
htm (last visited Apr. 7, 2005). See generally Richard A. Merrill, Human
Tissues and Reproductive Cloning: New Technologies Challenge FDA, 3 HOUS.
J. HEALTH L. & POL’Y 1, 52-78 (2002).
343. For a history of HFEA’s decisions on this issue, see
http://www.hfea.gov.uk/PressOffice/PressReleasesbysubject/PGDandtissuetypi
ng.
344. On the distinction between rules and standards, see CASS R.
SUNSTEIN, LEGAL REASONING AND POLITICAL CONFLICT 21-22 (1996); Louis
Kaplow, Rules Versus Standards: An Economic Analysis, 42 DUKE L.J. 557
(1992).
345. STEPHEN BREYER, REGULATION AND ITS REFORM 115–16 (1982);
Richard B. Stewart, Regulation, Innovation, and Administrative Law: A
Conceptual Framework, 69 CAL. L. REV. 1256, 1262, 1281 (1981); Murray
Mackay, Liability, Safety, and Innovation in the Automotive Industry, in THE
LIABILITY MAZE 220 (Peter W. Huber & Robert E. Litan eds., 1991).
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technological development than rules restricting the
characteristics of a new product or process. Because the control
is over outputs, designers are free to choose different
technological means of achieving mandated ends.
In the case of standard-like criteria, the distinction
between restrictions on the technology, its practitioners, and its
performance may be blurred. Compliance with a requirement
that a process be carried out with “due regard to safety” might
take account of design features of a product or the steps used in
a process, the characteristics and qualifications of those
making the product or carrying out the process, and the degree
of harm ultimately caused. Standards give less direction to
technologists than rules as to what is required, but by the same
token they allow technologists more flexibility in optimizing a
design or procedure.346
The relative advantages and disadvantages of rules and
standards have been discussed extensively elsewhere.347 In a
context of ongoing technological change, standards offer some
additional advantages over rules. Rule-like criteria as to how a
new product is to be designed or a new process carried out may
cease to be applicable or may constrain beneficial technological
development.348 Standards are particularly efficient when a
technology is in an early stage of development, with frequent
adjustments and low uptake.349
The deterrent effect of regulation is likely to depend on the
whether it requires pre-approval or sets out rule-like or
standard-like criteria as well as the consequences of noncompliance. Compliance with approval regimes or rule-like
criteria is easy to check.
The deterrent effect of these
mechanisms is therefore stronger than for standard-like
criteria, where there may be disagreement or uncertainty as to
what constitutes compliance. Although harsher penalties will
usually enhance compliance, they may also create an
adversarial atmosphere between the regulator and the
regulated, where compliance is minimal and forced, rather than
346. Tech. Assessment Panel of the Nat’l Acad. of Sciences, Technology:
Processes of Assessment and Choice (1969), in LAURENCE H. TRIBE,
CHANNELING TECHNOLOGY THROUGH LAW 596-97 (1973).
347. See, e.g., SUNSTEIN, supra note 344; Kaplow, supra note 344; Russell
B. Korobkin, Behavioral Analysis and Legal Form: Rules vs. Standards
Revisited, 79 OR. L. REV. 23 (2000).
348. See, e.g., SUNSTEIN, supra note 344, at 131-32, 163; Kaplow, supra
note 344, at 616.
349. See Kaplow, supra note 344, at 562-63.
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co-operative and willing.350 Deterrence is rarely absolute; even
clear rules with criminal consequences can be breached and no
regulatory regime can guarantee the absence of unscrupulous
or careless practices.351 Despite extensive IVF regulation in the
United Kingdom, there have been cases of accidental errors352
and even intentional foul play.353
B. THE REGULATORS
It may be possible to impose at least some of these different
types of regulation by alternative means. There are various
potential “regulators” of new technologies, the most well-known
of which are the market, courts relying on existing law
(especially tort, contract, and criminal law), private groups
(such as professional organizations), legislatures, and
administrative agencies.354 Some of these will be limited in the
types of regulation they can legitimately impose and some are
dependent on the existence of others (for example,
administrative agencies require empowering legislation). This
Part sets out some of the strengths and weaknesses of each
regulator in controlling a technology in order to achieve
relatively uncontroversial goals such as health, safety, and
consumer protection.
1. The Market
Markets do not regulate technologies directly. However,
they do control health and safety to the extent that, in a perfect
market, people will pay more for services that pose less risk. A
consumer-oriented
patient
population
with
adequate
information could use market power to protect itself from harm

350. Martin H. Johnson, The Art of Regulation and the Regulation of ART:
The Impact of Regulation on Research and Clinical Practice, 9 J.L. & MED.
399, 411 (2002).
351. See Judith F. Daar, Regulating Reproductive Technologies: Panacea or
Paper Tiger?, 34 HOUS. L. REV. 609, 664 (1997).
352. See Leeds Teaching Hospitals NHS Trust v A, [2003] E.W.H.C. 259
(involving a sperm mix-up).
353. For example, in the United Kingdom, an embryologist was found
guilty of assault causing actual bodily harm and false accounting to obtain
money by deception after being accused of pretending to transfer embryos that
in fact remained in storage. Embryologist Fooled IVF Patients, BBC NEWS,
Dec. 11, 2002, available at http://news.bbc.co.uk/1/hi/england/2562779.stm
(last visited Apr. 7, 2005).
354. See infra note 428.
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associated with IVF and related technologies.355
There are, however, imperfections in the market.
Consumers may be unaware of the nature and extent of the
risks posed. In a perfect market, consumers will spend
resources to obtain information in proportion to the perceived
benefit of that information (assuming of course that they are
aware that useful information might exist and can estimate its
However, information may have collective
value).356
importance to consumers without any single consumer or
provider being willing to spend the resources necessary to
obtain it. Further, consumers may be in a weak bargaining
position or may be emotionally involved and therefore less
willing to negotiate.357 Finally, a technology may have an
adverse impact on people who are not parties to any
transaction involving their use; in the case of IVF, the
conceived child is in this position. While hopeful parents will
usually take the interests of a future child into account, there
may be conflicts between their interests and those of the childto-be.358
Some deficiencies in the market can be reduced without
the need for broader regulation. For example, professional
organizations or administrative agencies might collect and
distribute data to minimize information deficiencies. In the
United States, SART and ASRM and, later, the Centers for
Disease Control and Prevention, under legislative mandate,
have collected information about success rates at different
clinics as well as other important statistics.359
Identifiable market deficiencies are not the only concern
with markets in sensitive areas such as IVF. For some people,
the very idea of a market in reproductive services, a market in
355. Daar, supra note 351, at 664.
356. See generally ANTHONY I. OGUS, REGULATION: LEGAL FORM AND
ECONOMIC THEORY 38-41 (1994).
357. Meena Lal, Comment, The Role of the Federal Government in Assisted
Reproductive Technologies, 13 SANTA CLARA COMPUTER & HIGH TECH. L.J.
517, 535 (1997).
358. RESOLVE, a United States advocacy group for people with infertility
problems, denies the existence of this conflict. See Letter from Vicki Baldwin,
Chair of the Board of Directors of RESOLVE to Leon R. Kass, Chairman,
President’s Council on Bioethics (Oct. 2, 2003), available at
http://www.resolve.org/main/national/advocacy/letters/Presidents-CouncilLetter-20031002.doc (last visited Mar. 29, 2005).
359. See, e.g., Med. Research Int’l et al., supra note 200. Reports issued by
the Centers for Disease Control and Prevention are available at
http://www.cdc.gov/reproductivehealth/art.htm (last visited Apr. 7, 2005).
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embryos, or a market in gestational services is abhorrent.360 To
the extent that new technologies create potential new markets
that are seen as degrading, legislation can be enacted to
prevent the market forming. For example, some jurisdictions
prohibit the sale of embryos.361
2. Existing Rules Enforced by the Courts
a. Problems with Existing Rules Following Technological
Change
Where conduct, including deceptive conduct or conduct
threatening health and safety, will violate existing legal norms,
the threat of litigation is one means of deterring that conduct.
In the context of technological change, there is a risk that
application of existing rules will appear uncertain (reducing
their deterrent effect) or existing rules will, on their terms, be
under-inclusive. In either case, rules designed to address a
particular problem may fail to prevent similar problems
because they were not crafted in contemplation of future
technological changes. A few examples will illustrate both the
potential regulatory effect of existing rules and their potential
for failure following technological change.
i. Del Zio v. Presbyterian Hospital362
In 1972, the Del Zios decided to undergo an IVF procedure,
after having been advised that IVF had not yet been attempted
in humans.363 On September 12, 1973, ova were removed from
Mrs. Del Zio and taken to the Presbyterian Hospital, where Dr.
Shettles mixed the ova with sperm from Mr. Del Zio in a test
tube culture.364 The result was stored in an incubator at the
Presbyterian Hospital, where it was to remain for four days.365
On September 13, however, Dr. Shettles’s supervisor, Dr.

360. See generally Margaret Jane Radin, Market-Inalienability, 100 HARV.
L. REV. 1849 (1987). But cf. Neil Duxbury, Do Markets Degrade?, 59 MOD. L.
REV. 331 (1996) (arguing that objections to certain types of markets are in fact
better expressed in terms of specific concerns, rather than as an objection to
markets per se).
361. See, e.g., FLA. STAT. ch. 873.05 (2003).
362. No. 74 Civ. 3588, 1978 U.S. Dist. LEXIS 14450 (S.D.N.Y. Nov. 14,
1978).
363. Id. at *2.
364. Id. at *3.
365. Id.
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Vande Wiele, with the concurrence of the President of the
hospital and the Dean of Columbia University Medical School,
had the test tube removed from the incubator, brought to his
office, and placed in the deep freeze.366 These actions destroyed
the culture.367 Following these events, Mrs. Del Zio claimed to
have suffered emotional distress.368 Mr. and Mrs. Del Zio sued
the hospital, Dr. Vande Wiele, and Columbia University on
theories of intentional infliction of emotional distress and
conversion.369 The jury, accepting the former claim only,
awarded Mrs. Del Zio $50,000 and Mr. Del Zio $3.370 A motion
to set aside the verdict or grant a new trial was dismissed.371
Thus, even in the early days of an experimental new
technology (these events took place even prior to the birth of
Louise Brown), new forms of conduct were restricted. Although
there were no specific laws governing what could or could not
be done with an in vitro embryo, the elements of the tort of
intentional infliction of emotional distress were broad enough
to cover the destruction of an embryo in circumstances where
the progenitors might be emotionally harmed.
The same tale also reveals some weaknesses in the notion
of courts as protectors. Tort law operates retrospectively.372
Mrs. Del Zio had already suffered emotional distress. The
money might offer a measure of vindication, but it did not make
the harm go away. Statutes, unlike tort law, can also operate
prospectively by setting up a system of statutory requirements
and monitoring compliance on a regular basis.
ii. Between Persons and Property
Both statutory and common law rules are based on
categories rooted in the state of the world at some time in the
past. When technological change creates entities that fall
outside established categories, existing doctrine may be
uncertain or ineffective. In such cases, protections traditionally
offered by tort, contract, property, or criminal law will not
apply. This problem is evident in cases involving conduct that
366. Id. at *3-4.
367. Del Zio v. Presbyterian Hosp., No. 74 Civ. 3588, 1978 U.S. Dist.
LEXIS 14450, *3 (S.D.N.Y. Nov. 14, 1978).
368. Id. at *4.
369. Id. at *5, *10.
370. Id. at *11.
371. Id. at *24.
372. Cohen, supra note 108, at 353.
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would constitute theft or conversion if embryos were treated as
property, or manslaughter, kidnapping, or false imprisonment
if embryos were treated as persons.
Consider the case of Cora Creed. She discovered that Dr.
Parker, who had assisted in the performance of her IVF
procedure, had transferred embryos created with her ova and
her partner’s sperm into another woman.373 Mrs. Creed sued
for malpractice, claiming not property conversion or harm
against the embryo but her emotional injuries as damages.
However, her malpractice action failed because the injuries
claimed were not related to physical trauma to her.374 The tort
of negligence proved insufficient to fill the gap caused by the
absence of torts addressing harm to embryos, being neither
property nor persons.
Another case illustrating a similar problem is Doe v. Irvine
Scientific Sales Co.375 In that case, human albumin used in the
culture during an IVF procedure had been exposed to
Creutzfeldt-Jakob Disease and the embryos had to be
discarded.376 The progenitors based their claim against the
manufacturer of the albumin on their emotional distress, the
financial loss they had suffered in obtaining medical services
that were now fruitless, and the loss of their potential child.377
A federal district court held that there was no claim for
negligent infliction of emotional distress because the harm was
not related to a physical injury to them, no claim for negligence
based on pure economic loss, and no claim for loss of life,
because the embryo was not yet a person.378
In Frisina v. Women and Infants Hospital the Superior
Court of Rhode Island considered motions to dismiss plaintiffs’
suit based on the alleged negligent destruction of their embryos
The plaintiffs had alleged
at defendant’s IVF clinic.379
negligent infliction of emotional distress (which, under Rhode
Island law, would require that the embryos be “victims”) and
emotional distress following breach of contract.380 Defendant
373. Creed v. United Hosp., 190 A.D.2d 489, 490 (N.Y. App. Div. 1993).
374. Id. at 492.
375. 7 F. Supp. 2d 737, 738 (E.D. Va. 1998).
376. Id. at 739.
377. Id.
378. Id. at 740-42.
379. No. CIV. A. 95-4037, No. CIV. A. 95-4469, No. CIV. A. 95-5827, 2002
WL 1288784 (Sup. Ct. R.I. May 30, 2002).
380. Id. at *2.
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succeeded in dismissing the first claim because embryos could
not be treated as persons (and thus were not “victims”),
plaintiffs were not physically present to witness their
destruction, and their emotional distress had no physical
symptoms.381 The motion to dismiss failed on the second claim
because Rhode Island law allows recovery for emotional
distress based on the loss of “property” in some
circumstances.382
These cases are examples of conduct of which most people
would disapprove (negligently transferring an embryo into the
wrong woman, negligently exposing embryos to disease, and
negligently destroying embryos) for which the tort system
proves inadequate. Various doctrinal areas of law provide
remedies for damage to persons and property, and even
sometimes gestating fetuses, but fall short of covering conduct
related to in vitro embryos. Where, as in Frisina, embryos are
treated as property, the claims have some chance of success.383
But so long as they fall outside the legal categories of property
and persons, plaintiffs can be left without remedy. Before the
creation of in vitro embryos, there was no need for legal rules to
protect them and their progenitors. General legal rules offered
protection against harm to persons and property. However,
courts may be unable to use such rules to protect an entity that
falls outside established categories.384
iii. Scandal in California
In May 1995, a lawsuit was filed by the University of
California at Irvine against three directors of its Center for
Reproductive Health.385 The suit alleged that the doctors stole
eggs from some women and transferred them into others,
administered unapproved fertility drugs, and performed
The allegations
research on patients without consent.386
followed complaints in 1994, internal investigations, and a
threat by the National Institutes of Health to pull the

381. Id. at *8.
382. Id. at *10.
383. See id.
384. See generally Freeman, supra note 39, at 6 (“Courts [in common law
systems] find themselves constricted by policies, concepts and categories
invented to deal with the issues of another age.”).
385. Weber & Marquis, supra note 171.
386. Id.
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University’s funding.387
The police and state district attorney investigated the
matter, but were concerned that many of the alleged activities
did not fall under any provisions of the penal code.388 Orange
County prosecutors ended up concluding that they could not
prosecute embryo theft because under theft and embezzlement
laws, a value would need to be assigned to the embryo.389 In
fact, California’s embezzlement statute contained no valuation
language, but did require that the entity appropriated be
property.390 In addition to these legal problems, prosecutors
faced the practical problem that two of the directors had fled
the country.391 The remaining director, whose involvement in
the scandal was the least direct, was convicted for mail fraud in
federal court as a result of misreported insurance claims.392
This case offers an example from criminal law of the same
types of problems discussed above. Sometimes, alternative
means of bringing an action exist (intentional infliction of
emotional distress in the Del Zio case and mail fraud in the
California scandal), but this is not guaranteed.
When
technological change creates the potential for harmful conduct
that falls outside existing rules designed to deal with similar
conduct, in other words, when existing rules are shown to be
uncertain or under-inclusive, courts may not be effective
regulators.
b. Problems with the Tort Law Generally
Other problems faced by potential plaintiffs have less to do
with the fact that the technology is new, and thus outside
existing legal categories, and more to do with hurdles
frequently faced by litigants. For example, causation problems
may prevent patients suing a clinic after failure to become
pregnant even if they can prove that the clinic’s negligent
practices resulted in a low success rate.393 The harm here is
387. Id.
388. See id.
389. See Daar, supra note 351, at 646.
390. CAL. PENAL CODE § 503. See also Daar, supra note 351, at 646-47.
391. Nick Anderson & Esther Schrader, $10-Million Accord with UC
Reported in Fertility Scandal, L.A. TIMES, July 19, 1997, at A1.
392. Peter M. Warren, Fertility Doctor Vows to Win Back his Job; US
Irvine: Sergio Stone, Who Was Linked to the Scandal that Closed the
University’s Clinic, Says He Will Challenge his Firing, L.A. TIMES, Mar. 21,
2000, at B8 (describing the doctor’s involvement).
393. See ISLAT Working Group, ART into Science: Regulation of Fertility
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diffuse; many people suffered a reduced chance of success, but
no one person can claim that they would otherwise have been
successful. Alternatively, numerous practitioners may have
been involved in a single course of treatment, and it may be
difficult to pinpoint the person responsible for causing harm.394
Tort law itself may develop to eliminate such problems, but the
process is slow.395
Tort law also deals poorly with problems that involve
multiple competing variables.396 Molding technology to satisfy
safety and environmental standards is an example of such a
problem; a technical modification that might be appropriate for
avoiding one kind of accident might have other disadvantages.
Tort law, which considers accidents on a case-by-case basis,
tends to focus on the design feature leading to the injury in
question without examining the effects of engineering decisions
in their entirety.397 The overall effect of tort law and the
technological modifications it engenders may thus be to
increase the total risk of harm.
c. Problems with Courts
The manner in which judges and juries gain expertise in
the technology underlying a case is less than ideal. When a
case turns on technical information, courts usually rely on
expert testimony to provide it. When the evidence presented by
each side differs, cross-examination is the primary vehicle by
which each party tries to undermine the other’s position. While
useful for exposing bias, lies, minor inconsistencies, and
unfounded assumptions, cross-examination will not necessarily
Techniques, 281 SCIENCE 651, 651 (1998).
394. I.R. Hill, Liability and In-Vitro Fertilization, 25 MED. SCI. L. 270, 27071 (1985).
395. See David L. Bazelon, Governing Technology: Values, Choices, and
Scientific Progress, in BIOTECHNOLOGY IN SOCIETY: PRIVATE INITIATIVES AND
PUBLIC OVERSIGHT 75, 77 (Joseph G. Perpich ed., 1986). In some sense,
significant movements in legal doctrine (in particular in areas of employer and
manufacturer liability) can be attributed to technological change.
396. See Thomas Barton, Justiciability: A Theory of Judicial Problem
Solving, 24 B.C. L. REV. 505, 550 (1983); Thomas D. Barton, Common Law and
Its Substitutes: The Allocation of Social Problems to Alternative Decisional
Institutions, 63 N.C. L. REV. 519 (1985); Lon L. Fuller, Adjudication and the
Rule of Law, 54 AM. SOC’Y INT’L L. PROC. 1 (1960); see also RICHARD A
EPSTEIN, SIMPLE RULES FOR A COMPLEX WORLD 238 (1995); STEPHEN BREYER,
BREAKING THE VICIOUS CIRCLE 57 (1993).
397. See Bazelon, supra note 395, at 75-76 (discussing trade-offs involving
technology).
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place the judge or jury in a position to understand the bases for
different expert views.398 It is easier to trip up the bad scientist
than to resolve legitimate differences in scientific or technical
opinion. The information that goes into crafting a statute or
rule generally comes in more varied and useful forms. Costbenefit analyses and risk assessments can provide a sensible
basis for policy formation, and differences of opinion between
experts can be resolved in more informal settings. Policymakers also have greater means of understanding the
information presented to them than do judges and juries. Even
with the assistance of parties’ experts or court-appointed
ones,399 judges and juries may be compelled to rely on their own
technically inexpert understandings.
3. Professional Societies
The law of negligence operates best as a deterrent when
potential defendants know what conduct they should avoid.
Acting alone, the law of negligence only deters conduct that
people think a court will find to be unreasonable. The existence
of guidelines can ensure that practitioners are aware of what is
expected of them, and can simultaneously educate judges and
juries. For example, the ASRM issues guidelines of relevance
to IVF clinics.400 Thus many scholars are of the view that tort
law, when viewed against the background of these professional
guidelines, provides a suitable means of reducing unsafe
practices in the medical arena, including IVF.401
Some authors question whether professionals are the
398. See Barry R. Furrow, Governing Science: Public Risks and Private
Remedies, 131 U. PA. L. REV. 1403, 1461 (1983) (pointing out that crossexamination can reveal underlying biases, unstated assumptions, and
methodological shortcomings in expert evidence); Joseph Sanders, From
Science to Evidence: The Testimony of Causation in the Bendectin Cases, 46
STAN. L. REV. 1, 47–51 (1993) (describing how the focus on credibility, putative
biases, and minor inconsistencies can make cross-examination less useful for
the fact finder); see also SHEILA JASANOFF, SCIENCE AT THE BAR 211 (1995).
399. Obviously, court-appointed experts are limited to jurisdictions in
which this option is available.
400. ASRM Website, at http://www.asrm.org/Media/Practice/practice.html
(last visited Feb. 4, 2005).
401. See, e.g., MICHAEL S. BARAM, ALTERNATIVES TO REGULATION 70
(1982); Harry D. Krause, Artificial Conception: Legislative Approaches, 19
FAM. L.Q. 185, 198 (1985); David Adamson, Regulation of Assisted
Reproductive Technologies in the United States, 78 FERTILITY & STERILITY
932, 938 (2002); Robertson, Decisional Authority, supra note 54; John A.
Robertson, Assisted Reproductive Technology and the Family, 47 HASTINGS
L.J. 911, 921 (1996).
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appropriate standard-setters for a technology.402 Although they
are clearly well-placed to evaluate evidence regarding risks,403
there is concern that professional interests, including the profit
motive, might be placed ahead of patient and social interests.404
Self-regulation may be effective at clarifying what constitutes
good conduct and marginalizing incompetent practitioners, but
it may not take account of broader concerns. Much depends on
the nature of the body preparing guidelines. For example,
RTAC, which creates guidelines for the practice of IVF in
Australia, includes seven consumer representatives.405
However, the members are not democratically elected and thus
cannot claim to reflect broader social values.
Issues of
importance to the public, that do not coincide with the concerns
of professionals and their patients, may be better addressed in
a democratic forum.
Another difficulty with professional regulation is the
relative lack of transparency.406 For example, many ASRM
practice guidelines are only available to members or at a fee.407
Legislation is more readily available and is subject to greater
public scrutiny. Professional codes of conduct may also lack a
direct enforcement mechanism. Violation of the rules is only
deterred if either there are legal consequences or consumers
are generally aware of the infraction.
Professional
organizations can encourage compliance by educating
consumers on the existence and importance of the rules.
Legislation can also increase observance of professional codes
by mandating or encouraging compliance.
Where the pressure to conform to a professional code of
conduct is sufficiently great, they can be a useful means of
regulation. Because organized professional groups are usually
aware of ongoing technological developments, professional
402. See, e.g., Hilary Rose, Victorian Values in the Test-Tube: The Politics
of Reproductive Science and Technology, in REPRODUCTIVE TECHNOLOGIES:
GENDER, MOTHERHOOD AND MEDICINE 151, 172 (Michelle Stanworth ed.,
1987).
403. See, e.g., Johnson, supra note 350, at 408.
404. Cohen, supra note 108, at 349-50.
405. Website of the Fertility Society of Australia, RTAC – Composition of
Committee, at http://www.fsa.au.com/rtac/committee.htm (last visited Apr. 7,
2005).
406. See, e.g., Johnson, supra note 350, at 409.
407. For example, ASRM charges for copies of most Practice Committee
guidelines.
See
ASRM
Website,
at
http://www.asrm.org/Media/Practice/practice.html (last visited Apr. 7, 2005).
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standards are likely to be up to date.
4. Legislators
Legislation is required to institute in any state regulatory
regime, although varying amounts of discretion are conferred
on an administrative agency or other body to interpret and
implement the law. Generally speaking, greater legislative
control ensures greater democratic legitimacy and visibility.408
Legislation speaks “with greater force and authority in the
public eye” than judicial, professional, or administrative
regulation.409 However, where technological change is ongoing,
legislation may be insufficiently flexible. As discussed in Part
II.G, statutory rules risk being over-inclusive or underinclusive with respect to future incarnations of a technology. It
is generally harder (and more expensive) to have legislation
amended to take into account further technological change than
to have similar changes made by a professional organization or
administrative agency. Even where legislation delegates power
to an agency, the empowering legislation may become outdated
and prove difficult to amend.
The history of IVF legislation in Victoria provides a good
example of this problem. Not only did the original 1984 Act
hinder the use of embryo biopsy for six years,410 but it was
drafted in such a way that it prohibited GIFT.411 This was
amended in 1987.412 The current Act regulates fertilization
procedures, defined as any of:
(a)the medical procedure of transferring to the body of a woman a
zygote formed outside the body of any woman; or
(b)the medical procedure of transferring to the body of a woman an
embryo formed outside the body of any woman; or
(c)the medical procedure of transferring –
(i)an oocyte,413 without also transferring sperm, to the body of a

408. Of course, much depends on operation of the democratic process.
409. REPRODUCTION & RESPONSIBILITY, supra note 142, at 189.
410. See Karen J. Dawson & John F. Leeton, The Regulation of Assisted
Reproductive Technology in Australia: Issues and Solutions, 163 MED. J.
AUSTL. 204, 204 (1995). Embryo biopsy is the removal of cells from an early
IVF embryo in order to carry out genetic testing to evaluate the suitability of
the embryo.
411. See, e.g., Infertility (Medical Procedures) Act, No. 10,163, 1984, §§ 3, 5
(Austl., Vic.).
412. See Infertility (Medical Procedures) (Amendment) Act, 1987, § 13A
(Austl., Vic.).
413. This is defined in the Infertility Treatment Act, 1995, § 3 (Austl., Vic.)
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woman; or
(ii)sperm (other than by artificial insemination) to the body of a
woman; or
(iii)an oocyte and sperm to the body of a woman.414

Yet it is always possible that the technology will mutate
further, rendering even this relatively broad definition obsolete.
For example, if prior to 2003 it had become possible to incubate
an embryo in an artificial womb for an extended period of time,
this conduct would not have been regulated. Since 2003, such
conduct has been prohibited.415 Yet it is still possible that
technological change will create loopholes in the regulatory
regime. Language cannot be completely technology-neutral; it
is impossible to draft legislation with sufficient precision and
clarity that addresses every possible future technical
variation.416
Similar problems have arisen in the United Kingdom. The
legislation prohibited one cloning technique, replacing the
nucleus of a cell of an embryo with another nucleus.417
However, another technique involving transplanting a nucleus
from a human cell and placing the nucleus in an unfertilized
ovum, did not fall within that prohibition. This newer cloning
technique was not within the contemplation of the British
Parliament in 1990 when it passed the UK Act. There was
some initial uncertainty as to whether the UK Act even
required a license for the newer technique.418 Section 3(1) of
the Act requires a license to “bring about the creation of an
embryo” or to “keep or use an embryo.” The procedure
described above would only require a license if the entity
created were an “embryo” for the purposes of the Act. The
rather confusing and self-referential definition of an “embryo”
in the Act is found in section 1(1):
In this Act, except where otherwise stated –
(a)embryo means a live human embryo where fertilisation is complete,

as an ovum from a woman not including a parthenogenetic oocyte.
414. Infertility Treatment Act, No. 63, 1995, § 3 (Austl., Vic.).
416. See Colin Tapper, Judicial Attitudes, Aptitudes and Abilities in the
Field of High Technology, 15 MONASH U.L. REV. 219, 228 (1989).
417. Human Fertilisation & Embryology Act (UK Act), 1990, § 3(3)(d)
(U.K.).
418. Placing a human embryo created by means other than fertilization
has since been banned in the United Kingdom. See Human Reproductive
Cloning Act, 2001, c. 23, § 1(1) (Eng.).
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and
(b)references to an embryo include an egg in the process of
fertilisation,
and, for this purpose, fertilisation is not complete until the
appearance of a two cell zygote.419

In standard IVF, a human egg is fertilized with human
sperm; the Act is clear that the product of this process, as well
as the entity in transition, is an embryo. But although the
entity created by the cloning process is similar (except that it is
almost genetically identical to the human from whose cell the
nucleus was extracted), the process of fertilization is not
involved. The question of whether an embryo produced by
cloning was an “embryo” came before the House of Lords in the
case of R (on the application of Quintavalle) v. Secretary of
State for Health.420 The House of Lords held that, on a proper
interpretation of the statute, the product of the cloning process
was an embryo. The word “where” in the definition of embryo
was held to create a temporal restriction, rather than to refer to
a particular process. However, prior to this case, the new
cloning technique generated uncertainty.
Because the legislature often lacks foresight as to ongoing
technological change, the question is often raised as to when
legislative regimes ought to be established. Perhaps we need to
wait until we have a good understanding of the technology and
its risks and benefits.421 On the other hand, there may be
advantages to intervening at a stage when a technology is still
developing
so
that
lawmakers
can
influence
the
Delay may allow the choices made by
development.422
professionals to become fixed as a result of material equipment,
economic investment, and habit.423 In some cases, it may even
lead to irreversible harm to the entities or values that would
419. UK Act, § 1(1) (emphasis added).
420. [2003] UKHL 13, [2003] 2 WLR 692.
421. See generally REPRODUCTION & RESPONSIBILITY, supra note 142. See
also Comments by George Annas, quoted in Anne Taylor Fleming, New
Frontiers in Conception, N.Y. TIMES, July 20, 1980, § 6, at 14.
422. See TRIBE, supra note 346, at ch. II; Sørensen, supra note 30, at 19,
23; Stewart Russell & Robin Williams, Social Shaping of Technology:
Frameworks, Findings and Implications for Policy, in SHAPING TECHNOLOGY,
GUIDING POLICY 37, 62 (Sørensen & Robin Williams eds., 2002). For similar
comments in the specific context of IVF, see BONNICKSEN, supra note 91, at 6,
9.
423. See Langdon Winner, Do Artifacts Have Politics, in TECHNOLOGY AND
THE FUTURE 148, 155 (Albert H. Teich ed., 9th ed. 2002); MAZUR, supra note
91, at 123; WESTRUM, supra note 24, at 77-78.
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otherwise have been protected.424
The question of when to intervene need not be absolute.
Andrea Bonnicksen, for example, argues in favor if
incrementalism; laws should be created as harms are
anticipated, but cautiously, so as not to outpace society’s
experience of a technology.425 The slower approach also allows
the government time to assess the success and limitations of
other means of regulation, including the market, general tort
and criminal laws, and professional control. In New South
Wales, for example, the new draft legislation on ART assumes
the existence of professional regulation and focuses only on
issues going beyond RTAC’s mandate.
The incremental
approach can also be criticized as creating a makeshift system
of regulation and risking political avoidance of important
issues.426 An alternative approach is to create mechanisms
that increase the likelihood that legislation will be kept up to
date.427
5. Administrative Agencies428
Agencies are better able to keep the law abreast of new
developments, because they are focused on a narrower range of
issues than are legislatures. Thus, even though administrative
regulations, like legislation, are textual they are more easily
adapted to ongoing technological change.429
Government agencies are diverse even within a single
jurisdiction, and differences between jurisdictions can make
comparison seem a futile exercise. Thus it has been said that
424. See WESTRUM, supra note 24, at 13-16 (discussing the ability of society
to manage its technology).
425. See BONNICKSEN, supra note 91, at 112-13.
426. See, e.g., Jean M. Eggen, The "Orwellian Nightmare" Reconsidered: A
Proposed Regulatory Framework for the Advanced Reproductive Technologies,
25 GA. L. REV. 625, 667, 692 (1991).
427. This will be easier in some jurisdictions than in others because the
speed of legislative response varies. See, e.g., Cass Sunstein, Problems with
Rules, 83 CAL. L. REV. 953, 1005-06 (1995).
428. United Kingdom and Australia have a different government structure
than the United States and the term “administrative agencies” might in some
contexts be misleading. However, in the context of IVF regulation, the U.K.
and Australian authorities to which power has been delegated are relatively
similar to U.S. administrative agencies. The references to administrative
agencies throughout include these bodies.
429. See Kerry Petersen, The Regulation of Assisted Reproductive
Technology: A Comparative Study of Permissive and Prescriptive Laws and
Policies, 9 J.L. & MED. 483, 497 (2002).
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an agency like HFEA could not operate in the United States,430
although a Hastings Center Report is in favor of establishing a
similar entity here.431 What administrative bodies do have in
common is expertise and flexibility advantages over
legislatures.
In particular, they have greater access to
information about particular cases, clinics, and technologies
and face fewer procedural hurdles in making or changing
rules.432
A statute coupled with administrative regulation is thus
more flexible than a statute that attempts to cover the field,
but less flexible than professional regulation. The more power
delegated to the agency to make and interpret law, the more
flexible the resulting regime. Goal-oriented statutes that set
out the goals considered important to the legislature, allowing
the agency to decide how those goals might be achieved in
regulation is the most flexible.433 Similarly, legislation that
prescribes standard-like criteria, leaving the development of
rules and application of the standards to an administrative
agency, is more flexible than legislation prescribing rule-like
criteria. However, because the enabling statute must define
and limit the agency’s power in some ways, the inflexibility
problems of legislation are never fully solved. If too much
power is delegated (for example, delegating power to make any
law without limit), the process loses democratic legitimacy.
Unlike professional organizations, agencies are not directly
associated with an interest group. However, they are
susceptible to “capture” by such groups.434 In particular, they
have little incentive to publicize broad criticisms of the
technology being regulated,435 especially if their funding
structure is linked to license fees.436 Whether or not there are
430. See REPRODUCTION & RESPONSIBILITY, supra note 142, at 189.
431. THE HASTINGS CTR., REPROGENETICS AND PUBLIC POLICY:
REFLECTIONS AND RECOMMENDATIONS S18 (July-Aug., 2003).
432. In the United States, administrative agencies must satisfy the
requirements of the Administrative Procedure Act, 5 U.S.C. §§ 551-59 (2000)
in making rules. Regulations made under the UK Act must in some
circumstances be approved by parliament, UK Act, § 45(4), and there is a
procedure set out for approval of the Code of Practice, UK Act, § 26.
433. See Rubin, supra note 322, at 411-15 (discussing the effectiveness of
goal-oriented legislation).
434. See, e.g., S. SMITH & A. SUTTON, THE HUMAN FERTILISATION &
EMBRYOLOGY AUTHORITY: A CRITIQUE OF ITS FIRST REPORTS (1992-94) 9-11
(1995) (criticizing HFEA).
435. See MAZUR, supra note 91, at 126-27.
436. See, e.g., SMITH & SUTTON, supra note 434, at 10, 21. But see Hagger,
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issues of capture, administrative agencies, like professional
organizations, may not be the most appropriate arbiter of
controversial ethical and moral issues.437 Such issues are best
left to elected representatives.
6. Combined Response
This Part has set out the advantages and disadvantages of
various
regulators―the
market,
courts,
professional
organizations, legislative bodies, and administrative agencies.
Any particular goal might be achieved through one or more of
these mechanisms. Two of the mechanisms (the market and
courts) operate in the background and do not require any steps
to implement. Professional regulation can be encouraged, but
is difficult for an outsider to set in motion.
Interested citizens and scholars are therefore most likely to
press for legislative change, either alone or facilitated by a new
or existing agency. Such proposals, however, should take
account of background mechanisms and, if relevant,
professional regulation or the potential for professional
regulation. It is possible that certain types of regulation,
otherwise desirable, can be omitted from legislation because
existing mechanisms are adequate. Thus the draft New South
Wales bill on assisted reproduction does not duplicate the
functions of RTAC.438
C. AN EXAMPLE: THE PROBLEM OF MULTIFETAL PREGNANCY
In order to illustrate the benefits of alternative forms of
regulation, this Section compares how different institutions in
different jurisdictions have responded to one problem generated
by IVF, high rates of multifetal pregnancies (twins, triplets,
etc.). Such pregnancies pose risks to the health of both mothers
and their children-to-be. While multiples do occur naturally,
there is a strong correlation between multifetal pregnancies
and the use of ART, including IVF.439 This fact gives rise to
arguments that certain practices ought to be prohibited,
restricted, or discouraged, and hence leads to calls for
regulation. Like all such arguments, they are contestable.
supra note 239, at 17-18.
437. See SMITH & SUTTON, supra note 434, at 26.
438. See generally Assisted Reproductive Technology Bill, 2003 (N.S.W.).
439. See generally Anne Lynch et al., Assisted Reproductive Interventions
and Multiple Birth, 97 OBSTETRICS & GYNECOLOGY 195 (2001).
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Altering the way in which IVF is practiced may decrease the
effectiveness of the procedure in terms of its primary goal,
achieving pregnancy and live birth. Further, direct restrictions
on what IVF practitioners may do affects the procreative liberty
of their patients, and may therefore be undesirable or even
contrary to international or constitutional norms.440
Consider the goal of reducing the risk of high order
multifetal pregnancies (triplets and higher-order) without
significantly affecting IVF success rates and without
preventing patients from making use of these techniques in
order to have children, except where their interest in
procreating is outweighed by the risks to their offspring.
Individuals may differ in articulating the circumstances in
which the risk of harm is sufficiently severe to trump
procreative liberty. Nevertheless, there is wide agreement on a
goal such as this. One could craft alternative goals that might
give more or less weight to considerations of procreative liberty
as against the risk of harm to future children, or that reduce
the rate of twins as well as triplets.441 In such a case, the
conclusions may be different, but the analysis would be similar.
Having chosen a goal, it is possible to analyze how different
types of regulation and different regulators might work to
achieve it.
1. The Nature of the Problem
Multifetal pregnancy poses risks to the woman carrying
the pregnancy as well as the fetuses she carries. It increases
the risk of complications in pregnancy including pre eclampsia,
gestational diabetes, and maternal anemia.442 Children who
were born as one of a multiple may suffer problems as a result
of the higher probability of being born prematurely and with
lower birth weight.443 For example, one study showed that
“more than half of all twins and [more than] 90% of triplets are
born preterm or [of low birth weight].”444 This increases the
440. See supra Part IIB.
441. See generally François Olivennes, Double Trouble: Yes a Twin
Pregnancy is an Adverse Outcome, 15 HUM. REPROD. 1663 (2000).
442. VIRGINIA J. BALDWIN, PATHOLOGY OF MULTIPLE PREGNANCY 355-56
(1994).
443. AM. SOC’Y FOR REPRODUCTIVE MED., FACT SHEET: MULTIPLE
GESTATION AND MULTIFETAL PREGNANCY REDUCTION, available at
http://www.asrm.org/Patients/FactSheets/Multiple_Gestation-Fact.pdf
(last
visited Apr. 7, 2005).
444. Elizabeth Arias et al., Annual Summary of Vital Statistics – 2002, 112
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odds of infant mortality and disability.445 In 1996, for example,
16% of all neonatal deaths were multiples, and multiples “were
seven times more likely than were singletons to die within the
Newborns in high order multiple
first year of life.”446
pregnancies
may
suffer
from
respiratory
distress,
intraventricular hemorrhage, motor and speech delay, and
other problems associated with premature birth.447 Later in
life, there is a correlation between multiple birth and
behavioral problems and reduced cognitive function.448
In addition to health problems, parents face additional
financial burdens.449 Costs relating to delivery are higher for
multiple births and will be borne either by the parents or else
by society as a whole in the form of insurance premiums or
taxes.450 There are also psychological consequences from
multiple births for parents, siblings, and the children
Financial and psychological risks are
themselves.451
compounded if one or more of the children suffers from a
significant disability. In addition, because the link between
multiple births and ART is well-known, parents may face social
stigma or be questioned about their fertility status and whether
their children were conceived “normally.”452
One “solution” to the problems of multifetal pregnancy is
PEDIATRICS 1215, 1221 (2003).
445. See Barbara Luke & Louis G. Keith, The Contribution of Singletons,
Twins, and Triplets to Low Birth Weight, Infant Mortality and Handicap in
the United States, 37 J. REPROD. MED. 661, 662 (1992).
446. Bernard Guyer et al., Annual Summary of Vital Statistics – 1997, 102
PEDIATRICS 1333, 1339 (1998).
447. See Schlomo Lipitz et al., High-order Multifetal Gestation –
Management and Outcome, 76 OBSTETRICS & GYNECOLOGY 215, 216-17
(1990).
448. See Adnan T. Bhutta et al., Cognitive and Behavioral Outcomes of
School-Aged Children Who Were Born Preterm: A Meta-Analysis, 288 JAMA
728, 735-36 (2002); L. John Horwood et al., Cognitive, Educational and
Behavioral Outcomes at 7 to 8 years in a National Very Low Birthweight
Cohort, 79 ARCH. DIS. CHILD FETAL NEONATAL ED. F12 (1998).
449. See Nanette Elster & Institute for Science, Law, and Technology
(ISLAT) Working Group on Reproductive Technology, Less is More: The Risks
of Multiple Births, 74 FERTILITY & STERILITY 617, 620 (2000).
450. See generally, e.g., Tamara L. Callahan et al., The Economic Impact of
Multiple-Gestation Pregnancies and the Contribution of Assisted-Reproduction
Techniques to Their Incidence, 331 NEW ENG. J. MED. 244 (1994).
451. See Elster & ISLAT Working Group, supra note 449, at 621.
452. Marcia A. Ellison & Janet E. Hall, Social Stigma and Compounded
Losses: Quality-of-life Issues for Multiple Birth Families, 80 FERTILITY &
STERILITY 405, 407-08 (2003).
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multifetal pregnancy reduction, in which one or more fetuses
are terminated in order to increase the chances of survival of
the remaining fetuses.453 Even disregarding anti-abortion
arguments, there are reasons why prevention is better than
cure. Reduction can create a risk of miscarrying the entire
pregnancy and may lead to feelings of loss and guilt.454 As a
practical matter, women may refuse to undergo selective
reduction.
High multiple birth rates are not an inevitable
consequence of reproductive technologies. There are choices
that can be made to reduce rates of multiple birth. In the case
of IVF, the probability of multiple gestation increases with the
number of embryos transferred into a woman’s uterus in a
single cycle.455 When forty countries in America, Europe and
Asia were classified into “[three] groups depending on the
number of transferred embryos (<2.5, 2.5-3, >3), the percentage
of triplets increased from 1.1% to 3.2% to 5.0%” respectively.456
Reducing the number of embryos transferred thus reduces the
risk of multiple pregnancy. In addition, studies suggest that,
at least for patients with a good prognosis, transfer of more
than two embryos does not increase the chances of success.457
453. AM. SOC’Y FOR REPRODUCTIVE MED., supra note 443.
454. See Am. Coll. of Obstetricians and Gynecologists, Multifetal Pregnancy
Reduction, in ETHICS IN OBSTETRICS AND GYNECOLOGY 43 (2d ed. 2003) (based
on the AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS,
SELECTIVE EMBRYO REDUCTION: ETHICAL GUIDANCE FOR THE OBSTETRICIANGYNECOLOGIST, ACOG COMMITTEE OPINION 215 (1999)).
455. See Allan Templeton & Joan K. Morris, Reducing the Risk of Multiple
Births by Transfer of Two Embryos After In Vitro Fertilization, 339 NEW ENG.
J. MED. 573 (1998).
456. J. De Mouzon, Incidence of High Order Multiple Gestation Associated
with ART: Registry Data Past and Present, paper presented at Bertarelli
Foundation, First Global Conference, Nov. 20-21, 1999, Bethesda, Md.,
available at http://www.bertarelli-foundation.ch/docs/GC_1999_abstracts.pdf
(last visited Apr. 7, 2005).
457. See F. Devreker et al., Comparison of Two Elective Transfer Policies of
Two Embryos to Reduce Multiple Pregnancies Without Impairing Pregnancy
Rates, 14 HUM. REPROD. 83, 87-89 (1999); Ozkan Ozturk & Allan Templeton,
Letter, In-Vitro Fertilisation and Risk of Multiple Pregnancy, 359 LANCET 232
(2002); C. Staessen et al., Avoidance of Triplet Pregnancies by Elective
Transfer of Two Good Quality Embryos, 8 HUM. REPROD. 1650, 1652 (1993);
Murat Tasdemir et al., Two Instead of Three Embryo Transfer in In-Vitro
Fertilization, 10 HUM. REPROD. 2155, 2157-58 (1995); Templeton & Morris,
supra note 455, at 576-77. Previously, it had been suspected that the transfer
of more embryos increased the chance that an embryo would implant. See
R.G. Edwards, In-vitro Fertilisation and Embryo Replacement: Opening
Lecture, 442 ANNALS N.Y. ACAD. SCI. 1, 17 (1985).
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Although the requirements for a patient to be treated as having
a good prognosis differed between studies, all would include
patients less than thirty-five years old who had not previously
attempted ART where at least four embryos were created (one
study required that at least one embryo be of good quality). As
a result, many experts recommend transfer of either one458 or
two459 embryos in such patients. These recommendations
depend on the ability to obtain a sufficient number of high
quality embryos and accurately assess their chance of
implantation.460
The numbers of embryos461 transferred in IVF procedures
in the United States are shown in the following chart (Figure
1).
FIGURE 1: NUMBER OF EMBRYOS TRANSFERRED DURING ART
CYCLES USING FRESH NON-DONOR EMBRYOS IN THE UNITED
458. See, e.g., T. Coetsier & M. Dhont, Avoiding Multiple Pregnancies in InVitro Fertilization: Who's Afraid of Single Embryo Transfer?, 13 HUM.
REPROD. 2663 (1998); David Gardner et al., Single Blastocyst Transfer: A
Prospective Randomized Trial, 81 FERTILITY & STERILITY 551 (2004); Jan
Gerris & Eric Van Royen, Avoiding Multiple Pregnancies in ART – A Plea for
Single Embryo Transfer, 15 HUM. REPROD. 1884 (2000); Jan Gerris et al.,
Prevention of Twin Pregnancy After In-Vitro Fertilization or Intracytoplasmic
Sperm Injection Based on Strict Embryo Criteria: A Prospective Randomized
Clinical Trial, 14 HUM. REPROD. 2581, 2583-86 (1999); H.G.M. Lukassen et
al., Two Cycles with Single Embryo Transfer Versus One Cycle with Double
Embryo Transfer: A Randomized Controlled Trial, 20 HUM. REPROD. 702
(2005); B. Stromberg et al., Neurological Sequelae in Children Born After InVitro Fertilisation: A Population-Based Study, 359 LANCET 461, 464 (2002). De
Sutter et al., Single Embryo Transfer and Multiple Pregnancy Rate Reduction
in IVF/ICSI: A Five Year Appraisal, 6 REPRODUCTIVE BIOMEDICINE ONLINE,
available at http://www.rbmonline.com/Article/836 (May 30, 2003); Single
Embryo Transfer, A New Understanding of Factors for Success, MED. NEWS
TODAY,
June
30,
2004,
available
at
http://www.medicalnewstoday.com/newssearch.php?newsid=10107
(last
visited Apr. 7, 2005).
459. See, e.g., Nicholas M. Fisk & Geoffrey Trew, Two's Company, Three's a
Crowd for Embryo Transfer, 354 LANCET 1572 (1999); Brian Lieberman, An
Embryo Too Many?, 13 HUM. REPROD. 2664, 2666 (1998); Jan Roest et al., A
Triplet Pregnancy After In Vitro Fertilization Is a Procedure-Related
Complication That Should Be Prevented by Replacement of Two Embryos Only,
67 FERTILITY & STERILITY 290, 294 (1997).
460. See generally Gerris & Royen, supra note 459; Helen Pearson, Test
Could
Boost
IVF
Success,
NATURE.COM,
May
13,
2004,
at
http://www.nature.com/news/2004/040510/full/040510-7.html
(subscription
service) (last visited Apr. 8, 2005).
461. The statistics also include eggs transferred in GIFT procedures. In
2002, GIFT accounted for only 0.2 percent of transfers. CENTERS FOR DISEASE
CONTROL AND PREVENTION, supra note 23, at 37.
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In light of the risks outlined above, the numbers of
transferred embryos seem unjustifiably high. Although it is
possible that the high numbers of embryos transferred could be
due to large numbers of poor prognosis patients, this seems
unlikely. Age and number of previous attempts are two strong
indicators of success,463 and were two of the factors taken into
account by studies considering the effectiveness of two embryo
transfer.464 In 2002, women less than thirty-five years old
accounted for approximately 44% of fresh non-donor embryo
transfers (transferring an average of 2.7 embryos per cycle) and
55.5% of cycles were commenced by women undergoing their
first treatment.465 While transfer of more embryos may be
necessary in some patients, the transfer of more than two in
the majority of cases more likely reflects clinic failure. Some
462. Uses data from reports issued by the Centers for Disease Control and
Prevention, available at http://www.cdc.gov/reproductivehealth/art.htm (last
visited Apr. 7, 2005).
463. CENTERS FOR DISEASE CONTROL AND PREVENTION, supra note 23, at
22, 32.
464. See supra note 457 and accompanying text.
465. CENTERS FOR DISEASE CONTROL AND PREVENTION, supra note 23, at
25, 31.
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clinics with poor laboratory culture conditions and ineffective
protocols attempt to compensate by transferring large numbers
of embryos to increase their success rate.466
This is unlikely to be resolved by patient pressure for safer
outcomes. In fact, patients may place pressure on clinics to
transfer more embryos than might be appropriate. Infertile
couples often prefer, or at least have no objection to, multifetal
pregnancies.467 In some cases, this may be the result of lack of
information about the risks of multifetal pregnancy, but there
are other factors. Patients who have been unable to conceive
may be looking for a two-child or three-child family. They may
be aware of, but reluctant to contemplate, the difficulties of
raising multiples. Patients are also concerned about the time
taken to achieve pregnancy and the costs of treatment, which
are incurred on a per cycle basis.468 These costs, as opposed to
the costs of pregnancy and birth, which are usually covered by
insurance, are usually incurred by the patient themselves.
Thus, although single embryo transfer for some patients may
be as cost-effective as double embryo transfer in the short term
and more cost-effective over the long term,469 the patient’s
466. See Richard Bronson, How Should the Number of Embryos
Transferred to the Uterus Following In-Vitro Fertilization Be Determined to
Avoid the Risk of Multiple Gestation?, 12 HUM. REPROD. 1605, 1606 (1997);
Kenneth Faber, IVF in the US: Multiple Gestation, Economic Competition and
the Necessity of Excess, 12 HUM. REPROD. 1614, 1615 (1997).
467. See N. Gleicher et al., The Desire For Multiple Births in Couples with
Infertility Problems Contradicts Present Practice Patterns, 10 HUM. REPROD.
1079 (1995) (recommending modifying clinical practice rather than altering
patient opinion); G.M. Hartshorne & R.J. Lilford, Different Perspectives of
Patients and Health Care Professionals on the Potential Benefits and Risks of
Blastocyst Culture and Multiple Embryo Transfer, 17 HUM. REPROD. 1023
(2002) (many infertile patients were aware of and prepared to accept risks of
multiple pregnancy); Ginny L. Ryan et al., The Desire of Infertile Patients for
Multiple Births, 81 FERTILITY & STERILITY 500 (2004) (study showed that one
in five women listed a multiple birth as their most desired outcome of fertility
treatment); see also Gardner, supra note 458, at 554 (discussing difficulty of
recruiting for a study on single blastocyst transfer); James Goldfarb et al.,
Attitudes of In Vitro Feritlization and Intrauterine Insemination Couples
Toward Multiple Gestation Pregnancy and Multifetal Pregnancy Reduction, 65
FERTILITY & STERILITY 815 (1996) (finding that couples tend to have a
favorable attitude to twins and triplets but less so toward quadruplets).
468. See Christopher J. De Jonge & Don P. Wolf, Editorial, Embryo
Number for Transfer Should Be Regulated, 68 FERTILITY & STERILITY 784, 785
(1997).
469. See Paul De Sutter, A Health-Economic Decision-Analytic Model
Comparing Double with Single Embryo Transfer in IVF/ICSI, 17 HUM.
REPROD. 2891 (2002); P. Wolner-Hanssen & H. Rydhstroem, Cost-Effectiveness
Analysis of In-Vitro Fertilization: Estimated Costs Per Successful Pregnancy
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perspective may be skewed.
2. Common Law Does Not Create Sufficient Incentives
As discussed in Part V.B.2 above, existing rules enforced
by courts can create incentives to eliminate or modify risky
behavior. As discussed below, existing rules have not created a
sufficient incentive to deter the transfer of unsuitably high
numbers of embryos.
a. Contract
If patients are aware of the risks of multifetal pregnancy,
and limit the scope of their consent to the transfer of a small
number of embryos, they can be compensated for damages
incurred if more than the agreed number of embryos are
transferred. In the United Kingdom, Peter and Patricia
Thompson signed a consent form after their initial consultation
at the Sheffield Infertility Centre, agreeing to have two
embryos transferred.470 Defendant argued that the Thompsons
orally communicated a change of heart (though the judge did
not find this credible), and three embryos were transferred.471
The Thompsons
Triplets were born in March 1997.472
succeeded against the infertility center in a suit for breach of
contract.473
Such cases do not, however, address the broader problem.
The Thompsons were either well-informed or lucky signing a
consent form that provided for the transfer of two embryos.
Other couples, due to poor information or emotional and
financial factors, will agree to transfer more embryos than may
be appropriate. Even couples who prefer to transfer fewer
embryos are unlikely to limit their consent explicitly. There
may also be limited opportunities for most patients to assess
the risks of multifetal pregnancy when giving consent; indeed,
women are sometimes required to decide how many embryos to
transfer at the time of the procedure.474

After Transfer of One or Two Embryos, 13 HUM. REPROD. 88 (1998).
470. Clare Dyer, Triplets’ Parents Win Right to Damages for Extra Child,
321 BRIT. MED. J. 1306 (2000).
471. Id.
472. Id.
473. Id.
474. See Ellison & Hall, supra note 452, at 411.
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b. Tort
Tort actions against practitioners for harm suffered due to
multifetal pregnancy following the transfer of too many
embryos are unlikely to be successful. There are significant
causation problems. The transfer of six embryos carries with it
a high risk of conceiving triplets.
If six embryos are
transferred, and triplets result, the defendant will be able to
argue that the same result could have followed from a transfer
of fewer embryos. The difference in risk is difficult to measure
because it depends on the patient’s age, the number of previous
failed IVF attempts, the quality of the embryos used, and the
nature of the patient’s infertility.
Because tort actions following a multiple pregnancy are
unlikely to succeed, the risk of litigation is unlikely to deter
practitioners from transferring more embryos than might be
appropriate. Nevertheless, tort law may create an incentive for
practitioners to advise patients of the risks of multiple
pregnancy. This reduces one of the market failures (lack of
information) but may not affect the patient’s willingness to
take risks as a consequence of their desperation or financial
circumstances.475

3. Attempting to Address Market Flaws – United States
The introduction of ARTs, including IVF, into the United
States has had a significant impact on the proportion of births
involving multiples. The rates of triplet and higher order
multiples per 100,000 births increased from 29 in 1971 to 37 in
1980 (following FDA approval of two ovulation-inducing drugs)

475. See Hartshorne & Lilford, supra note 467, at 1027-28 (noting that
patients are more willing to accept the risks of multiple pregnancy than their
doctors and clinicians); Ryan et al., supra note 467, at 502-03 (It was found
that the desire for multiple births was significantly associated with lower
family income and longer duration of pregnancy, but not associated with
knowledge about triplet gestation outcomes. However, the desire for multiple
births was also associated with limited knowledge about the outcomes of twin
gestation.).
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and then to 193.5 in 1998 (following the introduction of IVF).476
The three biggest contributors to the triplet and higher order
birth rate are IVF and related technologies, ovulation-inducing
drugs, and increasing maternal age.477 In 1998, for example,
56% of the infants born in the United States using IVF and
related procedures were one of multiples as compared with the
national average of 3%.478
There is currently no mandatory limit on the number of
embryos that can be transferred in the United States. Many
practitioners oppose mandated restrictions on the grounds that
individual patient factors, including age, need to be taken into
account in determining how many embryos to transfer.479
While some practitioners favor at least a professionally
recommended limit,480 legislatively mandated limits on embryo
transfer are generally opposed.481 The New York State Task
476. Centers for Disease Control, Contribution of Assisted Reproductive
Technology and Ovulation-Inducing Drugs to Triplet and Higher-Order
Multiple Births – United States, 1980-1997, 49 MORBIDITY & MORTALITY
WKLY. REP. 535, 536 (2000); Joyce A. Martin et al., Births: Final Data for
2000, 50 NAT’L VITAL STAT. REP. 1, 19 (2002).
477. See Martin, et al., supra note 476, at 19.
478. Centers for Disease Control, Use of Assisted Reproductive Technology
– United States, 1996 and 1998, 51 MORBIDITY & MORTALITY WKLY. REP. 97,
99 (2002).
479. See, e.g., Foad Azem et al., Transfer of Six or More Embryos Improves
Success Rates in Patients with Repeated In Vitro Fertilization Failures, 63
FERTILITY & STERILITY 1043, 1045-46 (1995) (recommending transfer of six or
more embryos for women with repeated IVF failures); Maria Bustillo,
Imposing Limits on the Number of Oocytes and Embryos Transferred: Is It
Necessary/Wise or Naughty/Nice?, 12 HUM. REPROD. 1616, 1617 (1997); Ian
Craft & Talha al-Shawaf, Correspondence, Limiting the Number of Oocytes
and Embryos Transferred in GIFT and IVF, 303 BRIT. MED. J. 185 (1991);
Howard W. Jones, Jr. & Jean Cohen, ART – The Number to Transfer, 76
FERTILITY & STERILITY S12, S13 (2001); Roelof J. van Kooij et al., AgeDependent Decrease in Embryo Implantation Rate After In Vitro Fertilization,
66 FERTILITY & STERILITY 769, 774 (1996) (recommending three embryos in
women over 38); Laura A. Schieve et al., Live-Birth Rates and Multiple-Birth
Risk Using In Vitro Fertilization, 282 JAMA 1832 (1999); Eric A. Widra et al.,
Achieving Multiple-Order Embryo Transfer Identifies Women over 40 Years of
Age with Improved In Vitro Fertilization Outcome, 65 FERTILITY & STERILITY
103, 107 (1996) (recommending transfer of four or more embryos in women
over 40). But see Selim Senoz et al., An IVF Fallacy: Multiple Pregnancy Risk
is Lower for Older Women, 14 J. ASSISTED REPROD. & GENETICS 192 (1997).
480. See, e.g., Howard W. Jones, Jr., Multiple Births: How Are We Doing?,
79 FERTILITY & STERILITY 17 (2003); Howard W. Jones, Jr. & John A. Schnorr,
Multiple Pregnancies: A Call for Action, 75 FERTILITY & STERILITY 11 (2001);
Jonge & Wolf, supra note 468.
481. See generally, e.g., Mina Alikani & Klaus Wiemer, Embryo Number for
Transfer Should Not be Strictly Regulated, 68 FERTILITY & STERILITY 782
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Force on Life and the Law considered recommending a limit on
the number of embryos transferred, but opted for professional
standards instead.482 Its reasoning (which is fairly typical) was
as follows:
In general, legislation is an inappropriate vehicle for making medical
treatment decisions, particularly those involving complex and
evolving clinical variables. In the context of ARTs, the appropriate
number of embryos and/or oocytes to transfer may vary considerably
from case to case, depending on the patient’s age, the number of
previously failed attempts, the condition of the embryos, or other
factors. The optimum number is also subject to change as clinicians
develop better methods for evaluating embryo condition prior to
transfer and for improving the likelihood of implantation. Limits set
by legislation are unlikely to keep pace with these developments.483

The ASRM Practice Committee has consistently sided with
those seeking flexibility. In 1994, it chose not to impose any
limit on the number of embryos that could be transferred,
however, it recommended that the number be chosen so that no
quadruplets and no more than 1% to 2% triplet pregnancies
were anticipated.484 In 1998, it repeated its conclusion that
there should be no limit on the number of embryos that could
be transferred.485 Instead, it suggested that clinics create their
own guidelines based on internally generated statistics.486 In
the absence of sufficient data at a clinic, it suggested that
between three and five good embryos be transferred, depending
on the patient’s profile, taking into account factors such as age
and prior treatment history.487 This was revised in November
1999, when the recommendation was changed to between two
(1997); David Adamson & Valerie Baker, Multiple Births from Assisted
Reproductive Technologies: A Challenge that Must Be Met, 81 FERTILITY &
STERILITY 517, 522 (2004); Bronson, supra note 466, at 1606; Faber, supra
note 466, at 1616; Larry I. Palmer, In-Vitro Fertilization as a Social
Experiment, 12 HUM. REPROD. 1617 (1997); Jamie Grifo et al. (on behalf of
SART), Commentary, We are Due for a Correction… and We are Working to
Achieve One, 75 FERTILITY & STERILITY 14 (2001); see also Andrea L.
Bonnicksen & Robert H. Blank, The Government and In Vitro Fertilization
(IVF): Views of IVF Directors, 49 FERTILITY & STERLITY 396 (1988).
482. N.Y. STATE TASK FORCE ON LIFE AND THE LAW, supra note 191, at 170.
483. Id. But see ISLAT Working Group, supra note 393, at 652
(recommending a mandatory limit of four embryos).
484. Ethics Comm. of the American Fertility Soc’y, Ethical Considerations
of Assisted Reproductive Technologies, 62 FERTILITY & STERILITY 1S, 37S
(1994).
485. AM. SOC’Y FOR REPROD. MED., GUIDELINES ON NUMBER OF EMBRYOS
TRANSFERRED (1998).
486. Id.
487. Id.
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and five embryos.488 These guidelines were flexible and
standard-like, allowing adjustment for “individual clinic
conditions”. The guidelines used terms such as “usually” and
addressed only “good quality” embryos, thus allowing for
deviation.489 The most recent version of the guidelines was
published in 2004 and uses less flexible language.490 ASRM
also seeks to educate patients about the risks of multiple births
and publishes a patient information guide on the issue.491 The
ACOG Committee on Ethics basically agrees with the ASRM
Practice Committee, although it is working towards the goal of
single embryo transfer.492
Perhaps because of the weak preferences expressed until
recently in professional guidelines, they have not been followed
by all practitioners. In response to criticism regarding the high
rates of non-compliance, SART has threatened loss of
membership,493 although it has not carried out this threat.494
The United States has not relied solely on professional
mechanisms to alleviate the problems of multiple births. The
Centers for Disease Control and Prevention publish statistics
pursuant to the Fertility Clinic Success Rate and Certification
Act that include indicators of the performance of each clinic.
For the first time, the 2001 statistics (published in 2003)
showed the number of singleton births per cycle for each
reporting clinic as a measure of success.495 If this becomes a
488. AM. SOC’Y FOR REPROD. MED., GUIDELINES ON NUMBER OF EMBRYOS
TRANSFERRED
(1999),
available
at
http://www.fertilityoregon.com/forms/NoEmbryosTransferred.pdf (last visited
Apr. 8, 2005).
489. Id.; N.Y. STATE TASK FORCE ON LIFE AND THE LAW, supra note 191, at
170.
490. Am. Soc’y for Reprod. Med., Guidelines on the Number of Embryos
Transferred, 82 FERTILITY & STERILITY 733 (2004) [hereinafter Embryo
Transfer
Guidelines],
available
at
http://www.asrm.org/Media/Practice/NoEmbryosTransferred.pdf (last visited
Apr. 8, 2005).
491. See AM. SOC’Y FOR REPROD. MED., MULTIPLE PREGNANCY AND BIRTH:
TWINS, TRIPLETS & HIGHER ORDER MULTIPLES: A GUIDE FOR PATIENTS (2004),
available at http://www.asrm.org/Literature/patient.html (last visited Apr. 15,
2005).
492. AM. COLL. OF OBSTETRICIANS AND GYNECOLOGISTS, supra note 454, at
42.
493. Grifo, et al., supra note 481, at 14.
494. Carson Strong, Too Many Twins, Triplets, Quadruplets, and So On: A
Call for New Priorities, 31 J.L. MED. & ETHICS 272, 276-77 (2003).
495. See CDC Website, at http://www.cdc.gov/node.do/id/0900f3ec8000ec28
(last visited Apr. 7, 2005).
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common basis for comparing the performance of different
clinics, it is likely to reduce the pressure on poorly performing
clinics to transfer more embryos in order to increase their
success rate. Information disclosures may thus serve to
enhance appropriate competition and improve performance.496
Increased insurance coverage for IVF and related services
may also decrease patient pressures to risk multifetal
pregnancies.497 This is because, unless covered by insurance,
couples must bear the cost of multiple IVF attempts but not the
costs associated with multifetal pregnancy.498 This hypothesis
is borne out in surveys on the link between insurance coverage
and multiple births. One survey suggests that mandated
insurance coverage for IVF leads to a decreased number of
embryos transferred and hence a lower multiple birth rate per
cycle.499 A more recent survey indicates that this may only
apply in states with mandatory insurance requirements that do
not restrict the number of IVF cycles covered.500 Thus, state
legislation mandating insurance coverage for IVF may reduce
multiple births.
It will take time to see whether these federal and state
measures reduce the rates of multiple pregnancies by reducing
the number of embryos practitioners are willing to transfer.
Thus far, there are signs that the situation is improving, if
slowly. Figure 1 reflects a slow decline in the number of
embryos transferred per cycle. The average number of embryos
transferred per cycle began decreasing in 1997, with the
steepest decline (an 11.1% decrease) between 1998 and 1999.501
This coincides with the publication of the 1998 ASRM
guidelines, which for the first time specified how many embryos
496. See generally Sage, supra note 320.
497. See supra note 137 and accompanying text.
498. Faber, supra note 466, at 1615.
499. D. Frankfurter et al., Insurance Mandates for IVF Coverage Effectively
Lower Multiple Births Per Embryo Transfer, 70 FERTILITY & STERILITY 51S
(1998).
500. Meredith A. Reynolds et al., Does Insurance Coverage Decrease the
Risk for Multiple Births Associated with Assisted Reproductive Technology?, 80
FERTILITY & STERILITY 16 (2003). See generally Tarun Jain et al., Insurance
Coverage and Outcomes of In Vitro Fertilization, 347 NEW ENG. J. MED. 661
(2002); William D. Schoff, Impact of Insurance Coverage on In Vitro
Ferilization Practice Patterns: A Complex Relationship, 80 FERTILITY &
STERILITY 30 (2003).
501. Tarun Jain, Trends in Embryo-Transfer Practice and in Outcomes of
the Use of Assisted Reproductive Technology in the United States, 350 NEW.
ENG. J. MED. 1639, 1641 (2004).
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ought to be transferred for particular classes of patients,
although other factors may also have played a role.502 There
are not yet any data on the effect of the more strongly worded
and precise 2004 guidelines.503
In part as a consequence of these changes in practice, the
number of triplets and other higher order multiple births per
100,000 in the United States declined from 193.5 in 1998 to
180.5 in 2000.504 The percentage of live-born infants conceived
using ARTs that were triplets or higher order decreased from
13.5% in 1997 to 9.9% in 2000.505 The reports issued by the
Centers for Disease Control and Prevention show a similar
trend, especially for triplets (see Figure 2).

FIGURE 2: PROPORTION OF ART BIRTHS USING FRESH NONDONOR
EGGS OR EMBRYOS THAT ARE SINGLETONS, TWINS, OR HIGHER
ORDER: 1998-2002506

502. Id. at 1641, 1643-44.
503. See Embryo Transfer Guidelines, supra note 490.
504. Martin et al., supra note 476, at 19.
505. Meredith A. Reynolds et al., Trends in Multiple Births Conceived
Using Assisted Reproductive Technology, United States, 1997-2000, 111
PEDIATRICS 1159, 1160 tbl.1 (2003).
506. The information is taken from the reports available at
http://www.cdc.gov/reproductivehealth/art.htm (last visited Apr. 7, 2005). Note
that the large difference in these figures compared to those above is due to the
differences in what is being measured (proportion of live infants versus
proportion of live births).
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The United States preference for slow improvement in
reducing the incidence of multiples is partly cultural and partly
pragmatic.
There are political forces, in addition to
professional groups, opposing regulation as a means of reducing
the number of multifetal pregnancies. RESOLVE, a patient
advocacy group, is against imposition of mandatory limits on
the number of embryos transferred.507 The current approach is
seen as reducing the number of multifetal pregnancies without
limiting the ability of medical practitioners to make a decision
to transfer greater numbers of embryos when appropriate. At
least according to SART’s website, this approach has some
supporters in Europe, too.508
4. Strong Professional Regulation – Australia
In most states of Australia509 and in New Zealand, there is
507. Letter from Bonnie Gilbert, Acting Executive Director, RESOLVE, to
Mr. O. Carter Snead, General Counsel, President’s Council on Bioethics (Apr.
15, 2003).
508. See SART Website, at http://www.sart.org/whatis.html (last visited
Mar. 21, 2005).
509. In South Australia, no more than three embryos may be transferred in
a single cycle. Reproductive Technology (Code of Ethical Clinical Practice)
Regulations, 1995, § 5 (S. Austl.). Approximately 6 % of cycles are carried out
on patients resident in South Australia. JISHAN H. DEAN & ELIZABETH A.
SULLIVAN, AUSTL. INST. OF HEALTH AND WELFARE, ASSISTED CONCEPTION
SERIES NO. 7, ASSISTED CONCEPTION: AUSTRALIA AND NEW ZEALAND: 2000
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no mandatory limit on the number of embryos that may be
transferred. However, the number of embryos transferred per
cycle is on average significantly less than in the United States,
as illustrated in Figure 3.
FIGURE 3: NUMBER OF EMBRYOS TRANSFERRED DURING FRESH
NON-DONOR ART CYCLES IN AUSTRALIA AND NEW ZEALAND AS
COMPARED TO THE UNITED STATES IN 2002.510
80
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There are various possible explanations for the difference,
other than cultural factors. Like ASRM, RTAC has issued
guidelines on the transfer of multiple embryos, but its
recommendations are more rule-like than the 1999 ASRM
guidelines.511 The RTAC Code of Practice provides:
RTAC requests that Centres consider very carefully the need to
transfer more than two oocytes or embryos in each treatment cycle.
Exceptional clinical circumstances may justify more than two
oocytes/embryos to be transferred but there should be good
documentation to support such decisions. Despite all care multiple
2001,
at
25
tbl.21
(2003),
available
at
http://www.npsu.unsw.edu.au/ac7.pdf (last visited Mar. 29, 2005).
510. See supra Part V.C.2 fig.1; JOANNA BRYANT ET AL., AUSTL. INST. OF
HEALTH AND WELFARE, ASSISTED CONCEPTION SERIES NO. 8, SUPPLEMENT TO
ASSISTED CONCEPTION: AUSTRALIA AND NEW ZEALAND: 2002, at 6 tbl.W3
(2004), available at http://www.npsu.unsw.edu.au/art8high.htm (last visited
Mar. 29, 2005).
511. It is not yet known whether the more rule-like 2004 ASRM guidelines
will reduce the number of multiple births in the United States.
AND
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births may occur and the patient(s) should be warned of this
possibility together with attendant risks of multiple pregnancy. The
availability (or otherwise) of selective reduction should be discussed
as clinically appropriate.512

This provision is clarified in Attachment F to the
Guidelines, which explains:
The phrase in exceptional circumstances must not be interpreted
liberally.
For women 40 years and older the higher genetic
abnormality rate may make it permissible to transfer three embryos
or oocytes. Each case should be considered on its merits and patients
must be warned that high order multiple pregnancies can
occasionally occur at any age . . . . RTAC will request additional
information from clinics reporting unacceptably high numbers of
multiple pregnancies.513

RTAC regards as “unacceptable” twin rates of more than
20%.514 RTAC may reduce the recommended number of
embryos for transfer.515
There are also greater incentives for clinics in Australia to
heed RTAC’s advice than for clinics in the United States to
follow ASRM guidelines.
In particular, participation in
government drug subsidies and research grants depend on
RTAC membership.516 RTAC also inspects clinics and monitors
performance to ensure compliance with its Code of Practice,
whereas SART allows its members to ignore guidelines without
consequence. In Victoria, which accounts for about 22% of IVF,
ISCI, and GIFT cycles, collectively,517 RTAC membership is
mandatory. In addition, licensed centers in Victoria are
required to put a notation on a patient’s medical record of the
number of oocytes or embryos transferred and, if more than
two, the reasons for the decision.518 However, although there
are few available data for comparison, it does not seem that
Victoria is achieving more than New South Wales in reducing
the number of high order pregnancies.519
512. FERTILITY SOC’Y OF AUSTL., supra note 268, at 5.1.
513. Id. Attachment F.
514. INFERTILITY TREATMENT AUTH., CONDITIONS FOR LICENCE 2.5.4 (5th
ed. 2004).
515. Michael Bradley, Push to Curb Multiple IVF Births, THE AGE, Mar. 8,
2004,
available
at
http://www.theage.com.au/articles/2004/03/07/1078594239255.html
(last
visited Apr. 7, 2005).
516. See supra notes 284, 285 and accompanying text.
517. Dean & Sullivan, supra note 509, at 25 tbl.21.
518. See INFERTILITY TREATMENT AUTH., supra note 514; FERTILITY SOC’Y
OF AUSTL., supra note 268, Attachment F.
519. In 2000, 0.8% of all births of at least 20 weeks gestation in New South
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Perhaps as a result of the reduced number of embryos
transferred, Australia has less of a problem with high order
multiples than the United States. In 2002, 0.6% of all
Australian ART deliveries were triplets (there were no higher
order deliveries), whereas in the United States, 3.8% of births
following fresh nondonor IVF cycles, 2.3% of births following
frozen nondonor IVF cycles, and 2.8% of births following fresh
donor IVF cycles resulted in triplet or higher order
deliveries.520 The data described here are insufficient to draw
firm conclusions. However, it would seem that professional
regulation can help reduce the number of high order multifetal
pregnancies, especially when there are strong incentives for
compliance.521 Both the United States and Australia have
reduced the number of multifetal pregnancies without
preventing practitioners from making an individualized
decision to transfer greater numbers of embryos when the
chance of pregnancy is otherwise poor.
5. State Regulation – United Kingdom
As in Australia and the United States, the introduction of
ART caused an increase in the numbers of multiple births in
the United Kingdom The rates of triplet and higher order
multiples per 100,000 births increased from 31 in 1966-1970 to
42 in 1985 and then to 81 in 1989.522 In 1988, over half of all
pregnancies and births in the United Kingdom involving
triplets or more were attributed to IVF and GIFT.523
Wales were triplets or higher order, as compared to 1.2% for Victoria. Dean &
Sullivan, supra note 517, at 44 tbl.70. However, the triplet rate in Victoria
had by 2002 decreased to 0.3%; there are no later data for New South Wales.
INFERTILITY TREATMENT AUTH., 2003 ANNUAL REPORT 23 (2003), available at
http://www.ita.org.au/_documents/reports/ITA_annualreport03.pdf.
520. CENTERS FOR DISEASE CONTROL AND PREVENTION, supra note 23, at
20, 46, 50; Bryant et al, supra note 510, at 22.
521. There was a significant reduction in the number of high order
multiple births in Australia soon after RTAC introduced its recommendation
on the number of embryos to transfer. See Helen A. Jonas & Judith Lumley,
Triplets and Quadruplets Born in Victoria Between 1982 and 1990, 158 MED.
J. AUST. 659, 663 (1993).
522. Beverley J. Botting et al, Background, in THREE, FOUR, AND MORE: A
STUDY OF TRIPLET AND HIGHER ORDER BIRTHS 19-21 (Beverley J. Botting et
al. eds., 1980).
523. GILLIAN DOUGLAS, LAW, FERTILITY AND REPRODUCTION 114-15 (1991).
A separate study found the figure to be 24% for IVF and 11% for GIFT.
Malcolm I. Levene et al., Higher Multiple Births and the Modern Management
of Infertility in Britain, 99 BR. J. OBSTETRICS & GYNAECOLOGY 607, 608
(1992).
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The issue of transferring multiple embryos was debated in
the United Kingdom from the mid-1980s.524 Prior to that,
multiple pregnancy was accepted by organizations such as the
Royal College of Obstetricians and Gynaecologists as justifiable
when balanced against the benefits of transferring multiple
embryos.525 The Voluntary Licensing Authority had initially
recommended transfer of up to three or four embryos.526 In
1986, the Voluntary Licensing Authority recommended that no
more than three embryos or eggs should be transferred in any
single cycle unless there were exceptional circumstances
justifying the transfer of four;527 in 1987, this became part of
the guidelines.528 The decision was controversial.529 One clinic,
the infertility unit at Humana Wellington Hospital, refused to
agree in writing to abide by the guideline and consequently lost
its license, although it later agreed.530 Nevertheless, by 1990,
compliance was not universal.531
In 1991, HFEA imposed a legal restriction limiting the
maximum number of embryos that could be transferred in the
course of an IVF procedure to three.532 This was done by
introducing a requirement into the Code of Practice that, if
breached, could result in loss or variation of a license.533 It has
been suggested that the Voluntary Licensing Authority would
524. See Price, supra note 216, at 43.
525. ROYAL COLL. OF OBSTETRICIANS AND GYNAECOLOGISTS, REPORT OF
THE RCOG ETHICS COMMITTEE ON IN VITRO FERTILIZATION AND EMBRYO
REPLACEMENT OR TRANSFER 2.5 (Mar. 1983)
526. GUNNING & ENGLISH, supra note 3, at 53.
527. See generally Jeremy Laurance, The Test-Tube Dilemma, 82 NEW
SOC’Y 19 (1987).
528. Price, supra note 216, at 43-44.
529. See Ian Craft et al., Letter, Voluntary Licensing and IVF/ET, 1
LANCET 1148, 1148 (1987); Ian Craft et al., Letter, Licensing Work on IVF and
Related Procedures, 1 LANCET 1373, 1373 (1987); David C. Anderson, Licensing
Work on IVF and Related Procedures, 1 LANCET 1373, 1373 (1987); Martin
Richards and Frances Price, Letter, Licensing Work on IVF and Related
Procedures, 1 LANCET 1373, 1373 (1987); Ian Craft et al., Letter, How Many
Oocytes/Embryos Should be Transferred, 2 LANCET 109, 109 (1987); Paul A.L.
Lancaster, Letter, How Many Oocytes/Embryos Should be Transferred, 2
LANCET 110, 110 ((1987).
530. GUNNING & ENGLISH, supra note 3, at 56; see also Laurance, supra
note 527, at 19.
531. HUMAN FERTILISATION AND EMBRYOLOGY AUTH., ANNUAL REPORT 2
(1992).
532. HUMAN FERTILISATION AND EMBRYOLOGY AUTH., CODE OF PRACTICE
7.6 (1st ed. 1991).
533. Human Fertilisation & Embryology Act (UK Act), 1990, § 25(6)
(U.K.).
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have taken the same step had it continued in operation.534
Although there are no reports of clinics defying the HFEA
limit, there is evidence to suggest that this measure failed to
reduce the rates of multiple births in women undergoing
This was perhaps due to the improvements in
IVF.535
technique that lead to higher rates of implantation.536
According to professional opinion at the time, it would have
been preferable to reduce the number of embryos to two in
younger women, but allow for up to four in older women.537
In 2000, the Royal College of Obstetricians and
Gynaecologists recommended the transfer of no more than two
embryos; this recommendation was adopted by HFEA in 2001,
which stated that exceptional circumstances should be
documented before three embryos are transferred.538 HFEA has
since restricted multiple embryo transfer further. Paragraph
5.5(vi) of the current Code of Practice requires that information
about the risks of multiple pregnancy be provided to
individuals seeking treatment.539 Paragraphs 8.20 and 8.21
require that IVF centers ensure that that women under 40 or
those using donated ova receive no more than two embryos, and
that other women receive no more than three.540 There are no
exceptions based on individual circumstances.541
The change in professional and HFEA recommendations
seems to have had a positive effect on the rate of triplets in the
United Kingdom. The rate of triplets and higher order
534. GUNNING & ENGLISH, supra note 3, at 119.
535. HUMAN FERTILISATION AND EMBRYOLOGY AUTH., SECOND ANNUAL
REPORT 19 (1993).
536. Id.
537. Lieberman, supra note 243, at 1781.
538. ROYAL COLL. OF OBSTETRICIANS AND GYNAECOLOGISTS, THE
MANAGEMENT OF INFERTILITY IN TERTIARY CARE 10 (2000); Press Release,
Human Fertilisation & Embryology Authority, HFEA Reduces Maximum
Number Of Embryos Transferred in Single IVF Treatment from Three to Two
(Aug.
8,
2001),
available
at
http://www.hfea.gov.uk/PressOffice/Archive/HFEAreducesmaximumnumberof
embryostransferredinsingleIVFtreatmentfromthreetotwo (last visited Apr. 7,
2005).
539. See HUMAN FERTILISATION AND EMBRYOLOGY AUTH., CODE OF
PRACTICE, supra note 532, at para. 5.5(vi). HFEA has published a leaflet for
this purpose.
Human Fertilisation & Embryology Authority, Avoiding
Multiple Births: Deciding How Many Embryos to Transfer, available at
http://www.hfea.gov.uk/HFEAPublications/HFEAleaflets (last visited Apr. 7,
2005).
540. Id. at paras. 8.20-.21.
541. See id.
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multiples per 100,000 births (including stillbirths) went from
132.0 in 2000, to 109.2 in 2001, to 90.4 in 2002 to 63.9 in
2003.542 This reversed a fairly consistent uptrend (Figure 4).
FIGURE 4: U.K. BABIES PER 100,000 BORN ONE OF TRIPLETS OR
MORE543
160

Number of babies

140
120
100
80
60
40
20

20
02

20
00

19
98

19
96

19
94

19
92

19
90

19
88

19
86

19
84

19
82

0

Year

The rigidity of HFEA’s approach, while creating general
benefits by reducing the rate of multiple births, significantly
restricts the freedom of individual patients and their clinicians.
The case of R (on the application of the Assisted Reproduction
and Gynaecology Centre) v HFEA544 is illustrative. Between
June 1996 and July 2000, Mrs. H underwent eight IVF
treatment cycles, in each of which three embryos were placed in
her uterus.545 The medical director at the clinic treating her,
Mr. Taranissi, was of the view that the risk of multiple
542. Based on data available from the Office of National Statistics in the
United Kingdom; OFFICE FOR NAT'L STATISTICS, DATASET PBH61, available at
http://www.statistics.gov.uk/statbase/xsdataset.asp?vlnk=4793&More=Y (last
visited Apr. 7, 2005). The difference between the U.S. and U.K. data cannot be
explained by differences in the proportion of births following ART procedures,
which is about 1% in both countries. See HUMAN FERTILIZATION &
EMBRYOLOGY
AUTH.,
FACTS
AND
FIGURES,
available
at
http://www.hfea.gov.uk/PressOffice/Factsandfigures (last visited Apr. 7, 2005);
CENTERS FOR DISEASE CONTROL AND PREVENTION, supra note 23, at 13.
543. OFFICE FOR NAT’L STATISTICS, supra note 542.
544. [2002] EWCA Civ 20.
545. Id. at [17].
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pregnancy was non-existent and believed that it was necessary
to transfer more than three embryos to have a reasonable
HFEA rejected Mr.
chance of achieving pregnancy.546
Taranissi’s request to transfer more than three embryos, and
judicial review of its decisions was unsuccessful. Restrictions
on the freedom of clinicians to determine what is best for each
individual patient in the context of multiple embryo transfer is
the most common criticism of HFEA by clinics.547
Interestingly, while the United Kingdom restricts how
many embryos may be transferred in the course of IVF, HFEA
has no power to limit the number of eggs transferred in a GIFT
procedure unless donor gametes are used.548 The irony of this
was observed by Mr. Taranissi in the course of his
correspondence with HFEA: “[S]hould [Mrs. H’s] tubes been
patent, GIFT procedure with the replacement of an unlimited
number of eggs would have been an accepted medical
practice.”549 Biological circumstance thus affects a patient’s
ability to increase her chance of pregnancy where the need for
more than three eggs is considered clinically necessary. By the
same token, HFEA is unable to directly influence the number of
multifetal pregnancies arising in the context of GIFT, although
it can give guidance.550 While there is no data on the statistical
effect of this loophole, anecdotal evidence suggests that,
although GIFT is rarely used in the United Kingdom, some
practitioners do transfer far more than two eggs per cycle.551
This is despite the fact that GIFT is mostly carried out in
HFEA licensed clinics and that, according to a survey
conducted by HFEA in 1994, there is no evidence of
“inappropriate” use.552
546. Id. at [18].
547. SECOND QUINQUENNIAL REVIEW OF THE HUMAN FERTILISATION AND
EMBRYOLOGY AUTHORITY, REPORT TO UK HEALTH MINISTERS 5.33 (Oct. 1,
2000).
548. GIFT is only subject to the UK Act if donor gametes are used. Human
Fertilisation & Embryology Act (UK Act), 1990, § 4(1)(b) (U.K.). This could be
altered by regulation. Id. § 4(3).
549. R v. HFEA at [20] (quoting July 9, 2000 letter from Mr. Taranissi to
HFEA).
550. UK Act § 25(3).
551. R. Winston, The UK National Policy Towards the Prevention of High
Order Multiple Gestation, paper presented at Bertarelli Foundation, First
Global Conference, November 20-21, 1999, Bethesda, MD, available at
http://www.bertarelli-foundation.ch/docs/GC_1999_abstracts.pdf (last visited
Apr. 7, 2005).
552. HUMAN FERTILISATION AND EMBRYOLOGY AUTH., FOURTH ANNUAL
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6. Conclusions
This Part looked at four different regulatory approaches:
professional
guidelines
supplemented
by
government
intervention (United States), professional guidelines with
strong incentives to comply (New South Wales), professional
guidelines with mandated compliance (Victoria), and regulation
by a government authority using a clear rule (United
Kingdom). The choice as to which regime is optimal in dealing
with the problem of multiple gestation will depend on the goal.
Generally speaking, codes of practice prepared by a
professional organization are likely to offer more flexibility
than those prepared by an administrative agency. If one is
concerned about procreative liberty and the importance of
keeping decisions within a therapeutic relationship, the former
course may be more attractive. On the other hand, there are
advantages in ensuring that guidelines are taken seriously,
either by creating incentives in legislation (New South Wales)
or by making compliance mandatory (Victoria). Much will also
depend on the content of the guidelines proffered (the ASRM
guideline allows for the transfer of more embryos than the
RTAC code of practice). Government may be able to exercise
some influence in encouraging professional organizations to
tighten
standards
and
adopt
internal
enforcement
The United States approach has been
mechanisms.553
successful at reducing rates of multifetal pregnancy, but is
apparently less successful than the approaches in Australia
and the United Kingdom. If the goal is to reduce the numbers
of multifetal pregnancies without unnecessarily reducing a
patient’s likelihood of having a child, the Australian
approaches seem best. These would also be less likely to run
into constitutional difficulties than a strict limit on the number
of embryos that can be transferred.554
A decision to abstain from state regulation in order to
assess the potential of professional regulation is not
REPORT 21 (1995).
553. The President’s Council on Bioethics recommended greater
enforcement of existing professional guidelines.
See REPRODUCTION &
RESPONSIBILITY, supra note 142, at 218-19.
554. See supra Part II.B.3. Although the health of the mother and her
future children could be compelling government interests, a limit that did not
take into account the circumstances of the woman would likely be considered
unduly burdensome because it may significantly reduce the ability of some
women to bear a child. Cf. Planned Parenthood v. Casey, 505 U.S. 833, 876-79
(1992).
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irreversible. Legislation has been introduced in New South
Wales that would control only those aspects of IVF that either
are not dealt with by RTAC or are important politically.555 If
the state decides to intervene, there may be advantages in
some fields to allowing professional organizations to craft the
rules (subject always to the possibility that they will be
overridden by legislation or regulation). Such rules are more
likely to factor in professional concerns (such as the need for
flexibility) and are easier to update with improvements in
technology and scientific understanding. On the other hand,
there are some areas, particularly those that generate social
controversy such as cloning, that are best left to a democratic
forum. What is important is that the benefits of alternative
forms of regulation are considered before proposing new
legislation.
VI. RESOLVING UNCERTAINTY
As discussed in Part II.E above, technological change can
bring about uncertainty in the law. No state of uncertainty is
irresolvable; the question might be answered if it arises in a
legal case or the law might be changed by legislation or
regulation.. If uncertainty arises in the context of a statutory
scheme administered by an agency, the agency may have power
to decide on an interpretation of the legislation.556 Of course,
the resolution reached may be ambiguous, incomplete, or
contain latent ambiguities that future technological change
may reveal.
There are two reasons why excess uncertainty might be
thought undesirable: (1) litigation may be required to resolve
disputes where the law is unclear; and (2) the fact of
uncertainty may be problematic in itself, as it may, for
example, impede the growth of a market. If the second concern
applies to a significant extent, so that the uncertainty itself has
wide-ranging effects, the need for prompt action will trump
most of the considerations raised here.557 That is not to say
that these considerations are not relevant, only that they will
usually be outweighed. The focus in this Part is therefore on
555. See supra notes 291-295 and accompanying text.
556. In the United States, an agency’s interpretation may be entitled to
judicial deference. See Chevron U.S.A., Inc. v. Natural Res. Def. Council, Inc.,
467 U.S. 837, 843-44, 865 (1984).
557. This concern may also be overestimated. See Mary L. Lyndon, Tort
Law and Technology, 12 YALE J. ON REG. 137, 154-56 (1995).
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situations where the primary reason to resolve an uncertainty
is to avoid disputes.
A. DISADVANTAGES OF LEGISLATION – THE LIMITS OF WORDS
Fear of uncertainty is often a driver for legislation. Thus
both legal scholars and law reform organizations frequently
move from the existence of uncertainty to the need for
legislation without further analysis. Sometimes, that jump can
be justified because the uncertainty itself causes problems.
However, when there is no specific need to resolve the
uncertainty promptly, it is important to consider the
disadvantages that are associated with pursuit of a legislative
solution.
The first factor to consider is the cost of pursuing
legislation. The time of political staff, legislators, committees
and the parliament or congress itself is valuable. The real
question is whether the cost of legislation (or, where relevant,
administrative action) exceeds the cost (for the parties and the
government) of a judicial decision. This is impossible to
measure in the abstract, and will depend on predictions as to
the likelihood of litigation and the number of cases it may to
take to resolve the uncertainty. Where a statutory rule is
uncertain, there are no other factors to consider.
When the uncertain rule is found in the common law, there
are flexibility losses in taking the rule out of the judicial realm
and placing it, reformed, into legislation. In particular, a
statutory rule risks greater over-inclusiveness or underinclusiveness in its application to new situations.558 A statute
resolving uncertainty will only apply to those situations within
the possible scope of the language used. Each time the
technology evolves beyond what the legislature had
contemplated, it is possible that new uncertainties will surface
or that the rule will become over-inclusive or under-inclusive.
This is evident from the history of laws governing gamete
donation; the legislation employed in many jurisdictions to
resolve issues related to paternity did not apply to the use of
egg donation.559 Thus a decision to move an uncertain common
558. See supra Part II.G.
559. Thus, as of 2001, 42 states had laws regulating sperm donation
whereas only five states had addressed oocyte donation. NAT’L CONFERENCE
OF STATE LEGISLATURES, GENETICS POLICY REPORT: REPRODUCTIVE
TECHNOLOGIES 9 (2001). See generally supra notes 134-135 and accompanying
text.
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law rule to a certain statutory rule needs to take account of
costs, not only the costs of the initial enactment, but also of
future enactments following further technological change.
It may seem as if an alternative solution would be
technologically-neutral drafting. The problem could be resolved
if initial legislation used terms like vehicle instead of horsedrawn carriage, gamete instead of sperm, and so forth.
Drafters, however, are limited by foresight. If technological
change is unpredictable, it is difficult to allow for it in advance.
It would have been prescient but surprising for legislation
referring generally to assisted reproduction rather than to
artificial insemination to have been enacted before the 1970s.
There is another sense in which the common law is more
flexible than legislation. Such a rule can be altered or
overturned by some courts and by legislation, whereas, unless
unconstitutional, statutory rules can only be amended by
legislation. Of course, judges can interpret the words in a
statute to accommodate advances in technology, including
within the scope of a statute conduct that was not possible at
the time it was drafted. But judges are limited to the words; it
would require a fair degree of judicial creativity to decide that
an automobile is really a horse-drawn carriage, that an egg is
the same as a sperm, or that a machine can be the “body of a
woman.” In such circumstances, a statutory rule must wait
until the legislature has time to address the problem. A
common law rule can be adjusted or further clarified (if
necessary) as soon as it becomes the subject of a formal dispute.
B. A POSSIBLE SOLUTION – DELEGATION
The reason why many statutes fail to keep up with
technological change is that the legislative process is
cumbersome. If rules are formulated in legislation, the limits
inherent in the words used continue until the legislation can be
amended. However, legislation can be designed to give other
institutions (such as agencies and courts) room to maneuver in
interpreting legislation in light of technological change. This
can be done by (1) delegating to an administrative agency the
power to resolve uncertainties, (2) employing broad language so
as to allow maximum scope for interpretation, or (3) creating
standards rather than rules, thus allowing the agency or courts
to make adjustments. While these mechanisms can reduce
problems in legislation, they do not eliminate them entirely.
Delegation is never complete, as some limits are inevitably
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spelled out in the legislation.
C. DISADVANTAGES OF THE COMMON LAW –LIMITED
POSSIBILITIES AND BURDENED LITIGANTS
The common law seems to hold an advantage over
legislation. This advantage has to be weighed against possible
objections to judicial resolution of uncertainty.
Most
significantly, the common law is stuck within its own
paradigms. While legislatures are only restricted by the
boundaries of any constitution and, in the case of a state,
federal legislation, judges are more limited. An area of
uncertainty might allow a judge a choice between alternatives,
but creative solutions that may be possible in a legislative
context may not be possible judicially.
When the manner of resolving the uncertainty will have
important policy implications or may implicate community
values, judges may not be the most appropriate decisionmakers. For example, the status of an embryo may be a matter
of legitimate community concern best resolved by democratic
means.
In addition, judges may be at a disadvantage because they
consider one case at a time. Statutes are typically drafted from
a broader perspective despite the fact that politics will
inevitably thrust some examples to the forefront of drafters’
minds. Entire legal regimes, together with exceptions and
transitional provisions can be enacted simultaneously. The
content of and exceptions to common law rules tend to evolve
more slowly in response to specific scenarios. This enables
flexibility but can create problems of consistency.560
In addition to these issues, a failure to legislate may lead
to inequity in the burden of costs required to clarify the
uncertainty. If legislation is enacted, these costs are ultimately
borne by taxpayers. If the question is left to the common law,
the cost of disputes falls on the litigants.
D. AN EXAMPLE: CONTROL OF EMBRYOS
It is thus apparent that there are a number of factors to be
considered in choosing to resolve uncertainty through
legislation. To illustrate how these factors play out in a specific
context, consider the example of uncertainty related to the
560. See, e.g., Heard, supra note 112, at 929; Lorne Elkin Rozovsky, Legal
Aspects of Human and Genetic Engineering, 6 MANITOBA L.J. 291, 295 (1975).
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control over cryopreserved (frozen) embryos in the event of a
dispute between a man and a woman who, prior to separation
or divorce, had commenced IVF treatment together. The issue
really involves two questions: (1) what is the status of an
embryo and what decisions can be made regarding them, and
(2) who is authorized to make such decisions. The focus here is
on the second question. In the United Kingdom, this question
was resolved by legislation through the requirement of
unwithdrawn consent by the gamete sources for transfer or
continued storage of embryos. Victoria has similar legislation,
except that the unwithdrawn consents of the spouses (or cohabiting heterosexual partners) of the gamete sources and the
woman being treated are also required for transfer and, in the
absence of agreement, the embryos remain in storage for the
statutory period.561 In the United States, the question was
resolved by courts in those states where disputes arose. New
South Wales also has no legislation and there have been no
proceedings in which the control of embryos has been in
dispute. The draft Assisted Reproductive Technology Bill, 2003
(N.S.W., Austl.) would have a similar effect to the United
Kingdom legislation.562 Because no different issues arise, the
law in Victoria and New South Wales will not be discussed
separately.
1. United Kingdom
The control of an embryo’s fate when gamete sources wish
to prevent its use is determined by the UK Act. Section 12(c)
provides that it is a condition of every license granted that the
provisions of Schedule 3 to the Act be complied with.563
Paragraph 6(3) of Schedule 3 provides that:
An embryo the creation of which was brought about in vitro must not
be received by any person unless there is an effective consent by each
person whose gametes were used to bring about the creation of the
embryo to the use for that purpose of the embryo and the embryo is
used in accordance with those consents.564

561. Infertility Treatment Act, 1995, §§ 8, 9, 12-15, 53 (Vic., Austl.).
562. Assisted Reproductive Technology Bill, 2003, §§ 16-18, 22, 28 (N.S.W.,
Austl.).
563. Human Fertilisation & Embryology Act (UK Act), 1990, § 12(c) (U.K.).
It is unclear to what extent either progenitor could maintain a private right of
action against a clinic.
See Michael Freeman, Medically Assisted
Reproduction, in PRINCIPLES OF MEDICAL LAW 546, 582-83 (Ian Kennedy &
Andrew Grubb eds., 1998).
564. UK Act, sched. 3, para. 6(3).

BENNETT_MOSES_4-24-05

610

7/11/2006 6:41:19 PM

MINN. J.L. SCI. & TECH.

[Vol. 6:2

“Effective consent” is defined in paragraph 1 to be a
written consent that has not been withdrawn.565 Consent may
only relate to one or more purposes listed in paragraph 2(1) of
Schedule 3, namely (1) use in providing treatment services to
the person giving consent or that person and another specified
person together, (2) use in providing treatment services to
persons not including the person giving consent, or (3) use for
the purposes of any project of research.566 The written consent
must specify the maximum period of storage (if less than the
statutory maximum), must state what is to happen to the
gametes or embryo if the person giving the consent dies or
becomes incapacitated, and may also specify storage
conditions.567 Consent may be amended or withdrawn by
written notice to the person storing the embryo.568 However,
the consent cannot be amended or withdrawn once the embryo
has been “used” in providing treatment services or for the
purposes of any project of research.569 A person giving consent
must be informed of the right to amend or withdraw it at the
time consent is given.570
Essentially, either gamete provider can, acting alone,
decide to destroy the embryos. This effectively protects the
right not to reproduce as against the right to reproduce. This is
a simple rule to follow―it has little uncertainty, but also little
flexibility.
Consider the following version of events. Ms. Evans
discovered in the course of seeking treatment for infertility that
she had serious tumors in both her ovaries and needed to have
them removed.571 Because she still wanted children, she and
her partner, Mr. Johnston, agreed that she should first attempt
to harvest some eggs. Her eggs would be fertilized with Mr.
Johnston’s sperm and frozen for use after the surgery.572 Ms.
Evans, concerned that Mr. Johnston might leave her, raised the
possibility of freezing her eggs, rather than the shared

565. Id. para. 1.
566. UK Act, sched. 3, para. 2(1).
567. Id. para. 2(2).
568. Id. para. 4(1).
569. Id. para. 4(2).
570. Id. para. 3(2).
571. Evans v. Amicus Healthcare Ltd., [2004] 2 WLR 713, at [4]., aff’d
[2004] EWCA Civ 727.
572. Id. at [4-6].
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embryos, with a nurse at the clinic.573 The nurse informed her
that egg freezing was not offered at the clinic and that, if she
wished to pursue this option, she would have to speak with the
treating physician.574 At that point, her partner reassured her
that egg freezing was unnecessary, that they were not going to
split up and that he wanted to be the father of her children.575
The consent forms signed by Ms. Evans and Mr. Johnston
consented to the use of the embryos for the treatment of the
couple, but noted the right of either party to withdraw or
amend the consent.576 The form contained no provision for
either party to consent to the treatment of Ms. Evans alone.577
Embryos using the gametes of Ms. Evans and Mr. Johnston
were thereafter used to create embryos, which were frozen as
planned.578 The relationship between Ms. Evans and Mr.
Johnston came to an end; Ms. Evans wished to have the
embryos transferred to her uterus and Mr. Johnston wished to
have them destroyed.
In the case of Evans v. Amicus Healthcare Ltd.,579 the trial
judge and the court of appeal held that even on these facts
(which in the actual case were subject to dispute), Ms. Evans
could not use the frozen embryos because: (1) that use would
not constitute treatment together with Mr. Johnston, which is
the only use of the embryos to which Mr. Johnston had
consented; and (2) the UK Act does not permit a gamete
provider to give irrevocable consent in advance to the use of
embryos derived in part from his gametes.580 Thus, any
reassurances by Mr. Johnston cannot prevent him from
withdrawing his consent.581 The court also concluded that the
UK Act was not contrary to European law.582
The Evans case itself could have been foreseen by
Parliament. The head of the section in the Department of
Health that has responsibility for policy on assisted conception
and embryology gave evidence in the Evans case that indicated
573.
574.
575.
576.
577.
578.
579.
580.
581.
582.

Id. at [5].
Id.
Id. at [5-6].
Id.
Id. at [7-10].
Id. at [12-14].
[2004] EWCA Civ 727.
Id. at [295-96].
Id.
[2004] EWCA Civ at [57-74], [106]-[119].
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that the Secretary of State for Health preferred a bright-line
Democratic
rule to a fact-sensitive rule in the Act.583
institutions are entitled to give weight to the value of certainty
in deciding how to craft a legal rule.
However, the British parliament was limited in its ability
to foresee the future. We therefore do not know if it would have
opted for the same bright-line rule had it thought of the
possibility of the following case (which could not have arisen in
1990 because the technology had not yet been developed). Ms.
X donates oocytes to Mr. and Mrs. Y, giving her consent. Mrs.
Y does not need the nuclear genetic material, but defects in her
mitochondria mean that her eggs can only be fertilized through
the technique of cytoplasm transfer. A HFEA license is
granted584 and the procedure is performed; some of the embryos
produced are frozen. If Ms. X withdraws her consent before the
frozen embryos are used, Mr. and Mrs. Y will be unable to have
Although completely
a genetically-related child.585
hypothetical, this is an example of how technological change
can cause statutory rules to operate in ways not contemplated,
and perhaps ways not desired.
2. United States
It was established in 1989 in the United States that a
couple undergoing IVF treatment with their own gametes have
a joint right to control the use of embryos.586 In Davis v.
Davis,587 the Tennessee Supreme Court went on to state in
more detail who would control frozen embryos, in the context of
a dispute between a couple using their own gametes:
In summary, we hold that disputes involving the disposition of
preembryos [early embryos] produced by in vitro fertilization should
be resolved, first, by looking to the preferences of the progenitors. If
their wishes cannot be ascertained, or if there is dispute, then their
prior agreement concerning disposition should be carried out. If no
prior agreement exists, then the relative interests of the parties in
using or not using the preembryos must be weighed. Ordinarily, the
party wishing to avoid procreation should prevail, assuming that the
583. [2004] 2 WLR at [187-88].
584. HFEA is considering an application for research on this technique.
See Alastair Dalton, UK Scientists Raise Specter of Babies with Three
SCOTSMAN,
Oct.
18,
2004,
available
at
Parents,
THE
http://news.scotsman.com/scitech.cfm?id=1209592004 (last visited Apr. 10,
2005).
585. This is because Ms. X’s gametes were used to produce the embryos.
586. York v. Jones, 717 F. Supp. 421, 425-27 (E.D. Va. 1989).
587. 842 S.W.2d 588 (Tenn. 1992).
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other party has a reasonable possibility of achieving parenthood by
means other than use of the preembryos in question. If no other
reasonable alternatives exist, then the argument in favor of using the
preembryos to achieve pregnancy should be considered. However, if
the party seeking control of the preembryos intends merely to donate
them to another couple, the objecting party obviously has the greater
interest and should prevail.588

The statement that the progenitors’ “prior agreement
concerning disposition should be carried out” has been subject
to some controversy in later cases. In Kass v. Kass,589 a New
York case, a prior agreement that the embryos would be
donated for research was held to control the embryos’ fate. The
Supreme Court of Massachusetts refused to enforce a prior
agreement in A.Z. v. B.Z.590 Although the court held for
various case-specific reasons that the document stating the wife
would receive the embryos in the event of a separation was
deficient,591 it went further and stated it would not have
enforced the agreement in any event. The court determined it
was against public policy to compel a person to become a parent
against that person’s will, even if that outcome had been
previously sought.592 Similar sentiments were expressed by the
Supreme Court in New Jersey in J.B. v. M.B.593 Again, the
agreement itself was insufficient, but the court indicated that
any agreement would be subject to the right of either party to
change his or her mind up to the point of either use or
destruction of the embryos.594 The Iowa Supreme Court
reached a similar conclusion in In re Marriage of Witten.595 The
agreement in this case provided that the frozen embryos could
only be transferred, released, or disposed of with the consent of
both husband and wife.596 The court stated that judges should
not enforce any agreement between a couple as to the future
disposition of embryos when one of them has communicated a
change of heart.597
An agreement to destroy the embryos was upheld,

588.
589.
590.
591.
592.
593.
594.
595.
596.
597.

Davis v. Davis, 842 S.W.2d 588, 604 (Tenn. 1992).
696 N.E.2d 174, 181 (N.Y. 1998).
725 N.E.2d 1051 (Mass. 2000).
Id. at 1056-57.
Id. at 1057-59.
783 A.2d 707 (N.J. 2001).
Id. at 714, 717-19.
672 N.W.2d 768 (Iowa 2003).
Id. at 772.
Id. at 782-83.
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however, in the Washington case of Litowitz v. Litowitz.598 In
that case, the agreement with the clinic provided for the
destruction of the embryos (made with the husband’s sperm
and donated eggs) after five years unless extended “at our
In fact, neither party wanted the embryos
request.”599
destroyed; the wife wished to have the embryos transferred into
a surrogate and the husband wished to donate them to another
couple.600 Nevertheless, the majority of the court upheld the
contract.601 Judge Chambers wrote a separate concurring
judgment, in which he stated that it was important to consider
equity and public policy in enforcing agreements, but noted
that equity and public policy were in accordance with the
parties’ original intentions.602
There is no way to reconcile these cases, although there
seems to be great reluctance to enforce agreements to become a
parent when a party has later decided against it. When the
agreement provides for some other result (destruction or use for
research), the results vary by state.
When there is no agreement, or the agreement is not
binding on the parties, courts have articulated different tests
although the results are largely similar. In Davis, the court,
using a balancing test, held that the interest of one party in
donating the embryos lost to the interest of the other in not
becoming a parent.603 In A.Z. v B.Z., the Massachusetts
Supreme Court indicated a court should not give an order that
would force one party to become a parent against his or her
will.604 In J.B. v M.B., the New Jersey Supreme Court stated
that the party wishing to avoid parenthood would “ordinarily”
prevail.605 Five of the seven judges, however, stated that they
expressed no opinion on what would they would have decided if
the party wishing to procreate had no other physiological
means of doing so.606 In separate concurring opinions, Judge
Verniero and Judge Zazzali stated that in such a situation, the

598.
599.
600.
601.
602.
603.
604.
605.
606.

48 P.3d 261 (Wash. 2002).
Id. at 272.
Id. at 264.
Id. at 271.
Id. (Chambers, J., concurring in part and dissenting in part).
842 S.W.2d at 604.
725 N.E.2d at 1059.
783 A.2d at 719.
Id.

BENNETT_MOSES_4-24-05

2005]

7/11/2006 6:41:19 PM

RESPONSES TO TECHNOLOGICAL CHANGE

615

party wishing to procreate ought to prevail.607 Thus it is likely
that Ms. Evans would have had a better chance of success had
she undergone the IVF procedure in the United States, though
not in Iowa, where the Supreme Court has held that embryos
can only be removed from frozen storage with the consent of
both gamete providers.608
Among clinics, the emphasis seems to be on requiring
couples to consider in advance what they wish done with their
embryos in the event of divorce or separation. A 1989 survey of
embryo cryopreservation in the United States found that
twenty-three of the twenty-five SART member programs that
reported offering embryo freezing required the patient to
designate the disposition of frozen embryos in case of parental
death or divorce.609 ARSM recommends that programs require
couples contemplating embryo storage to give written
The
instruction concerning disposition of embryos.610
instructions should be amendable but only by both partners.611
In the absence of an agreement, programs should be able to
treat embryos as abandoned after five years and destroy them
if diligent efforts to contact the couple fail.612 The Council on
Ethical and Judicial Affairs of the American Medical
Association also recommends the use of advance agreements
but does not believe they should be mandatory.613
3. Observations
The main difference between the law in the United
Kingdom and the law in the United States is the generality of
the rules. The UK Act creates a clear but inflexible rule that
may apply to situations in which many would think it
inappropriate. Further, it may apply even where further
technological change creates a situation beyond the
contemplation of the legislature.
In the United States,
clarification of the law was slow as cases raised new questions
607.
608.
609.
610.

Id. at 720.
In re Marriage of Witten, 672 N.W.2d 768, 783 (Iowa 2003).
Fugger, supra note 14, at 987.
Ethics Comm. of the Am. Fertility Soc’y, supra note 484, at 58S-59S;
ETHICS COMM. OF THE AM. SOC’Y FOR REPROD. MED., DISPOSITION OF
ABANDONED
EMBRYOS,
available
at
http://
www.asrm.org/Media/Ethics/abandon.html (last visited Apr. 7, 2005).
611. Id.
612. Id.
613. COUNCIL ON ETHICAL AND JUDICIAL AFFAIRS, supra note 193, at E2.141 (1994).

BENNETT_MOSES_4-24-05

616

7/11/2006 6:41:19 PM

MINN. J.L. SCI. & TECH.

[Vol. 6:2

unanswered by previous cases.
As a consequence, more
litigation has arisen in the context of cryopreservation and
relationship dissolutions in the United States than in the
United Kingdom. One advantage of the American approach is
that the courts retain the ability to create new exceptions to the
general rule as the facts of specific cases demand. The Evans
case would probably have gone the other way in the United
States, and the cytoplasm transfer hypothetical would almost
certainly be resolved in favor of the couple.
Problems of uncertainty caused by technological change
may be overemphasized. Uncertainty as to the control of
embryos following the breakdown of a relationship has few
large-scale effects.614 Such uncertainty is unlikely to deter
many couples from using IVF or alter the economics of the
reproduction industry.615 Couples who stay together or reach
agreement upon separation will not face any negative
consequences as the result of uncertainty in this area. Clinics
are not greatly affected because they can maintain the status
quo pending judicial resolution of a dispute.616 The persons
most affected are couples who split up and are unable to agree
on the disposition of the embryos. In that context, the dispute
will rarely create new litigation, as the parties are already
likely to be in divorce proceedings, but may add to the existing
litigation burden and reduce the likelihood of out-of-court
settlement. The amount of thought that has been put into the
question of control of embryos in academia likely exceeds that
in private practice. The additional burden of litigation for
these couples is slight, and the cost of bright-line rules can be
significant, as is evident from the Evans case. Reaching the
best result seems more important than ensuring predictability.
A decision to “wait and see,” observing the common law
resolution of uncertainty and enacting a statute only if the
resolution is undesirable or any residual uncertainty has
undesirable consequences, has advantages.
First, if the
614. See DWORKIN, supra note 328, at 69 (commenting that identifying
parents of children conceived with donor sperm is a small social problem and
thus that there is no need for a speedy or comprehensive solution).
615. See William A. Sieck, Comment, In Vitro Fertilization and the Right to
Procreate: The Right to No, 147 U. Pa. L. Rev. 435, 465-66 (1998) (discussing
the tendency to assume that marriage will last forever, and the difficulty of
thinking rationally about the disposition of embryos at the time of treatment).
616. See In re Marriage of Witten, 672 N.W.2d at 782-83 (stating that
agreements, while not enforceable by one progenitor against the other, would
be enforceable by clinics until advised of a change in writing).
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common law solution is similar to that what have been enacted
in any event, the flexibility of the common law is retained. In
particular, the rule is likely to be more adaptable to future
technological change. Second, even if a change is sought
through legislation, the statute can be crafted to reflect greater
experience gained with the technology.
CONCLUSION
The purpose of this article has been to analyze the types of
problems law faces as a consequence of technological change
and the means for resolving them. Notions of law struggling to
keep up with technology or society facing a “legal vacuum,”
while graphic, fail to identify the nature of the problem. Worse,
they can lead to the belief that “something” needs to be done,
which can lead to a rush to legislate. In fact, while technology
can pose problems for law, there are mechanisms other than
legislation to deal with these problems. While these may be
insufficient or inadequate in particular circumstances (at least
in the view of some), they should not be ignored.
Often, there may be advantages in adopting a “wait and
see” approach, delaying the enactment of technology-specific
solutions until other mechanisms have had a chance to respond
to the challenges posed. When the advantages of this approach
outweigh the disadvantages, it is not enough to respond that
leaving issues to the courts or a professional body is
undemocratic. A decision by a political body not to legislate is
as democratic as any. While leaving uncertainties to be
resolved by courts and regulation to professional bodies in the
absence of any monitoring or review might meet with
disapproval, the fact that a legislature consciously decides not
to take action, while monitoring other developments, is not
necessarily an undemocratic result. When uncertainties are
satisfactorily resolved by courts or regulatory goals are
achieved by professional guidelines, legislation may not be
necessary. Nevertheless, professional bodies may not step up
to the plate and government encouragement or the threat of
stringent legislation may be necessary to provoke them into
action. It was such a threat that led to the creation of the
Voluntary Licensing Authority in the United Kingdom.617 To
create stronger restrictions on multiple embryo transfer in the
617. See MICHAEL MULKAY, THE EMBRYO RESEARCH DEBATE: SCIENCE AND
THE POLITICS OF REPRODUCTION 57-58 (1997).
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United States than exist at present, one could either regulate
the practice directly or threaten such regulation, hoping to
encourage ASRM and SART to adopt more stringent
restrictions with greater consequences for non-compliance.
Direct regulation will remain as an option if the threat proves
to be ineffective.
In some cases, legislation will be the most effective means
of achieving a desired result. Looking at a more recent
controversy, if one believes that reproductive cloning is
unacceptable under any circumstances, a legislative prohibition
backed by stringent sanctions is the best means of ensuring
that it never takes place. If, however, safety concerns were
resolved and one believed that cloning was in principle
acceptable, professional regulation could be sufficient to ensure
that procedures were carried out responsibly.
Some
uncertainties, such as whether the spouse of the person cloned
has any rights in relation to a frozen cloned embryo upon
divorce, could be left to the courts in the first instance. Others,
such as whether clones have one or two parents, might be best
resolved by legislation, especially if it were felt that lack of
certainty would itself cause harm to a cloned child.
There is no single best response to problems posed by
technological change. The possible responses will depend on
the nature of the problem, and in particular, whether it is the
technology itself, lack of regulation, uncertainty, or
obsolescence, over-inclusiveness, or under-inclusiveness of
existing rules. Legislation will sometimes, but not always, be
the best response. Accordingly, when setting out a proposal for
law reform in light of technological change, it is necessary to
ask not only how the law ought to be changed, but also by
whom and when.

